N	DE	P.DE	FDR
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	62	0	1	1
KEGG_CITRATE_CYCLE_TCA_CYCLE	30	0	1	1
KEGG_PENTOSE_PHOSPHATE_PATHWAY	26	0	1	1
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	27	0	1	1
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	34	0	1	1
KEGG_GALACTOSE_METABOLISM	26	0	1	1
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	25	0	1	1
KEGG_FATTY_ACID_METABOLISM	42	0	1	1
KEGG_STEROID_BIOSYNTHESIS	17	0	1	1
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	16	0	1	1
KEGG_STEROID_HORMONE_BIOSYNTHESIS	55	0	1	1
KEGG_OXIDATIVE_PHOSPHORYLATION	116	0	1	1
KEGG_PURINE_METABOLISM	159	1	0.0443926500291986	1
KEGG_PYRIMIDINE_METABOLISM	98	1	0.0261764451491302	1
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	32	0	1	1
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	31	0	1	1
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	34	0	1	1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	44	0	1	1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	11	0	1	1
KEGG_LYSINE_DEGRADATION	44	0	1	1
KEGG_ARGININE_AND_PROLINE_METABOLISM	54	0	1	1
KEGG_HISTIDINE_METABOLISM	29	0	1	1
KEGG_TYROSINE_METABOLISM	41	0	1	1
KEGG_PHENYLALANINE_METABOLISM	17	0	1	1
KEGG_TRYPTOPHAN_METABOLISM	39	0	1	1
KEGG_BETA_ALANINE_METABOLISM	22	0	1	1
KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM	10	0	1	1
KEGG_SELENOAMINO_ACID_METABOLISM	26	0	1	1
KEGG_GLUTATHIONE_METABOLISM	50	0	1	1
KEGG_STARCH_AND_SUCROSE_METABOLISM	51	0	1	1
KEGG_N_GLYCAN_BIOSYNTHESIS	46	0	1	1
KEGG_OTHER_GLYCAN_DEGRADATION	16	0	1	1
KEGG_O_GLYCAN_BIOSYNTHESIS	30	0	1	1
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	44	0	1	1
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	21	0	1	1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	22	0	1	1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	14	0	1	1
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	26	0	1	1
KEGG_GLYCEROLIPID_METABOLISM	48	0	1	1
KEGG_INOSITOL_PHOSPHATE_METABOLISM	54	0	1	1
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	25	0	1	1
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	76	0	1	1
KEGG_ETHER_LIPID_METABOLISM	33	0	1	1
KEGG_ARACHIDONIC_ACID_METABOLISM	58	0	1	1
KEGG_LINOLEIC_ACID_METABOLISM	29	0	1	1
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	19	0	1	1
KEGG_SPHINGOLIPID_METABOLISM	39	0	1	1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	25	0	1	1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	14	0	1	1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	15	0	1	1
KEGG_PYRUVATE_METABOLISM	40	0	1	1
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	16	0	1	1
KEGG_PROPANOATE_METABOLISM	32	0	1	1
KEGG_BUTANOATE_METABOLISM	34	0	1	1
KEGG_ONE_CARBON_POOL_BY_FOLATE	17	0	1	1
KEGG_RIBOFLAVIN_METABOLISM	16	0	1	1
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	24	0	1	1
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	16	0	1	1
KEGG_FOLATE_BIOSYNTHESIS	11	0	1	1
KEGG_RETINOL_METABOLISM	64	0	1	1
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	41	0	1	1
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	15	0	1	1
KEGG_LIMONENE_AND_PINENE_DEGRADATION	9	0	1	1
KEGG_NITROGEN_METABOLISM	23	0	1	1
KEGG_SULFUR_METABOLISM	13	0	1	1
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	40	0	1	1
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	70	0	1	1
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	72	0	1	1
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	51	0	1	1
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	22	0	1	1
KEGG_ABC_TRANSPORTERS	44	0	1	1
KEGG_RIBOSOME	87	0	1	1
KEGG_RNA_DEGRADATION	56	0	1	1
KEGG_RNA_POLYMERASE	29	0	1	1
KEGG_BASAL_TRANSCRIPTION_FACTORS	34	0	1	1
KEGG_DNA_REPLICATION	36	0	1	1
KEGG_SPLICEOSOME	125	0	1	1
KEGG_PROTEASOME	44	0	1	1
KEGG_PROTEIN_EXPORT	23	0	1	1
KEGG_PPAR_SIGNALING_PATHWAY	69	0	1	1
KEGG_BASE_EXCISION_REPAIR	34	0	1	1
KEGG_NUCLEOTIDE_EXCISION_REPAIR	43	0	1	1
KEGG_MISMATCH_REPAIR	23	0	1	1
KEGG_HOMOLOGOUS_RECOMBINATION	28	0	1	1
KEGG_NON_HOMOLOGOUS_END_JOINING	13	0	1	1
KEGG_MAPK_SIGNALING_PATHWAY	267	0	1	1
KEGG_ERBB_SIGNALING_PATHWAY	87	0	1	1
KEGG_CALCIUM_SIGNALING_PATHWAY	176	0	1	1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	249	0	1	1
KEGG_CHEMOKINE_SIGNALING_PATHWAY	189	0	1	1
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	76	0	1	1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	269	0	1	1
KEGG_CELL_CYCLE	124	0	1	1
KEGG_OOCYTE_MEIOSIS	112	0	1	1
KEGG_P53_SIGNALING_PATHWAY	68	0	1	1
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	133	0	1	1
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	37	0	1	1
KEGG_REGULATION_OF_AUTOPHAGY	26	0	1	1
KEGG_LYSOSOME	121	1	0.0363244201052679	1
KEGG_ENDOCYTOSIS	181	0	1	1
KEGG_PEROXISOME	78	0	1	1
KEGG_MTOR_SIGNALING_PATHWAY	52	0	1	1
KEGG_APOPTOSIS	86	0	1	1
KEGG_CARDIAC_MUSCLE_CONTRACTION	73	0	1	1
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	115	0	1	1
KEGG_WNT_SIGNALING_PATHWAY	150	0	1	1
KEGG_DORSO_VENTRAL_AXIS_FORMATION	24	0	1	1
KEGG_NOTCH_SIGNALING_PATHWAY	47	0	1	1
KEGG_HEDGEHOG_SIGNALING_PATHWAY	56	0	1	1
KEGG_TGF_BETA_SIGNALING_PATHWAY	85	0	1	1
KEGG_AXON_GUIDANCE	129	0	1	1
KEGG_VEGF_SIGNALING_PATHWAY	76	0	1	1
KEGG_FOCAL_ADHESION	199	0	1	1
KEGG_ECM_RECEPTOR_INTERACTION	84	0	1	1
KEGG_CELL_ADHESION_MOLECULES_CAMS	130	0	1	1
KEGG_ADHERENS_JUNCTION	73	0	1	1
KEGG_TIGHT_JUNCTION	132	0	1	1
KEGG_GAP_JUNCTION	89	0	1	1
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	0	1	1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	73	0	1	1
KEGG_RENIN_ANGIOTENSIN_SYSTEM	17	0	1	1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	93	0	1	1
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	62	0	1	1
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	60	0	1	1
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	46	0	1	1
KEGG_JAK_STAT_SIGNALING_PATHWAY	139	0	1	1
KEGG_HEMATOPOIETIC_CELL_LINEAGE	82	0	1	1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	123	0	1	1
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	108	0	1	1
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	75	0	1	1
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	79	0	1	1
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	96	0	1	1
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	115	0	1	1
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	46	0	1	1
KEGG_CIRCADIAN_RHYTHM_MAMMAL	13	0	1	1
KEGG_LONG_TERM_POTENTIATION	70	0	1	1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	126	0	1	1
KEGG_LONG_TERM_DEPRESSION	70	0	1	1
KEGG_OLFACTORY_TRANSDUCTION	375	0	1	1
KEGG_TASTE_TRANSDUCTION	51	0	1	1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	213	0	1	1
KEGG_INSULIN_SIGNALING_PATHWAY	137	0	1	1
KEGG_GNRH_SIGNALING_PATHWAY	101	0	1	1
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	85	0	1	1
KEGG_MELANOGENESIS	101	0	1	1
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	67	0	1	1
KEGG_TYPE_II_DIABETES_MELLITUS	47	0	1	1
KEGG_TYPE_I_DIABETES_MELLITUS	41	0	1	1
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	25	0	1	1
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	42	0	1	1
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	44	0	1	1
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	23	0	1	1
KEGG_ALZHEIMERS_DISEASE	157	0	1	1
KEGG_PARKINSONS_DISEASE	112	0	1	1
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	53	0	1	1
KEGG_HUNTINGTONS_DISEASE	171	0	1	1
KEGG_PRION_DISEASES	35	0	1	1
KEGG_VIBRIO_CHOLERAE_INFECTION	54	0	1	1
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	68	0	1	1
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	55	0	1	1
KEGG_LEISHMANIA_INFECTION	70	0	1	1
KEGG_PATHWAYS_IN_CANCER	324	0	1	1
KEGG_COLORECTAL_CANCER	62	0	1	1
KEGG_RENAL_CELL_CARCINOMA	70	0	1	1
KEGG_PANCREATIC_CANCER	70	0	1	1
KEGG_ENDOMETRIAL_CANCER	52	0	1	1
KEGG_GLIOMA	65	0	1	1
KEGG_PROSTATE_CANCER	89	0	1	1
KEGG_THYROID_CANCER	29	0	1	1
KEGG_BASAL_CELL_CARCINOMA	55	0	1	1
KEGG_MELANOMA	71	0	1	1
KEGG_BLADDER_CANCER	42	0	1	1
KEGG_CHRONIC_MYELOID_LEUKEMIA	73	0	1	1
KEGG_ACUTE_MYELOID_LEUKEMIA	57	0	1	1
KEGG_SMALL_CELL_LUNG_CANCER	84	0	1	1
KEGG_NON_SMALL_CELL_LUNG_CANCER	54	0	1	1
KEGG_ASTHMA	28	0	1	1
KEGG_AUTOIMMUNE_THYROID_DISEASE	42	0	1	1
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	124	0	1	1
KEGG_ALLOGRAFT_REJECTION	35	0	1	1
KEGG_GRAFT_VERSUS_HOST_DISEASE	37	0	1	1
KEGG_PRIMARY_IMMUNODEFICIENCY	35	0	1	1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	83	0	1	1
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	74	0	1	1
KEGG_DILATED_CARDIOMYOPATHY	90	0	1	1
KEGG_VIRAL_MYOCARDITIS	68	0	1	1
BIOCARTA_RELA_PATHWAY	15	0	1	1
BIOCARTA_NO1_PATHWAY	28	0	1	1
BIOCARTA_CSK_PATHWAY	20	0	1	1
BIOCARTA_SRCRPTP_PATHWAY	11	0	1	1
BIOCARTA_AMI_PATHWAY	20	0	1	1
BIOCARTA_GRANULOCYTES_PATHWAY	15	0	1	1
BIOCARTA_LYM_PATHWAY	14	0	1	1
BIOCARTA_ARAP_PATHWAY	17	0	1	1
BIOCARTA_AGR_PATHWAY	33	0	1	1
BIOCARTA_AKAP95_PATHWAY	11	0	1	1
BIOCARTA_AKT_PATHWAY	22	0	1	1
BIOCARTA_ALK_PATHWAY	37	0	1	1
BIOCARTA_AT1R_PATHWAY	27	0	1	1
BIOCARTA_ACE2_PATHWAY	13	0	1	1
BIOCARTA_ASBCELL_PATHWAY	13	0	1	1
BIOCARTA_DNAFRAGMENT_PATHWAY	10	0	1	1
BIOCARTA_CHEMICAL_PATHWAY	18	0	1	1
BIOCARTA_SPPA_PATHWAY	16	0	1	1
BIOCARTA_ATM_PATHWAY	20	0	1	1
BIOCARTA_AGPCR_PATHWAY	11	0	1	1
BIOCARTA_BCELLSURVIVAL_PATHWAY	15	0	1	1
BIOCARTA_BLYMPHOCYTE_PATHWAY	12	0	1	1
BIOCARTA_BCR_PATHWAY	33	0	1	1
BIOCARTA_BIOPEPTIDES_PATHWAY	29	0	1	1
BIOCARTA_RANKL_PATHWAY	13	0	1	1
BIOCARTA_CACAM_PATHWAY	9	0	1	1
BIOCARTA_CDMAC_PATHWAY	16	0	1	1
BIOCARTA_CARM_ER_PATHWAY	25	0	1	1
BIOCARTA_CASPASE_PATHWAY	22	0	1	1
BIOCARTA_CBL_PATHWAY	12	0	1	1
BIOCARTA_CCR3_PATHWAY	19	0	1	1
BIOCARTA_CD40_PATHWAY	15	0	1	1
BIOCARTA_MCM_PATHWAY	18	0	1	1
BIOCARTA_G1_PATHWAY	28	0	1	1
BIOCARTA_G2_PATHWAY	24	0	1	1
BIOCARTA_CELL2CELL_PATHWAY	12	0	1	1
BIOCARTA_LAIR_PATHWAY	17	0	1	1
BIOCARTA_CERAMIDE_PATHWAY	21	0	1	1
BIOCARTA_TID_PATHWAY	19	0	1	1
BIOCARTA_CLASSIC_PATHWAY	14	0	1	1
BIOCARTA_COMP_PATHWAY	19	0	1	1
BIOCARTA_VDR_PATHWAY	24	0	1	1
BIOCARTA_HDAC_PATHWAY	25	0	1	1
BIOCARTA_GCR_PATHWAY	17	0	1	1
BIOCARTA_CTCF_PATHWAY	24	0	1	1
BIOCARTA_CTL_PATHWAY	13	0	1	1
BIOCARTA_CXCR4_PATHWAY	19	0	1	1
BIOCARTA_CELLCYCLE_PATHWAY	23	0	1	1
BIOCARTA_CFTR_PATHWAY	11	0	1	1
BIOCARTA_CYTOKINE_PATHWAY	17	0	1	1
BIOCARTA_INFLAM_PATHWAY	25	0	1	1
BIOCARTA_D4GDI_PATHWAY	12	0	1	1
BIOCARTA_DC_PATHWAY	15	0	1	1
BIOCARTA_P35ALZHEIMERS_PATHWAY	8	0	1	1
BIOCARTA_RNA_PATHWAY	10	0	1	1
BIOCARTA_MTA3_PATHWAY	18	0	1	1
BIOCARTA_SKP2E2F_PATHWAY	10	0	1	1
BIOCARTA_CALCINEURIN_PATHWAY	18	0	1	1
BIOCARTA_EGF_PATHWAY	27	0	1	1
BIOCARTA_ETC_PATHWAY	9	0	1	1
BIOCARTA_NDKDYNAMIN_PATHWAY	17	0	1	1
BIOCARTA_EPHA4_PATHWAY	8	0	1	1
BIOCARTA_EPO_PATHWAY	19	0	1	1
BIOCARTA_ECM_PATHWAY	19	0	1	1
BIOCARTA_ERK_PATHWAY	27	0	1	1
BIOCARTA_ERYTH_PATHWAY	15	0	1	1
BIOCARTA_EPONFKB_PATHWAY	11	0	1	1
BIOCARTA_EIF_PATHWAY	16	0	1	1
BIOCARTA_EXTRINSIC_PATHWAY	13	0	1	1
BIOCARTA_FAS_PATHWAY	30	0	1	1
BIOCARTA_FCER1_PATHWAY	39	0	1	1
BIOCARTA_FIBRINOLYSIS_PATHWAY	12	0	1	1
BIOCARTA_FMLP_PATHWAY	34	0	1	1
BIOCARTA_FREE_PATHWAY	10	0	1	1
BIOCARTA_GABA_PATHWAY	10	0	1	1
BIOCARTA_GATA3_PATHWAY	14	0	1	1
BIOCARTA_SET_PATHWAY	10	0	1	1
BIOCARTA_GH_PATHWAY	27	0	1	1
BIOCARTA_AHSP_PATHWAY	12	0	1	1
BIOCARTA_TCAPOPTOSIS_PATHWAY	9	0	1	1
BIOCARTA_HIVNEF_PATHWAY	56	0	1	1
BIOCARTA_SALMONELLA_PATHWAY	5	0	1	1
BIOCARTA_MPR_PATHWAY	21	0	1	1
BIOCARTA_HCMV_PATHWAY	17	0	1	1
BIOCARTA_P53HYPOXIA_PATHWAY	21	0	1	1
BIOCARTA_HIF_PATHWAY	15	0	1	1
BIOCARTA_IGF1_PATHWAY	21	0	1	1
BIOCARTA_IL17_PATHWAY	15	0	1	1
BIOCARTA_IL2_PATHWAY	22	0	1	1
BIOCARTA_IL3_PATHWAY	14	0	1	1
BIOCARTA_IL4_PATHWAY	11	0	1	1
BIOCARTA_IL5_PATHWAY	11	0	1	1
BIOCARTA_IL6_PATHWAY	21	0	1	1
BIOCARTA_IL10_PATHWAY	13	0	1	1
BIOCARTA_IL12_PATHWAY	20	0	1	1
BIOCARTA_IL2RB_PATHWAY	37	0	1	1
BIOCARTA_IL22BP_PATHWAY	9	0	1	1
BIOCARTA_IL7_PATHWAY	16	0	1	1
BIOCARTA_GSK3_PATHWAY	20	0	1	1
BIOCARTA_DEATH_PATHWAY	29	0	1	1
BIOCARTA_RACCYCD_PATHWAY	26	0	1	1
BIOCARTA_GLEEVEC_PATHWAY	23	0	1	1
BIOCARTA_INSULIN_PATHWAY	21	0	1	1
BIOCARTA_INTEGRIN_PATHWAY	34	0	1	1
BIOCARTA_INTRINSIC_PATHWAY	23	0	1	1
BIOCARTA_KERATINOCYTE_PATHWAY	46	0	1	1
BIOCARTA_TCRA_PATHWAY	12	0	1	1
BIOCARTA_LECTIN_PATHWAY	12	0	1	1
BIOCARTA_PYK2_PATHWAY	27	0	1	1
BIOCARTA_EGFR_SMRTE_PATHWAY	11	0	1	1
BIOCARTA_MAPK_PATHWAY	81	0	1	1
BIOCARTA_MCALPAIN_PATHWAY	19	0	1	1
BIOCARTA_PPARA_PATHWAY	52	0	1	1
BIOCARTA_ETS_PATHWAY	17	0	1	1
BIOCARTA_MONOCYTE_PATHWAY	11	0	1	1
BIOCARTA_MTOR_PATHWAY	22	0	1	1
BIOCARTA_IGF1R_PATHWAY	23	0	1	1
BIOCARTA_PITX2_PATHWAY	16	0	1	1
BIOCARTA_NGF_PATHWAY	20	0	1	1
BIOCARTA_VIP_PATHWAY	26	0	1	1
BIOCARTA_NFAT_PATHWAY	51	0	1	1
BIOCARTA_NTHI_PATHWAY	23	0	1	1
BIOCARTA_NFKB_PATHWAY	21	0	1	1
BIOCARTA_NOS1_PATHWAY	21	0	1	1
BIOCARTA_NO2IL12_PATHWAY	16	0	1	1
BIOCARTA_RARRXR_PATHWAY	7	0	1	1
BIOCARTA_NUCLEARRS_PATHWAY	34	0	1	1
BIOCARTA_ARENRF2_PATHWAY	20	0	1	1
BIOCARTA_P38MAPK_PATHWAY	36	0	1	1
BIOCARTA_P53_PATHWAY	16	0	1	1
BIOCARTA_PDGF_PATHWAY	28	0	1	1
BIOCARTA_CCR5_PATHWAY	17	0	1	1
BIOCARTA_PTDINS_PATHWAY	23	0	1	1
BIOCARTA_PLCE_PATHWAY	11	0	1	1
BIOCARTA_EDG1_PATHWAY	22	0	1	1
BIOCARTA_CDK5_PATHWAY	13	0	1	1
BIOCARTA_MYOSIN_PATHWAY	11	0	1	1
BIOCARTA_PLATELETAPP_PATHWAY	14	0	1	1
BIOCARTA_PS1_PATHWAY	14	0	1	1
BIOCARTA_AKAPCENTROSOME_PATHWAY	14	0	1	1
BIOCARTA_PTEN_PATHWAY	18	0	1	1
BIOCARTA_RAB_PATHWAY	13	0	1	1
BIOCARTA_RAC1_PATHWAY	21	0	1	1
BIOCARTA_RAS_PATHWAY	22	0	1	1
BIOCARTA_NKCELLS_PATHWAY	20	0	1	1
BIOCARTA_RB_PATHWAY	13	0	1	1
BIOCARTA_BAD_PATHWAY	24	0	1	1
BIOCARTA_CK1_PATHWAY	16	0	1	1
BIOCARTA_EIF2_PATHWAY	11	0	1	1
BIOCARTA_EIF4_PATHWAY	24	0	1	1
BIOCARTA_STEM_PATHWAY	15	0	1	1
BIOCARTA_P27_PATHWAY	13	0	1	1
BIOCARTA_PGC1A_PATHWAY	15	0	1	1
BIOCARTA_PML_PATHWAY	17	0	1	1
BIOCARTA_DREAM_PATHWAY	13	0	1	1
BIOCARTA_LEPTIN_PATHWAY	11	0	1	1
BIOCARTA_RHO_PATHWAY	21	0	1	1
BIOCARTA_AKAP13_PATHWAY	11	0	1	1
BIOCARTA_ATRBRCA_PATHWAY	22	0	1	1
BIOCARTA_CARDIACEGF_PATHWAY	18	0	1	1
BIOCARTA_HER2_PATHWAY	23	0	1	1
BIOCARTA_ERK5_PATHWAY	14	0	1	1
BIOCARTA_MAL_PATHWAY	19	0	1	1
BIOCARTA_MEF2D_PATHWAY	18	0	1	1
BIOCARTA_MITOCHONDRIA_PATHWAY	19	0	1	1
BIOCARTA_ACH_PATHWAY	14	0	1	1
BIOCARTA_PARKIN_PATHWAY	8	0	1	1
BIOCARTA_CDC42RAC_PATHWAY	8	0	1	1
BIOCARTA_RANMS_PATHWAY	10	0	1	1
BIOCARTA_BARR_MAPK_PATHWAY	14	0	1	1
BIOCARTA_TOB1_PATHWAY	19	0	1	1
BIOCARTA_BARRESTIN_SRC_PATHWAY	17	0	1	1
BIOCARTA_NKT_PATHWAY	26	0	1	1
BIOCARTA_IL1R_PATHWAY	29	0	1	1
BIOCARTA_MET_PATHWAY	33	0	1	1
BIOCARTA_GPCR_PATHWAY	30	0	1	1
BIOCARTA_IGF1MTOR_PATHWAY	19	0	1	1
BIOCARTA_SODD_PATHWAY	10	0	1	1
BIOCARTA_SHH_PATHWAY	16	0	1	1
BIOCARTA_PTC1_PATHWAY	11	0	1	1
BIOCARTA_SPRY_PATHWAY	16	0	1	1
BIOCARTA_BARRESTIN_PATHWAY	12	0	1	1
BIOCARTA_STATHMIN_PATHWAY	20	0	1	1
BIOCARTA_HSP27_PATHWAY	14	0	1	1
BIOCARTA_TCR_PATHWAY	44	0	1	1
BIOCARTA_TCYTOTOXIC_PATHWAY	12	0	1	1
BIOCARTA_THELPER_PATHWAY	12	0	1	1
BIOCARTA_TALL1_PATHWAY	15	0	1	1
BIOCARTA_TEL_PATHWAY	17	0	1	1
BIOCARTA_TGFB_PATHWAY	19	0	1	1
BIOCARTA_TH1TH2_PATHWAY	21	0	1	1
BIOCARTA_41BB_PATHWAY	18	0	1	1
BIOCARTA_CTLA4_PATHWAY	20	0	1	1
BIOCARTA_LONGEVITY_PATHWAY	15	0	1	1
BIOCARTA_SARS_PATHWAY	7	0	1	1
BIOCARTA_PAR1_PATHWAY	19	0	1	1
BIOCARTA_STRESS_PATHWAY	24	0	1	1
BIOCARTA_TNFR1_PATHWAY	29	0	1	1
BIOCARTA_TNFR2_PATHWAY	17	0	1	1
BIOCARTA_TOLL_PATHWAY	25	0	1	1
BIOCARTA_TPO_PATHWAY	24	0	1	1
BIOCARTA_CREB_PATHWAY	22	0	1	1
BIOCARTA_CARM1_PATHWAY	12	0	1	1
BIOCARTA_TFF_PATHWAY	24	0	1	1
BIOCARTA_TRKA_PATHWAY	14	0	1	1
BIOCARTA_ARF_PATHWAY	17	0	1	1
BIOCARTA_UCALPAIN_PATHWAY	14	0	1	1
BIOCARTA_VEGF_PATHWAY	27	0	1	1
BIOCARTA_VITCB_PATHWAY	11	0	1	1
BIOCARTA_WNT_PATHWAY	24	0	1	1
BIOCARTA_ACTINY_PATHWAY	12	0	1	1
SA_B_CELL_RECEPTOR_COMPLEXES	24	0	1	1
SIG_CD40PATHWAYMAP	34	0	1	1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	67	0	1	1
SA_CASPASE_CASCADE	19	0	1	1
SIG_CHEMOTAXIS	45	0	1	1
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	27	0	1	1
WNT_SIGNALING	89	0	1	1
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	35	0	1	1
SA_FAS_SIGNALING	8	0	1	1
SA_G1_AND_S_PHASES	15	0	1	1
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	51	0	1	1
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	36	0	1	1
SIG_BCR_SIGNALING_PATHWAY	46	0	1	1
SA_G2_AND_M_PHASES	8	0	1	1
SA_MMP_CYTOKINE_CONNECTION	15	0	1	1
SA_PROGRAMMED_CELL_DEATH	12	0	1	1
SA_PTEN_PATHWAY	17	0	1	1
SA_REG_CASCADE_OF_CYCLIN_EXPR	13	0	1	1
SA_TRKA_RECEPTOR	17	0	1	1
PID_FANCONI_PATHWAY	47	0	1	1
PID_SMAD2_3NUCLEAR_PATHWAY	80	0	1	1
PID_FCER1_PATHWAY	59	0	1	1
PID_ENDOTHELIN_PATHWAY	63	0	1	1
PID_BCR_5PATHWAY	63	0	1	1
PID_PRL_SIGNALING_EVENTS_PATHWAY	23	0	1	1
PID_RHOA_PATHWAY	45	0	1	1
PID_ERBB4_PATHWAY	38	0	1	1
PID_AURORA_B_PATHWAY	39	0	1	1
PID_LYSOPHOSPHOLIPID_PATHWAY	65	0	1	1
PID_INSULIN_PATHWAY	44	0	1	1
PID_NOTCH_PATHWAY	59	0	1	1
PID_INTEGRIN1_PATHWAY	66	0	1	1
PID_P73PATHWAY	79	0	1	1
PID_P38_MKK3_6PATHWAY	26	0	1	1
PID_GMCSF_PATHWAY	35	0	1	1
PID_WNT_NONCANONICAL_PATHWAY	32	0	1	1
PID_NFKAPPAB_ATYPICAL_PATHWAY	17	0	1	1
PID_IL4_2PATHWAY	61	0	1	1
PID_HDAC_CLASSII_PATHWAY	34	0	1	1
PID_BETA_CATENIN_DEG_PATHWAY	18	0	1	1
PID_HDAC_CLASSIII_PATHWAY	26	0	1	1
PID_GLYPICAN_1PATHWAY	27	0	1	1
PID_TCR_PATHWAY	65	0	1	1
PID_IL27_PATHWAY	26	0	1	1
PID_NFKAPPAB_CANONICAL_PATHWAY	23	0	1	1
PID_E2F_PATHWAY	73	0	1	1
PID_ER_NONGENOMIC_PATHWAY	40	0	1	1
PID_DNA_PK_PATHWAY	16	0	1	1
PID_HIF2PATHWAY	34	0	1	1
PID_CD40_PATHWAY	31	0	1	1
PID_ATR_PATHWAY	39	0	1	1
PID_INTEGRIN_CS_PATHWAY	26	0	1	1
PID_MET_PATHWAY	79	0	1	1
PID_PTP1B_PATHWAY	52	0	1	1
PID_INTEGRIN3_PATHWAY	43	0	1	1
PID_IL12_2PATHWAY	63	0	1	1
PID_S1P_S1P3_PATHWAY	29	0	1	1
PID_LPA4_PATHWAY	15	0	1	1
PID_AR_PATHWAY	61	0	1	1
PID_NFAT_TFPATHWAY	45	0	1	1
PID_EPHB_FWD_PATHWAY	40	0	1	1
PID_AVB3_OPN_PATHWAY	31	0	1	1
PID_S1P_S1P4_PATHWAY	14	0	1	1
PID_FRA_PATHWAY	37	0	1	1
PID_MYC_ACTIV_PATHWAY	79	0	1	1
PID_ARF6_TRAFFICKING_PATHWAY	49	0	1	1
PID_RHOA_REG_PATHWAY	46	0	1	1
PID_REELIN_PATHWAY	28	0	1	1
PID_PS1_PATHWAY	46	0	1	1
PID_ILK_PATHWAY	45	0	1	1
PID_NECTIN_PATHWAY	30	0	1	1
PID_P38_ALPHA_BETA_PATHWAY	30	0	1	1
PID_WNT_SIGNALING_PATHWAY	28	0	1	1
PID_TRAIL_PATHWAY	28	0	1	1
PID_CDC42_PATHWAY	70	0	1	1
PID_RET_PATHWAY	39	0	1	1
PID_CDC42_REG_PATHWAY	30	0	1	1
PID_ATM_PATHWAY	34	0	1	1
PID_ARF6_PATHWAY	35	0	1	1
PID_LKB1_PATHWAY	47	0	1	1
PID_CD8_TCR_PATHWAY	53	0	1	1
PID_WNT_CANONICAL_PATHWAY	20	0	1	1
PID_TCPTP_PATHWAY	42	0	1	1
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	49	0	1	1
PID_FAS_PATHWAY	38	0	1	1
PID_CIRCADIAN_PATHWAY	16	0	1	1
PID_TXA2PATHWAY	56	0	1	1
PID_SHP2_PATHWAY	57	0	1	1
PID_HDAC_CLASSI_PATHWAY	66	0	1	1
PID_S1P_S1P1_PATHWAY	21	0	1	1
PID_TELOMERASE_PATHWAY	67	0	1	1
PID_HNF3B_PATHWAY	45	0	1	1
PID_NETRIN_PATHWAY	32	0	1	1
PID_IL1_PATHWAY	34	0	1	1
PID_NFAT_3PATHWAY	53	0	1	1
PID_REG_GR_PATHWAY	82	0	1	1
PID_CONE_PATHWAY	23	0	1	1
PID_INTEGRIN_A9B1_PATHWAY	24	0	1	1
PID_ERB_GENOMIC_PATHWAY	15	0	1	1
PID_ARF6_DOWNSTREAM_PATHWAY	15	0	1	1
PID_MTOR_4PATHWAY	69	0	1	1
PID_IL2_1PATHWAY	55	0	1	1
PID_CXCR4_PATHWAY	101	0	1	1
PID_IGF1_PATHWAY	29	0	1	1
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	35	0	1	1
PID_TNF_PATHWAY	46	0	1	1
PID_PLK1_PATHWAY	46	0	1	1
PID_TCR_RAS_PATHWAY	14	0	1	1
PID_IL5_PATHWAY	14	0	1	1
PID_FOXO_PATHWAY	49	0	1	1
PID_VEGF_VEGFR_PATHWAY	10	0	1	1
PID_THROMBIN_PAR4_PATHWAY	15	0	1	1
PID_MYC_PATHWAY	25	0	1	1
PID_RANBP2_PATHWAY	11	0	1	1
PID_PI3KCI_PATHWAY	48	0	1	1
PID_AJDISS_2PATHWAY	48	0	1	1
PID_IL2_PI3K_PATHWAY	34	0	1	1
PID_CERAMIDE_PATHWAY	44	0	1	1
PID_P53_DOWNSTREAM_PATHWAY	137	0	1	1
PID_AR_TF_PATHWAY	53	0	1	1
PID_P75_NTR_PATHWAY	68	0	1	1
PID_S1P_META_PATHWAY	21	0	1	1
PID_ECADHERIN_NASCENT_AJ_PATHWAY	39	0	1	1
PID_INTEGRIN4_PATHWAY	11	0	1	1
PID_AMB2_NEUTROPHILS_PATHWAY	41	0	1	1
PID_AVB3_INTEGRIN_PATHWAY	74	0	1	1
PID_IFNG_PATHWAY	40	0	1	1
PID_RXR_VDR_PATHWAY	26	0	1	1
PID_LIS1_PATHWAY	28	0	1	1
PID_ERBB1_DOWNSTREAM_PATHWAY	105	0	1	1
PID_SYNDECAN_4_PATHWAY	32	0	1	1
PID_ATF2_PATHWAY	59	0	1	1
PID_AP1_PATHWAY	70	0	1	1
PID_INTEGRIN2_PATHWAY	29	0	1	1
PID_UPA_UPAR_PATHWAY	42	0	1	1
PID_ERBB2_ERBB3_PATHWAY	44	0	1	1
PID_FOXM1_PATHWAY	40	0	1	1
PID_EPHA_FWDPATHWAY	34	0	1	1
PID_HIF1A_PATHWAY	19	0	1	1
PID_BMP_PATHWAY	42	0	1	1
PID_IL3_PATHWAY	25	0	1	1
PID_IL6_7_PATHWAY	47	0	1	1
PID_ECADHERIN_KERATINOCYTE_PATHWAY	21	0	1	1
PID_ALK1_PATHWAY	26	0	1	1
PID_PDGFRB_PATHWAY	129	0	1	1
PID_TRKR_PATHWAY	61	0	1	1
PID_TCR_JNK_PATHWAY	14	0	1	1
PID_NEPHRIN_NEPH1_PATHWAY	31	0	1	1
PID_CMYB_PATHWAY	84	0	1	1
PID_IL23_PATHWAY	37	0	1	1
PID_HIV_NEF_PATHWAY	35	0	1	1
PID_SYNDECAN_1_PATHWAY	46	0	1	1
PID_P38_MK2_PATHWAY	21	0	1	1
PID_ERA_GENOMIC_PATHWAY	64	0	1	1
PID_ERBB_NETWORK_PATHWAY	15	0	1	1
PID_ALK2_PATHWAY	11	0	1	1
PID_RHODOPSIN_PATHWAY	23	0	1	1
PID_PDGFRA_PATHWAY	22	0	1	1
PID_RETINOIC_ACID_PATHWAY	30	0	1	1
PID_P38_GAMMA_DELTA_PATHWAY	11	0	1	1
PID_IL8_CXCR2_PATHWAY	34	0	1	1
PID_HEDGEHOG_2PATHWAY	22	0	1	1
PID_INTEGRIN5_PATHWAY	17	0	1	1
PID_AR_NONGENOMIC_PATHWAY	31	0	1	1
PID_ERBB1_INTERNALIZATION_PATHWAY	41	0	1	1
PID_HEDGEHOG_GLI_PATHWAY	48	0	1	1
PID_CASPASE_PATHWAY	51	0	1	1
PID_CXCR3_PATHWAY	43	0	1	1
PID_BETA_CATENIN_NUC_PATHWAY	79	0	0.999999999999999	1
PID_VEGFR1_PATHWAY	26	0	1	1
PID_SMAD2_3PATHWAY	16	0	1	1
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	38	0	1	1
PID_KIT_PATHWAY	52	0	1	1
PID_ECADHERIN_STABILIZATION_PATHWAY	41	0	1	1
PID_EPO_PATHWAY	33	0	1	1
PID_IL2_STAT5_PATHWAY	30	0	1	1
PID_TCR_CALCIUM_PATHWAY	28	0	1	1
PID_DELTA_NP63_PATHWAY	47	0	1	1
PID_VEGFR1_2_PATHWAY	69	0	1	1
PID_THROMBIN_PAR1_PATHWAY	43	0	1	1
PID_A6B1_A6B4_INTEGRIN_PATHWAY	46	0	1	1
PID_SYNDECAN_2_PATHWAY	33	0	1	1
PID_RAC1_REG_PATHWAY	38	0	1	1
PID_AURORA_A_PATHWAY	31	0	1	1
PID_ARF_3PATHWAY	19	0	1	1
PID_INSULIN_GLUCOSE_PATHWAY	26	0	1	1
PID_PI3KCI_AKT_PATHWAY	35	0	1	1
PID_SYNDECAN_3_PATHWAY	17	0	1	1
PID_IL8_CXCR1_PATHWAY	28	0	1	1
PID_MYC_REPRESS_PATHWAY	62	0	1	1
PID_HIF1_TFPATHWAY	66	0	1	1
PID_TAP63_PATHWAY	54	0	1	1
PID_EPHRINB_REV_PATHWAY	30	0	1	1
PID_BARD1_PATHWAY	29	0	1	1
PID_P53_REGULATION_PATHWAY	59	0	1	1
PID_TOLL_ENDOGENOUS_PATHWAY	24	0	1	1
PID_NCADHERIN_PATHWAY	33	0	1	1
PID_ANTHRAX_PATHWAY	18	0	1	1
PID_S1P_S1P2_PATHWAY	24	0	1	1
PID_RAS_PATHWAY	30	0	1	1
PID_MAPK_TRK_PATHWAY	34	0	1	1
PID_PI3K_PLC_TRK_PATHWAY	36	0	1	1
PID_CD8_TCR_DOWNSTREAM_PATHWAY	57	0	1	1
PID_EPHA2_FWD_PATHWAY	19	0	1	1
PID_LYMPH_ANGIOGENESIS_PATHWAY	25	0	1	1
PID_ALPHA_SYNUCLEIN_PATHWAY	32	0	1	1
PID_FGF_PATHWAY	55	0	1	1
PID_INTEGRIN_A4B1_PATHWAY	33	0	1	1
PID_RAC1_PATHWAY	54	0	1	1
PID_RB_1PATHWAY	64	0	1	1
PID_FAK_PATHWAY	59	0	1	1
PID_HNF3A_PATHWAY	44	0	1	1
PID_TGFBR_PATHWAY	54	0	1	1
PID_HES_HEY_PATHWAY	48	0	1	1
PID_IL12_STAT4_PATHWAY	33	0	1	1
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	15	0	1	1
REACTOME_TRANSLATION	292	0	1	1
REACTOME_PYRIMIDINE_CATABOLISM	12	0	1	1
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	20	0	1	1
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	55	0	1	1
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	38	0	1	1
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	33	0	1	1
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS	19	0	1	1
REACTOME_GAP_JUNCTION_DEGRADATION	12	0	1	1
REACTOME_BASE_EXCISION_REPAIR	83	0	1	1
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	43	0	1	1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	24	0	1	1
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	16	0	1	1
REACTOME_SIGNALING_BY_RHO_GTPASES	436	0	1	1
REACTOME_SIGNALING_BY_WNT	321	0	1	1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL	14	0	1	1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	34	0	1	1
REACTOME_ANDROGEN_BIOSYNTHESIS	11	0	1	1
REACTOME_INSULIN_RECEPTOR_RECYCLING	26	0	1	1
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	10	0	1	1
REACTOME_SIGNALING_BY_SCF_KIT	43	0	1	1
REACTOME_DEVELOPMENTAL_BIOLOGY	1107	0	1	1
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	50	0	1	1
REACTOME_SIGNALING_BY_NODAL	20	0	1	1
REACTOME_DAG_AND_IP3_SIGNALING	41	0	1	1
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	16	0	1	1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	99	0	1	1
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	24	0	1	1
REACTOME_CELL_CELL_COMMUNICATION	130	0	1	1
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	11	0	1	1
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	10	0	1	1
REACTOME_MEIOSIS	109	0	1	1
REACTOME_G0_AND_EARLY_G1	27	0	1	1
REACTOME_REGULATION_OF_KIT_SIGNALING	16	0	1	1
REACTOME_MEMBRANE_TRAFFICKING	625	0	1	1
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	21	0	1	1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	128	0	1	1
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	17	0	1	1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	189	0	1	1
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	71	0	1	1
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	25	0	1	1
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS	10	0	1	1
REACTOME_CELL_CYCLE	659	0	1	1
REACTOME_SIGNALING_BY_ERBB4	58	0	1	1
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	71	0	1	1
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	60	0	1	1
REACTOME_SULFUR_AMINO_ACID_METABOLISM	27	0	1	1
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	13	0	1	1
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	81	0	1	1
REACTOME_PROLACTIN_RECEPTOR_SIGNALING	15	0	1	1
REACTOME_SIGNALING_BY_ERBB2	49	0	1	1
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	43	0	1	1
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	21	0	1	1
REACTOME_DEFENSINS	46	0	1	1
REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS	19	0	1	1
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	16	0	1	1
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	25	0	1	1
REACTOME_BETA_DEFENSINS	37	0	1	1
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	113	0	1	1
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	10	0	1	1
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	14	0	1	1
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	16	0	1	1
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	32	0	1	1
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	45	0	1	1
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	139	0	1	1
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	63	0	1	1
REACTOME_SIGNALING_BY_HIPPO	20	0	1	1
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	31	0	1	1
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	13	0	1	1
REACTOME_SIGNALING_BY_NOTCH4	82	0	1	1
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	81	0	1	1
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	15	0	1	1
REACTOME_SIGNALING_BY_NOTCH2	33	0	1	1
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	110	0	1	1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	110	0	1	1
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	300	0	1	1
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	48	0	1	1
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	18	0	1	1
REACTOME_SIGNALING_BY_NOTCH1	74	0	1	1
REACTOME_SIGNALING_BY_NOTCH3	49	0	1	1
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	14	0	1	1
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	54	0	1	1
REACTOME_ARMS_MEDIATED_ACTIVATION	7	0	1	1
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	14	0	1	1
REACTOME_SIGNALLING_TO_RAS	20	0	1	1
REACTOME_SIGNALING_BY_BMP	28	0	1	1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	135	0	1	1
REACTOME_SIGNALLING_TO_ERKS	34	0	1	1
REACTOME_P38MAPK_EVENTS	13	0	1	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	17	0	1	1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	16	0	1	1
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	26	0	1	1
REACTOME_COLLAGEN_FORMATION	90	0	1	1
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	32	0	1	1
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	63	0	1	1
REACTOME_HS_GAG_DEGRADATION	22	0	1	1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE	16	0	1	1
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	5	0	1	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	27	0	1	1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	18	0	1	1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	32	0	1	1
REACTOME_PHOSPHOLIPID_METABOLISM	209	0	1	1
REACTOME_CS_DS_DEGRADATION	14	0	1	1
REACTOME_SYNTHESIS_OF_PA	38	0	1	1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE	11	0	1	1
REACTOME_SYNTHESIS_OF_PE	13	0	1	1
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	18	0	1	1
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	20	0	1	1
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION	12	0	1	1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	53	0	1	1
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES	13	0	1	1
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	44	0	1	1
REACTOME_HYALURONAN_METABOLISM	17	0	1	1
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	23	0	1	1
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	27	0	1	1
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	12	0	1	1
REACTOME_PI_METABOLISM	84	0	1	1
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM	10	0	1	1
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	50	0	1	1
REACTOME_SYNTHESIS_OF_PC	28	0	1	1
REACTOME_HS_GAG_BIOSYNTHESIS	31	0	1	1
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	33	0	1	1
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	13	0	1	1
REACTOME_KERATAN_SULFATE_DEGRADATION	13	0	1	1
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	55	0	1	1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	123	0	1	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	18	0	1	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	29	0	1	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	22	0	1	1
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	122	1	0.038006873747217	1
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	126	0	1	1
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	26	0	1	1
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	15	0	1	1
REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	8	0	1	1
REACTOME_MICRORNA_MIRNA_BIOGENESIS	25	0	1	1
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	61	0	1	1
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	14	0	1	1
REACTOME_ERKS_ARE_INACTIVATED	13	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	110	0	1	1
REACTOME_PI3K_AKT_ACTIVATION	9	0	1	1
REACTOME_EGFR_DOWNREGULATION	31	0	1	1
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	241	0	1	1
REACTOME_PECAM1_INTERACTIONS	12	0	1	1
REACTOME_TCR_SIGNALING	117	0	1	1
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX	16	0	1	1
REACTOME_BASIGIN_INTERACTIONS	25	0	1	1
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	14	0	1	1
REACTOME_GAB1_SIGNALOSOME	17	0	1	1
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	14	0	1	1
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	60	0	1	1
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	24	0	1	1
REACTOME_ERK_MAPK_TARGETS	22	0	1	1
REACTOME_TIE2_SIGNALING	18	0	1	1
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	32	0	1	1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	131	0	1	1
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	84	0	1	1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	371	0	1	1
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	36	0	1	1
REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION	9	0	1	1
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	13	0	1	1
REACTOME_BIOLOGICAL_OXIDATIONS	220	0	1	1
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	11	0	1	1
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	267	0	1	1
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	12	0	1	1
REACTOME_XENOBIOTICS	24	0	1	1
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	85	0	1	1
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	65	0	1	1
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS	11	0	1	1
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	55	0	1	1
REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS	11	0	1	1
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	16	0	1	1
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	1348	0	1	1
REACTOME_NEURONAL_SYSTEM	408	0	1	1
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	42	0	1	1
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	72	0	1	1
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	51	0	1	1
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	93	0	1	1
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	33	0	1	1
REACTOME_ENDOGENOUS_STEROLS	27	0	1	1
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	21	0	1	1
REACTOME_GLYCOLYSIS	72	0	1	1
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	15	0	1	1
REACTOME_MRNA_CAPPING	28	0	1	1
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION	37	0	1	1
REACTOME_SIGNALING_BY_GPCR	1142	0	1	1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	197	0	1	1
REACTOME_METABOLISM_OF_POLYAMINES	59	0	1	1
REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	28	0	1	1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	108	0	1	1
REACTOME_CELL_CYCLE_MITOTIC	546	0	1	1
REACTOME_GLUCONEOGENESIS	34	0	1	1
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	23	0	1	1
REACTOME_OPIOID_SIGNALLING	90	0	1	1
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	80	0	1	1
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	20	0	1	1
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	23	0	1	1
REACTOME_CA_DEPENDENT_EVENTS	37	0	1	1
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	17	0	1	1
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	10	0	1	1
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	14	0	1	1
REACTOME_DARPP_32_EVENTS	24	0	1	1
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	57	0	1	1
REACTOME_CELL_CYCLE_CHECKPOINTS	283	0	1	1
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	15	0	1	1
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	18	0	1	1
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	14	0	1	1
REACTOME_G_PROTEIN_ACTIVATION	28	0	1	1
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	14	0	1	1
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	103	0	1	1
REACTOME_TRNA_AMINOACYLATION	41	0	1	1
REACTOME_OLFACTORY_SIGNALING_PATHWAY	363	0	1	1
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	20	0	1	1
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	93	0	1	1
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	53	0	1	1
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	33	0	1	1
REACTOME_SIGNALING_BY_PDGF	58	0	1	1
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	39	0	1	1
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS	12	0	1	1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	35	0	1	1
REACTOME_PROTEIN_FOLDING	101	0	1	1
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	25	0	1	1
REACTOME_PEROXISOMAL_LIPID_METABOLISM	29	0	1	1
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	22	0	1	1
REACTOME_STRIATED_MUSCLE_CONTRACTION	36	0	1	1
REACTOME_METABOLISM_OF_NUCLEOTIDES	98	1	0.0274049557437397	1
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	42	0	1	1
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	29	0	1	1
REACTOME_MUSCLE_CONTRACTION	205	0	1	1
REACTOME_SEROTONIN_RECEPTORS	12	0	1	1
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX	11	0	1	1
REACTOME_MRNA_SPLICING	187	0	1	1
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	52	0	1	1
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	28	0	1	1
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS	12	0	1	1
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	22	0	1	1
REACTOME_POLYMERASE_SWITCHING	14	0	1	1
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	109	0	1	1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	216	0	1	1
REACTOME_P2Y_RECEPTORS	12	0	1	1
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	31	0	1	1
REACTOME_NCAM1_INTERACTIONS	42	0	1	1
REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	39	0	1	1
REACTOME_REGULATION_OF_INSULIN_SECRETION	78	0	1	1
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	63	0	1	1
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	16	0	1	1
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS	15	0	1	1
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	94	0	1	1
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	33	0	1	1
REACTOME_FANCONI_ANEMIA_PATHWAY	38	0	1	1
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	17	0	1	1
REACTOME_PROSTANOID_LIGAND_RECEPTORS	9	0	1	1
REACTOME_OPSINS	9	0	1	1
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX	59	0	1	1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	249	0	1	1
REACTOME_CD28_CO_STIMULATION	33	0	1	1
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	19	0	1	1
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	33	0	1	1
REACTOME_CRMPS_IN_SEMA3A_SIGNALING	16	0	1	1
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	19	0	1	1
REACTOME_PURINE_SALVAGE	13	0	1	1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	403	0	1	1
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	16	0	1	1
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY	12	0	1	1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	24	0	1	1
REACTOME_SEMAPHORIN_INTERACTIONS	64	0	1	1
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	20	0	1	1
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	14	0	1	1
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	34	0	1	1
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	25	0	1	1
REACTOME_SPHINGOLIPID_METABOLISM	88	0	1	1
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	505	0	1	1
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	65	0	1	1
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	48	0	1	1
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	66	0	1	1
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	22	0	1	1
REACTOME_TIGHT_JUNCTION_INTERACTIONS	30	0	1	1
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	32	0	1	1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	106	0	1	1
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	55	0	1	1
REACTOME_CTLA4_INHIBITORY_SIGNALING	21	0	1	1
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	21	0	1	1
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	39	0	1	1
REACTOME_DEADENYLATION_OF_MRNA	25	0	1	1
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE	15	0	1	1
REACTOME_SIGNAL_AMPLIFICATION	33	0	1	1
REACTOME_ZINC_TRANSPORTERS	17	0	1	1
REACTOME_METAL_ION_SLC_TRANSPORTERS	26	0	1	1
REACTOME_SMOOTH_MUSCLE_CONTRACTION	38	0	1	1
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	16	0	1	1
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	56	0	1	1
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	24	0	1	1
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS	18	0	1	1
REACTOME_CELL_JUNCTION_ORGANIZATION	92	0	1	1
REACTOME_PYRUVATE_METABOLISM	31	0	1	1
REACTOME_PURINE_CATABOLISM	18	0	1	1
REACTOME_METABOLISM_OF_RNA	668	0	1	1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	148	0	1	1
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	32	0	1	1
REACTOME_MYOGENESIS	29	0	1	1
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	30	0	1	1
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS	10	0	1	1
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	31	0	1	1
REACTOME_GPCR_LIGAND_BINDING	462	0	1	1
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	22	0	1	1
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	32	0	1	1
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	29	0	1	1
REACTOME_MITOTIC_G2_G2_M_PHASES	197	0	1	1
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	23	0	1	1
REACTOME_DNA_REPAIR	321	0	1	1
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	27	0	1	1
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	1389	0	1	1
REACTOME_CHROMOSOME_MAINTENANCE	108	0	1	1
REACTOME_L1CAM_INTERACTIONS	119	0	1	1
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	31	0	1	1
REACTOME_SIGNAL_TRANSDUCTION_BY_L1	21	0	1	1
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	43	0	1	1
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	11	0	1	1
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT	15	0	1	1
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING	14	0	1	1
REACTOME_RECYCLING_PATHWAY_OF_L1	47	0	1	1
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS	63	0	1	1
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	90	0	1	1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	303	0	1	1
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	68	0	1	1
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	78	0	1	1
REACTOME_CGMP_EFFECTS	16	0	1	1
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	22	0	1	1
REACTOME_CALNEXIN_CALRETICULIN_CYCLE	26	0	1	1
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS	13	0	1	1
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	22	0	1	1
REACTOME_PLATELET_HOMEOSTASIS	86	0	1	1
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE	35	0	1	1
REACTOME_PLATELET_SENSITIZATION_BY_LDL	17	0	1	1
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	52	0	1	1
REACTOME_RAP1_SIGNALLING	16	0	1	1
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	28	0	1	1
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	19	0	1	1
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	19	0	1	1
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	23	0	1	1
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	12	0	1	1
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1	20	0	1	1
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX	14	0	1	1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	20	0	1	1
REACTOME_CIRCADIAN_CLOCK	70	0	1	1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	157	0	1	1
REACTOME_REGULATION_OF_IFNG_SIGNALING	14	0	1	1
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	87	0	1	1
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	13	0	1	1
REACTOME_GABA_B_RECEPTOR_ACTIVATION	43	0	1	1
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	184	0	1	1
REACTOME_IRON_UPTAKE_AND_TRANSPORT	58	0	1	1
REACTOME_INTERFERON_GAMMA_SIGNALING	91	0	1	1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION	15	0	1	1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING	14	0	1	1
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON	17	0	1	1
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	55	0	1	1
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	61	0	1	1
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	13	0	1	1
REACTOME_GABA_RECEPTOR_ACTIVATION	60	0	1	1
REACTOME_KINESINS	59	0	1	1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	26	0	1	1
REACTOME_REGULATION_OF_IFNA_SIGNALING	17	0	1	1
REACTOME_INTERFERON_SIGNALING	190	0	1	1
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	31	0	1	1
REACTOME_DSCAM_INTERACTIONS	11	0	1	1
REACTOME_ION_CHANNEL_TRANSPORT	183	0	1	1
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1	23	0	1	1
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	42	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	84	0	1	1
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	31	0	1	1
REACTOME_MEIOTIC_RECOMBINATION	77	0	1	1
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	39	0	1	1
REACTOME_SIGNALING_BY_NOTCH	237	0	1	1
REACTOME_LAGGING_STRAND_SYNTHESIS	20	0	1	1
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	12	0	1	1
REACTOME_ETHANOL_OXIDATION	12	0	1	1
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS	24	0	1	1
REACTOME_DNA_REPLICATION	127	0	1	1
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	21	0	1	1
REACTOME_METABOLISM_OF_CARBOHYDRATES	291	0	1	1
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	78	0	1	1
REACTOME_SIGNAL_ATTENUATION	10	0	1	1
REACTOME_SOS_MEDIATED_SIGNALLING	7	0	1	1
REACTOME_HEMOSTASIS	606	0	1	1
REACTOME_HIV_INFECTION	231	0	1	1
REACTOME_HIV_LIFE_CYCLE	150	0	1	1
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE	14	0	1	1
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	130	0	1	1
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS	112	0	1	1
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	44	0	1	1
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	36	0	1	1
REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING	16	0	1	1
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	72	0	1	1
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	37	0	1	1
REACTOME_UNWINDING_OF_DNA	12	0	1	1
REACTOME_GLUCURONIDATION	25	0	1	1
REACTOME_INNATE_IMMUNE_SYSTEM	1028	0	1	1
REACTOME_MITOTIC_PROMETAPHASE	201	0	1	1
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	23	0	1	1
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	29	0	1	1
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	73	0	1	1
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	19	0	1	1
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	19	0	1	1
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	24	0	1	1
REACTOME_INTEGRATION_OF_PROVIRUS	9	0	1	1
REACTOME_GLUTATHIONE_CONJUGATION	36	0	1	1
REACTOME_COMPLEMENT_CASCADE	57	0	1	1
REACTOME_MTORC1_MEDIATED_SIGNALLING	23	0	1	1
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	30	0	1	1
REACTOME_GLUCOSE_METABOLISM	92	0	1	1
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	43	0	1	1
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	747	1	0.193626750086143	1
REACTOME_NOD1_2_SIGNALING_PATHWAY	36	0	1	1
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	835	0	1	1
REACTOME_MEIOTIC_SYNAPSIS	71	0	1	1
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	25	0	1	1
REACTOME_THE_NLRP3_INFLAMMASOME	15	0	1	1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	369	0	0.999999999999999	1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	307	0	1	1
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS	12	0	1	1
REACTOME_INFLAMMASOMES	20	0	1	1
REACTOME_POTASSIUM_CHANNELS	103	0	1	1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	55	0	1	1
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	35	0	1	1
REACTOME_TELOMERE_MAINTENANCE	82	0	1	1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	260	0	1	1
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND	11	0	1	1
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	14	0	1	1
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	25	0	1	1
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	22	0	1	1
REACTOME_EXTENSION_OF_TELOMERES	44	0	1	1
REACTOME_G2_M_CHECKPOINTS	160	0	1	1
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT	87	0	1	1
REACTOME_S_PHASE	161	0	1	1
REACTOME_TRYPTOPHAN_CATABOLISM	14	0	1	1
REACTOME_DNA_STRAND_ELONGATION	32	0	1	1
REACTOME_CHOLESTEROL_BIOSYNTHESIS	25	0	1	1
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	13	0	1	1
REACTOME_METABOLISM_OF_PORPHYRINS	26	0	1	1
REACTOME_SIGNALING_BY_FGFR	87	0	1	1
REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE	10	0	1	1
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	16	0	1	1
REACTOME_GAP_JUNCTION_ASSEMBLY	36	0	1	1
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	18	0	1	1
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	53	0	1	1
REACTOME_APOPTOTIC_EXECUTION_PHASE	52	0	1	1
NAKAMURA_CANCER_MICROENVIRONMENT_UP	26	0	1	1
NAKAMURA_CANCER_MICROENVIRONMENT_DN	46	0	1	1
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	22	0	1	1
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	20	0	1	1
WINTER_HYPOXIA_UP	94	0	1	1
WINTER_HYPOXIA_DN	50	0	1	1
PARENT_MTOR_SIGNALING_UP	558	0	1	1
PARENT_MTOR_SIGNALING_DN	43	0	1	1
PYEON_HPV_POSITIVE_TUMORS_UP	94	0	1	1
PYEON_HPV_POSITIVE_TUMORS_DN	10	0	1	1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	275	0	1	1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	614	0	1	1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	207	0	1	1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	132	0	1	1
LU_TUMOR_VASCULATURE_UP	29	0	1	1
LU_TUMOR_VASCULATURE_DN	13	0	1	1
KORKOLA_EMBRYONAL_CARCINOMA_UP	42	0	1	1
KORKOLA_EMBRYONAL_CARCINOMA_DN	12	0	1	1
KORKOLA_TERATOMA_UP	17	0	1	1
KORKOLA_YOLK_SAC_TUMOR_UP	20	0	1	1
KORKOLA_CHORIOCARCINOMA_UP	6	0	1	1
KORKOLA_CHORIOCARCINOMA_DN	11	0	1	1
KORKOLA_SEMINOMA_UP	43	0	1	1
KORKOLA_SEMINOMA_DN	11	0	1	1
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	109	0	1	1
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	92	0	1	1
HOLLMANN_APOPTOSIS_VIA_CD40_UP	197	0	1	1
HOLLMANN_APOPTOSIS_VIA_CD40_DN	258	0	1	1
LIU_PROSTATE_CANCER_UP	96	0	1	1
LIU_PROSTATE_CANCER_DN	481	0	1	1
LIU_SOX4_TARGETS_UP	138	0	1	1
LIU_SOX4_TARGETS_DN	308	0	1	1
ONKEN_UVEAL_MELANOMA_UP	786	0	1	1
ONKEN_UVEAL_MELANOMA_DN	516	0	1	1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	200	1	0.0565258610666939	1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	174	0	1	1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	348	0	1	1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	83	0	1	1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	59	0	1	1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	20	0	1	1
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	19	0	1	1
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN	6	0	1	1
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	11	0	1	1
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	22	0	1	1
NAM_FXYD5_TARGETS_DN	18	0	1	1
FRASOR_TAMOXIFEN_RESPONSE_UP	50	0	1	1
FRASOR_TAMOXIFEN_RESPONSE_DN	12	0	1	1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	131	0	1	1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	10	0	1	1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	297	0	1	1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	347	0	1	1
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	28	0	1	1
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	66	0	1	1
KOBAYASHI_EGFR_SIGNALING_6HR_UP	7	0	1	1
KOBAYASHI_EGFR_SIGNALING_6HR_DN	18	0	1	1
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	154	0	1	1
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	52	0	1	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	26	0	1	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	446	0	1	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	30	0	1	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	37	0	1	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	39	0	1	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	64	0	1	1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	142	0	1	1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	368	0	1	1
ZERBINI_RESPONSE_TO_SULINDAC_UP	9	0	1	1
ZERBINI_RESPONSE_TO_SULINDAC_DN	6	0	1	1
IGARASHI_ATF4_TARGETS_UP	5	0	1	1
IGARASHI_ATF4_TARGETS_DN	97	0	1	1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	180	0	1	1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	70	0	1	1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	336	0	1	1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	176	0	1	1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	257	0	1	1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	66	1	0.019941242922638	1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	64	0	1	1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	14	0	1	1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	393	0	1	1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	167	0	1	1
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	63	0	1	1
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN	7	0	1	1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	46	0	1	1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	193	0	1	1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	73	0	1	1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	67	0	1	1
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	22	0	1	1
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN	7	0	1	1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	67	0	1	1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	88	0	1	1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	96	0	1	1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	73	0	1	1
CHANDRAN_METASTASIS_TOP50_UP	37	0	1	1
CHANDRAN_METASTASIS_TOP50_DN	44	0	1	1
WILCOX_RESPONSE_TO_PROGESTERONE_UP	150	0	1	1
WILCOX_RESPONSE_TO_PROGESTERONE_DN	62	0	1	1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	572	1	0.151007165515652	1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	443	0	1	1
GARY_CD5_TARGETS_UP	466	0	1	1
GARY_CD5_TARGETS_DN	434	0	1	1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	422	0	1	1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	364	0	1	1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP	8	0	1	1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	59	0	1	1
HOOI_ST7_TARGETS_UP	88	0	1	1
HOOI_ST7_TARGETS_DN	114	0	1	1
PRAMOONJAGO_SOX4_TARGETS_UP	52	0	1	1
PRAMOONJAGO_SOX4_TARGETS_DN	49	0	1	1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	76	0	1	1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	143	0	1	1
PIEPOLI_LGI1_TARGETS_UP	17	0	1	1
PIEPOLI_LGI1_TARGETS_DN	15	0	1	1
THUM_SYSTOLIC_HEART_FAILURE_UP	415	0	1	1
THUM_SYSTOLIC_HEART_FAILURE_DN	193	0	1	1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	162	0	1	1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	665	0	1	1
CORRE_MULTIPLE_MYELOMA_UP	69	0	1	1
CORRE_MULTIPLE_MYELOMA_DN	56	0	1	1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	272	1	0.0771627422899947	1
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	57	0	1	1
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	1393	0	1	1
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	117	0	1	1
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	37	0	1	1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	350	0	1	1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	311	2	0.00292176645385822	1
LIU_CMYB_TARGETS_UP	161	0	1	1
LIU_CMYB_TARGETS_DN	6	0	1	1
LIU_VMYB_TARGETS_UP	121	0	1	1
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	15	0	1	1
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	43	0	1	1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	372	0	1	1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	447	0	1	1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	444	1	0.128801586101594	1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	457	0	1	1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	122	0	1	1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	50	0	1	1
DOANE_BREAST_CANCER_CLASSES_UP	70	0	1	1
DOANE_BREAST_CANCER_CLASSES_DN	32	0	1	1
DOANE_RESPONSE_TO_ANDROGEN_UP	175	0	1	1
DOANE_RESPONSE_TO_ANDROGEN_DN	242	0	1	1
DOANE_BREAST_CANCER_ESR1_UP	109	0	1	1
DOANE_BREAST_CANCER_ESR1_DN	47	0	1	1
WANG_RESPONSE_TO_ANDROGEN_UP	27	0	1	1
WANG_RESPONSE_TO_FORSKOLIN_UP	21	0	1	1
WANG_RESPONSE_TO_FORSKOLIN_DN	9	0	1	1
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16	0	1	1
LAIHO_COLORECTAL_CANCER_SERRATED_UP	112	0	1	1
LAIHO_COLORECTAL_CANCER_SERRATED_DN	83	0	1	1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	308	0	1	1
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	98	0	1	1
ROY_WOUND_BLOOD_VESSEL_UP	49	0	1	1
ROY_WOUND_BLOOD_VESSEL_DN	23	0	1	1
GRABARCZYK_BCL11B_TARGETS_UP	76	0	1	1
GRABARCZYK_BCL11B_TARGETS_DN	56	0	1	1
NEWMAN_ERCC6_TARGETS_UP	24	0	1	1
NEWMAN_ERCC6_TARGETS_DN	39	0	1	1
HORIUCHI_WTAP_TARGETS_UP	298	1	0.0801916151674031	1
HORIUCHI_WTAP_TARGETS_DN	312	0	1	1
GAL_LEUKEMIC_STEM_CELL_UP	124	0	1	1
GAL_LEUKEMIC_STEM_CELL_DN	231	0	1	1
CHOI_ATL_CHRONIC_VS_ACUTE_DN	19	0	1	1
BASAKI_YBX1_TARGETS_UP	285	1	0.0866051011746539	1
BASAKI_YBX1_TARGETS_DN	378	0	1	1
NOJIMA_SFRP2_TARGETS_UP	32	0	1	1
NOJIMA_SFRP2_TARGETS_DN	24	0	1	1
WIKMAN_ASBESTOS_LUNG_CANCER_UP	17	0	1	1
WIKMAN_ASBESTOS_LUNG_CANCER_DN	29	0	1	1
RODRIGUES_DCC_TARGETS_UP	6	0	1	1
RODRIGUES_DCC_TARGETS_DN	119	0	1	1
RODRIGUES_NTN1_TARGETS_UP	16	0	1	1
RODRIGUES_NTN1_TARGETS_DN	158	0	1	1
WANG_LMO4_TARGETS_UP	345	0	1	1
WANG_LMO4_TARGETS_DN	350	0	1	1
WANG_CLIM2_TARGETS_UP	240	0	1	1
WANG_CLIM2_TARGETS_DN	177	0	1	1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	172	0	1	1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	140	0	1	1
VECCHI_GASTRIC_CANCER_EARLY_UP	422	0	1	1
VECCHI_GASTRIC_CANCER_EARLY_DN	358	0	1	1
BARRIER_COLON_CANCER_RECURRENCE_UP	42	0	1	1
BARRIER_COLON_CANCER_RECURRENCE_DN	19	0	1	1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	158	0	1	1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN	5	0	1	1
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	78	0	1	1
JAEGER_METASTASIS_UP	44	0	1	1
JAEGER_METASTASIS_DN	255	1	0.0654198063283393	1
OSMAN_BLADDER_CANCER_UP	394	0	1	1
OSMAN_BLADDER_CANCER_DN	410	0	1	1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	68	0	1	1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	327	0	1	1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	107	0	1	1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	171	0	1	1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	220	0	1	1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	274	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	32	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	23	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	79	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	54	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	26	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	26	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	12	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	11	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	25	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	23	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	133	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	60	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	32	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	11	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	18	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	76	0	1	1
RUNNE_GENDER_EFFECT_UP	9	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	82	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	43	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	177	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	30	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	152	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	193	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	189	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	141	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	173	0	1	1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	117	0	1	1
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	14	0	1	1
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN	7	0	1	1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	30	0	1	1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	32	0	1	1
BILBAN_B_CLL_LPL_UP	62	0	1	1
BILBAN_B_CLL_LPL_DN	40	0	1	1
HOEBEKE_LYMPHOID_STEM_CELL_UP	94	0	1	1
HOEBEKE_LYMPHOID_STEM_CELL_DN	88	0	1	1
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	32	0	1	1
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	21	0	1	1
AKL_HTLV1_INFECTION_UP	27	0	1	1
AKL_HTLV1_INFECTION_DN	67	0	1	1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	75	0	1	1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	366	0	1	1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	257	0	1	1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	123	0	1	1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	128	0	1	1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	74	0	1	1
MULLIGHAN_MLL_SIGNATURE_1_UP	376	0	1	1
MULLIGHAN_MLL_SIGNATURE_1_DN	235	0	1	1
MULLIGHAN_MLL_SIGNATURE_2_UP	413	0	1	1
MULLIGHAN_MLL_SIGNATURE_2_DN	274	0	1	1
MULLIGHAN_NPM1_SIGNATURE_3_UP	324	0	1	1
MULLIGHAN_NPM1_SIGNATURE_3_DN	159	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	15	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN	7	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	183	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	188	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	54	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	18	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	202	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	56	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	157	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	18	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	21	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN	10	0	1	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	44	0	1	1
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	14	0	1	1
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN	7	0	1	1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	53	0	1	1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	42	0	1	1
DITTMER_PTHLH_TARGETS_UP	112	0	1	1
DITTMER_PTHLH_TARGETS_DN	70	0	1	1
UDAYAKUMAR_MED1_TARGETS_UP	135	1	0.0431232263958913	1
UDAYAKUMAR_MED1_TARGETS_DN	239	0	1	1
ODONNELL_TFRC_TARGETS_UP	365	0	1	1
ODONNELL_TFRC_TARGETS_DN	128	0	1	1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	78	0	1	1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	45	0	1	1
SENESE_HDAC1_TARGETS_UP	435	1	0.121219111478118	1
SENESE_HDAC1_TARGETS_DN	248	0	1	1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	230	0	1	1
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	224	0	1	1
SENESE_HDAC2_TARGETS_UP	111	0	1	1
SENESE_HDAC2_TARGETS_DN	121	0	1	1
SENESE_HDAC3_TARGETS_UP	477	0	1	1
SENESE_HDAC3_TARGETS_DN	532	0	1	1
LEE_NEURAL_CREST_STEM_CELL_UP	146	0	1	1
LEE_NEURAL_CREST_STEM_CELL_DN	120	0	1	1
HUMMEL_BURKITTS_LYMPHOMA_UP	42	0	1	1
HUMMEL_BURKITTS_LYMPHOMA_DN	15	0	1	1
TIEN_INTESTINE_PROBIOTICS_2HR_UP	29	0	1	1
TIEN_INTESTINE_PROBIOTICS_2HR_DN	88	0	1	1
TIEN_INTESTINE_PROBIOTICS_6HR_UP	50	0	1	1
TIEN_INTESTINE_PROBIOTICS_6HR_DN	168	0	1	1
TIEN_INTESTINE_PROBIOTICS_24HR_UP	556	1	0.155720278405349	1
TIEN_INTESTINE_PROBIOTICS_24HR_DN	213	0	1	1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	477	0	1	1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	268	1	0.0748765110425489	1
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	375	0	1	1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	1268	0	1	1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	323	0	1	1
SABATES_COLORECTAL_ADENOMA_SIZE_UP	20	0	1	1
SABATES_COLORECTAL_ADENOMA_SIZE_DN	13	0	1	1
SABATES_COLORECTAL_ADENOMA_UP	135	0	1	1
SABATES_COLORECTAL_ADENOMA_DN	287	0	1	1
SCIBETTA_KDM5B_TARGETS_UP	19	0	1	1
SCIBETTA_KDM5B_TARGETS_DN	79	0	1	1
NAGASHIMA_NRG1_SIGNALING_UP	172	0	1	1
NAGASHIMA_NRG1_SIGNALING_DN	54	0	1	1
NAGASHIMA_EGF_SIGNALING_UP	57	0	1	1
KIM_WT1_TARGETS_UP	216	0	1	1
KIM_WT1_TARGETS_DN	465	0	1	1
KIM_WT1_TARGETS_8HR_UP	167	0	1	1
KIM_WT1_TARGETS_8HR_DN	122	0	1	1
KIM_WT1_TARGETS_12HR_UP	166	0	1	1
KIM_WT1_TARGETS_12HR_DN	213	0	1	1
ELVIDGE_HYPOXIA_UP	170	0	1	1
ELVIDGE_HYPOXIA_DN	147	0	1	1
ELVIDGE_HYPOXIA_BY_DMOG_UP	133	0	1	1
ELVIDGE_HYPOXIA_BY_DMOG_DN	59	0	1	1
ELVIDGE_HIF1A_TARGETS_UP	67	0	1	1
ELVIDGE_HIF1A_TARGETS_DN	91	0	1	1
ELVIDGE_HIF2A_TARGETS_UP	6	0	1	1
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	41	0	1	1
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	104	0	1	1
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	314	1	0.0892180398338189	1
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	230	0	1	1
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	20	0	1	1
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	12	0	1	1
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	24	0	1	1
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	11	0	1	1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	94	0	1	1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	45	0	1	1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	58	0	1	1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	11	0	1	1
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	13	0	1	1
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN	10	0	1	1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	184	0	1	1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	92	0	1	1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	63	0	1	1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	89	0	1	1
BIDUS_METASTASIS_UP	215	0	1	1
BIDUS_METASTASIS_DN	149	0	1	1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	265	0	1	1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	194	0	1	1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	140	0	1	1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	70	0	1	1
MAYBURD_RESPONSE_TO_L663536_UP	29	0	1	1
MAYBURD_RESPONSE_TO_L663536_DN	55	0	1	1
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	19	0	1	1
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	15	0	1	1
DODD_NASOPHARYNGEAL_CARCINOMA_UP	1671	1	0.386293177558988	1
DODD_NASOPHARYNGEAL_CARCINOMA_DN	1353	0	1	1
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	625	0	1	1
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	759	0	1	1
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	699	0	1	1
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	510	0	1	1
RODRIGUES_THYROID_CARCINOMA_UP	15	0	1	1
RODRIGUES_THYROID_CARCINOMA_DN	77	0	1	1
GOZGIT_ESR1_TARGETS_UP	144	0	1	1
GOZGIT_ESR1_TARGETS_DN	734	0	1	1
HAHTOLA_SEZARY_SYNDROM_UP	99	0	1	1
HAHTOLA_SEZARY_SYNDROM_DN	42	0	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	175	0	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	27	0	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	62	0	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	113	0	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_UP	18	0	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_DN	15	0	1	1
PROVENZANI_METASTASIS_UP	197	0	1	1
PROVENZANI_METASTASIS_DN	140	0	1	1
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	36	0	1	1
LIU_CDX2_TARGETS_UP	34	0	1	1
LIU_CDX2_TARGETS_DN	8	0	1	1
COLDREN_GEFITINIB_RESISTANCE_UP	85	0	1	1
COLDREN_GEFITINIB_RESISTANCE_DN	218	1	0.0619941455815275	1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	128	0	1	1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	61	0	1	1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	116	0	1	1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	72	0	1	1
PASTURAL_RIZ1_TARGETS_UP	10	0	1	1
PASTURAL_RIZ1_TARGETS_DN	5	0	1	1
CHOW_RASSF1_TARGETS_UP	26	0	1	1
CHOW_RASSF1_TARGETS_DN	30	0	1	1
ENK_UV_RESPONSE_EPIDERMIS_UP	293	0	1	1
ENK_UV_RESPONSE_EPIDERMIS_DN	509	0	1	1
ENK_UV_RESPONSE_KERATINOCYTE_UP	529	0	1	1
ENK_UV_RESPONSE_KERATINOCYTE_DN	481	1	0.141914408345261	1
LANDIS_BREAST_CANCER_PROGRESSION_UP	46	0	1	1
LANDIS_BREAST_CANCER_PROGRESSION_DN	71	0	1	1
GESERICK_TERT_TARGETS_DN	21	0	1	1
YEMELYANOV_GR_TARGETS_DN	11	0	1	1
LAU_APOPTOSIS_CDKN2A_UP	55	0	1	1
LAU_APOPTOSIS_CDKN2A_DN	5	0	1	1
DELYS_THYROID_CANCER_UP	441	0	1	1
DELYS_THYROID_CANCER_DN	232	0	1	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	58	0	1	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	53	0	1	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	130	0	1	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	140	0	1	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	123	0	1	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	151	0	1	1
CASTELLANO_HRAS_TARGETS_DN	6	0	1	1
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP	5	0	1	1
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN	8	0	1	1
CASTELLANO_NRAS_TARGETS_UP	70	0	1	1
CASTELLANO_NRAS_TARGETS_DN	14	0	1	1
CHEBOTAEV_GR_TARGETS_UP	75	0	1	1
CHEBOTAEV_GR_TARGETS_DN	118	0	1	1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	29	0	1	1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	48	0	1	1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP	8	0	1	1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	30	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	119	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	372	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP	8	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	140	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	322	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	224	0	1	1
KOINUMA_COLON_CANCER_MSI_UP	16	0	1	1
KOINUMA_COLON_CANCER_MSI_DN	8	0	1	1
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	34	0	1	1
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	0	1	1
NADERI_BREAST_CANCER_PROGNOSIS_UP	50	0	1	1
NADERI_BREAST_CANCER_PROGNOSIS_DN	18	0	1	1
MARKEY_RB1_CHRONIC_LOF_UP	111	0	0.999999999999999	1
MARKEY_RB1_CHRONIC_LOF_DN	120	0	1	1
MARKEY_RB1_ACUTE_LOF_UP	233	0	1	1
MARKEY_RB1_ACUTE_LOF_DN	227	0	1	1
CHIN_BREAST_CANCER_COPY_NUMBER_UP	27	0	1	1
CHIN_BREAST_CANCER_COPY_NUMBER_DN	12	0	1	1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	555	0	1	1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	232	0	1	1
VANHARANTA_UTERINE_FIBROID_UP	44	0	1	1
VANHARANTA_UTERINE_FIBROID_DN	67	0	1	1
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	66	0	1	1
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	36	0	1	1
LANDIS_ERBB2_BREAST_TUMORS_65_UP	22	0	1	1
LANDIS_ERBB2_BREAST_TUMORS_65_DN	39	0	1	1
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	19	0	1	1
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	57	0	1	1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	237	0	1	1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	170	0	1	1
ODONNELL_METASTASIS_UP	74	0	1	1
ODONNELL_METASTASIS_DN	24	0	1	1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	212	0	1	1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	83	0	1	1
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	1136	0	1	1
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	1743	0	1	1
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	604	0	1	1
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	759	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	192	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	94	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	27	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN	8	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	167	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	21	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	38	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN	9	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	97	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	22	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	181	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	36	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	235	0	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	34	0	1	1
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	21	0	1	1
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	30	0	1	1
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	22	0	1	1
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN	13	0	1	1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	116	0	1	1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	12	0	1	1
LANDIS_ERBB2_BREAST_TUMORS_324_UP	151	0	1	1
LANDIS_ERBB2_BREAST_TUMORS_324_DN	150	0	1	1
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	33	0	1	1
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	30	0	1	1
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16	0	1	1
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	11	0	1	1
BARIS_THYROID_CANCER_UP	23	0	1	1
BARIS_THYROID_CANCER_DN	59	0	1	1
BERENJENO_TRANSFORMED_BY_RHOA_UP	547	0	1	1
BERENJENO_TRANSFORMED_BY_RHOA_DN	398	0	1	1
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP	7	0	1	1
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	28	0	1	1
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	26	0	1	1
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	36	0	1	1
KERLEY_RESPONSE_TO_CISPLATIN_UP	44	0	1	1
KERLEY_RESPONSE_TO_CISPLATIN_DN	5	0	1	1
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	124	0	1	1
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	119	0	1	1
TANG_SENESCENCE_TP53_TARGETS_UP	33	0	1	1
TANG_SENESCENCE_TP53_TARGETS_DN	56	0	1	1
WANG_BARRETTS_ESOPHAGUS_UP	52	0	1	1
WANG_BARRETTS_ESOPHAGUS_DN	25	0	1	1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	118	0	1	1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	100	0	1	1
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP	9	0	1	1
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	14	0	1	1
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	18	0	1	1
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	59	0	1	1
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	25	0	1	1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	56	0	1	1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	21	0	1	1
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	212	0	1	1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	38	0	1	1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	268	0	1	1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	196	0	1	1
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	122	0	1	1
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	127	0	1	1
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	188	0	1	1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	78	0	1	1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	16	0	1	1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	16	0	1	1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	51	0	1	1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	19	0	1	1
LUI_THYROID_CANCER_PAX8_PPARG_UP	45	0	1	1
LUI_THYROID_CANCER_PAX8_PPARG_DN	46	0	1	1
HAMAI_APOPTOSIS_VIA_TRAIL_UP	646	0	1	1
HAMAI_APOPTOSIS_VIA_TRAIL_DN	198	0	1	1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	68	0	1	1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	35	0	1	1
HUMMERICH_BENIGN_SKIN_TUMOR_UP	16	0	1	1
HUMMERICH_BENIGN_SKIN_TUMOR_DN	20	0	1	1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	166	0	1	1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	63	0	1	1
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	17	0	1	1
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	20	0	1	1
LUCAS_HNF4A_TARGETS_UP	58	0	1	1
LUCAS_HNF4A_TARGETS_DN	8	0	1	1
ZIRN_TRETINOIN_RESPONSE_WT1_UP	23	0	1	1
ZIRN_TRETINOIN_RESPONSE_WT1_DN	6	0	1	1
ZIRN_TRETINOIN_RESPONSE_UP	20	0	1	1
ZIRN_TRETINOIN_RESPONSE_DN	6	0	1	1
STREICHER_LSM1_TARGETS_UP	43	0	1	1
STREICHER_LSM1_TARGETS_DN	19	0	1	1
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	121	0	1	1
LANG_MYB_FAMILY_TARGETS	28	0	1	1
MCBRYAN_TERMINAL_END_BUD_UP	13	0	1	1
MCBRYAN_TERMINAL_END_BUD_DN	6	0	1	1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	29	0	1	1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	13	0	1	1
DARWICHE_SKIN_TUMOR_PROMOTER_UP	142	0	1	1
DARWICHE_SKIN_TUMOR_PROMOTER_DN	183	0	1	1
DARWICHE_PAPILLOMA_RISK_LOW_UP	159	0	1	1
DARWICHE_PAPILLOMA_RISK_LOW_DN	165	0	1	1
DARWICHE_PAPILLOMA_RISK_HIGH_UP	147	0	1	1
DARWICHE_PAPILLOMA_RISK_HIGH_DN	177	0	1	1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	147	0	1	1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	177	0	1	1
MAHADEVAN_IMATINIB_RESISTANCE_UP	21	0	1	1
MAHADEVAN_IMATINIB_RESISTANCE_DN	20	0	1	1
TOMIDA_METASTASIS_UP	25	0	1	1
TOMIDA_METASTASIS_DN	18	0	1	1
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN	13	0	1	1
OZANNE_AP1_TARGETS_UP	14	0	1	1
HWANG_PROSTATE_CANCER_MARKERS	28	0	1	1
HU_ANGIOGENESIS_UP	20	0	1	1
HU_ANGIOGENESIS_DN	37	0	1	1
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	59	0	1	1
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	43	0	1	1
DARWICHE_PAPILLOMA_PROGRESSION_RISK	73	1	0.0188644675458313	1
SHIRAISHI_PLZF_TARGETS_UP	10	0	1	1
SHIRAISHI_PLZF_TARGETS_DN	9	0	1	1
MOTAMED_RESPONSE_TO_ANDROGEN_DN	6	0	1	1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP	10	0	1	1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN	10	0	1	1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP	6	0	1	1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN	8	0	1	1
OLSSON_E2F3_TARGETS_UP	25	0	1	1
OLSSON_E2F3_TARGETS_DN	37	0	1	1
MARKS_HDAC_TARGETS_UP	23	0	1	1
MARKS_HDAC_TARGETS_DN	15	0	1	1
CHOI_ATL_ACUTE_STAGE	6	0	1	1
CHOI_ATL_STAGE_PREDICTOR	44	0	1	1
WONG_ENDMETRIUM_CANCER_UP	25	0	1	1
WONG_ENDMETRIUM_CANCER_DN	76	0	1	1
WONG_ENDOMETRIAL_CANCER_LATE	8	0	1	1
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	13	0	1	1
KONG_E2F1_TARGETS	11	0	1	1
KONG_E2F3_TARGETS	101	0	1	1
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	102	0	1	1
EGUCHI_CELL_CYCLE_RB1_TARGETS	22	0	1	1
CROSBY_E2F4_TARGETS	6	0	1	1
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	11	0	1	1
IVANOV_MUTATED_IN_COLON_CANCER	13	0	1	1
TAKAYAMA_BOUND_BY_AR	10	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION	81	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	42	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	37	0	1	1
CHASSOT_SKIN_WOUND	9	0	1	1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	181	0	1	1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	783	1	0.228123967349487	1
MUELLER_METHYLATED_IN_GLIOBLASTOMA	40	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	26	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	25	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION_6HR	37	0	1	1
RIZ_ERYTHROID_DIFFERENTIATION_12HR	36	0	1	1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	191	0	1	1
PEREZ_TP53_TARGETS	1150	0	1	1
PEREZ_TP63_TARGETS	342	0	1	1
PEREZ_TP53_AND_TP63_TARGETS	204	0	1	1
WAKASUGI_HAVE_ZNF143_BINDING_SITES	54	0	1	1
RODRIGUES_NTN1_AND_DCC_TARGETS	34	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	26	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	85	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	60	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	83	0	1	1
TURJANSKI_MAPK1_AND_MAPK2_TARGETS	12	0	1	1
TURJANSKI_MAPK8_AND_MAPK9_TARGETS	8	0	1	1
TURJANSKI_MAPK7_TARGETS	7	0	1	1
TURJANSKI_MAPK11_TARGETS	5	0	1	1
TURJANSKI_MAPK14_TARGETS	10	0	1	1
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	15	0	1	1
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	38	0	1	1
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	51	0	1	1
NAGY_TFTC_COMPONENTS_HUMAN	17	0	1	1
NAGY_STAGA_COMPONENTS_HUMAN	12	0	1	1
NAGY_PCAF_COMPONENTS_HUMAN	9	0	1	1
BAKER_HEMATOPOESIS_STAT1_TARGETS	9	0	1	1
BAKER_HEMATOPOIESIS_STAT3_TARGETS	14	0	1	1
BAKER_HEMATOPOESIS_STAT5_TARGETS	6	0	1	1
SEIDEN_MET_SIGNALING	20	0	1	1
AUNG_GASTRIC_CANCER	50	0	1	1
SANCHEZ_MDM2_TARGETS	15	0	1	1
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	14	0	1	1
NAKAMURA_LUNG_CANCER	9	0	1	1
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	41	0	1	1
HAEGERSTRAND_RESPONSE_TO_IMATINIB	9	0	1	1
MATHEW_FANCONI_ANEMIA_GENES	11	0	1	1
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	52	0	1	1
GILMORE_CORE_NFKB_PATHWAY	12	0	1	1
SCHEIDEREIT_IKK_TARGETS	17	0	1	1
DUTTA_APOPTOSIS_VIA_NFKB	31	0	1	1
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	20	0	1	1
ROVERSI_GLIOMA_COPY_NUMBER_DN	53	0	1	1
SEIDEN_ONCOGENESIS_BY_MET	89	0	1	1
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	87	0	1	1
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	101	0	1	1
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	31	0	1	1
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	41	0	1	1
ROVERSI_GLIOMA_LOH_REGIONS	44	0	1	1
ROVERSI_GLIOMA_COPY_NUMBER_UP	99	0	1	1
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	39	0	1	1
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	124	0	1	1
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	45	0	1	1
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	47	0	1	1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	129	0	1	1
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	76	0	1	1
RASHI_NFKB1_TARGETS	17	0	1	1
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	24	0	1	1
AIGNER_ZEB1_TARGETS	35	0	1	1
SUZUKI_AMPLIFIED_IN_ORAL_CANCER	15	0	1	1
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3	7	0	1	1
MARTIN_INTERACT_WITH_HDAC	39	0	1	1
LASTOWSKA_COAMPLIFIED_WITH_MYCN	39	0	1	1
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM	6	0	1	1
LI_LUNG_CANCER	41	0	1	1
LI_AMPLIFIED_IN_LUNG_CANCER	180	0	1	1
LINDGREN_BLADDER_CANCER_CLUSTER_2B	386	0	1	1
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	48	0	1	1
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	116	0	1	1
NAKAMURA_ALVEOLAR_EPITHELIUM	5	0	1	1
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA	6	0	1	1
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	13	0	1	1
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	12	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	18	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24	14	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25	9	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7	7	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27	10	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15	10	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29	8	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9	8	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16	9	0	1	1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	49	0	1	1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	47	0	1	1
SCHAVOLT_TARGETS_OF_TP53_AND_TP63	15	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8	12	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	19	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2	5	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21	6	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30	5	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6	6	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12	11	0	1	1
MATTIOLI_MGUS_VS_PCL	100	0	1	1
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	14	0	1	1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	327	0	1	1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	328	0	1	1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	327	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5	6	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18	5	0	1	1
LUI_THYROID_CANCER_CLUSTER_1	50	0	1	1
LUI_THYROID_CANCER_CLUSTER_2	43	0	1	1
LUI_THYROID_CANCER_CLUSTER_3	28	0	1	1
LUI_THYROID_CANCER_CLUSTER_4	12	0	1	1
LUI_THYROID_CANCER_CLUSTER_5	16	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22	11	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1	5	0	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13	5	0	1	1
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	14	0	1	1
LUI_TARGETS_OF_PAX8_PPARG_FUSION	34	0	1	1
SCHLOSSER_SERUM_RESPONSE_UP	122	0	1	1
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	104	0	1	1
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	33	0	1	1
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	160	0	1	1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	48	0	1	1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	48	0	1	1
SCHLOSSER_SERUM_RESPONSE_DN	697	0	1	1
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15	0	1	1
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	36	0	1	1
FARMER_BREAST_CANCER_CLUSTER_1	39	0	1	1
FARMER_BREAST_CANCER_CLUSTER_8	6	0	1	1
FARMER_BREAST_CANCER_CLUSTER_7	20	0	1	1
FARMER_BREAST_CANCER_CLUSTER_2	33	0	1	1
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	140	0	1	1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	50	0	1	1
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	40	0	1	1
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER	13	0	1	1
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER	7	0	1	1
OHASHI_AURKA_TARGETS	5	0	1	1
OHASHI_AURKB_TARGETS	7	0	1	1
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	19	0	1	1
LA_MEN1_TARGETS	25	0	1	1
KOMMAGANI_TP63_GAMMA_TARGETS	9	0	1	1
LUND_SILENCED_BY_METHYLATION	15	0	1	1
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	15	0	1	1
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	17	0	1	1
BOWIE_RESPONSE_TO_TAMOXIFEN	18	0	1	1
AIYAR_COBRA1_TARGETS_UP	40	0	1	1
AIYAR_COBRA1_TARGETS_DN	29	0	1	1
LI_CISPLATIN_RESISTANCE_DN	33	0	1	1
LI_CISPLATIN_RESISTANCE_UP	26	0	1	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	23	0	1	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN	7	0	1	1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	35	0	1	1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	38	0	1	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	73	0	1	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	22	0	1	1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	62	0	1	1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	18	0	1	1
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	25	0	1	1
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	19	0	1	1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	35	0	1	1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	20	0	1	1
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	13	0	1	1
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	24	0	1	1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP	10	0	1	1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	86	0	1	1
XU_AKT1_TARGETS_6HR	26	0	1	1
XU_AKT1_TARGETS_48HR	9	0	1	1
SHI_SPARC_TARGETS_UP	23	0	1	1
SHI_SPARC_TARGETS_DN	12	0	1	1
WAESCH_ANAPHASE_PROMOTING_COMPLEX	13	0	1	1
AGARWAL_AKT_PATHWAY_TARGETS	9	0	1	1
NEBEN_AML_WITH_FLT3_OR_NRAS_UP	8	0	1	1
NEBEN_AML_WITH_FLT3_OR_NRAS_DN	12	0	1	1
DIRMEIER_LMP1_RESPONSE_EARLY	63	0	1	1
EINAV_INTERFERON_SIGNATURE_IN_CANCER	27	0	1	1
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	16	0	1	1
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	37	0	1	1
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF	8	0	1	1
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	19	0	1	1
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3	7	0	1	1
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	46	0	1	1
DAUER_STAT3_TARGETS_UP	48	0	1	1
DAUER_STAT3_TARGETS_DN	48	0	1	1
PATIL_LIVER_CANCER	658	0	1	1
KORKOLA_EMBRYONAL_CARCINOMA	11	0	1	1
KORKOLA_TERATOMA	41	0	1	1
KORKOLA_YOLK_SAC_TUMOR	62	0	1	1
KORKOLA_CHORIOCARCINOMA	7	0	1	1
WANG_METHYLATED_IN_BREAST_CANCER	35	0	1	1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	57	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_1	14	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_3	7	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_4	15	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_5	7	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_6	26	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_7	18	0	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_8	8	0	1	1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	74	0	1	1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	32	0	1	1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	70	0	1	1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	23	0	1	1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	12	0	1	1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	19	0	1	1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	28	0	1	1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	35	0	1	1
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	14	0	1	1
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN	9	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	315	1	0.0904977318159438	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	853	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	454	0	1	1
DIRMEIER_LMP1_RESPONSE_LATE_UP	55	0	1	1
DIRMEIER_LMP1_RESPONSE_LATE_DN	31	0	1	1
HEIDENBLAD_AMPLICON_8Q24_UP	39	0	1	1
HEIDENBLAD_AMPLICON_8Q24_DN	39	0	1	1
HEIDENBLAD_AMPLICON_12P11_12_UP	36	0	1	1
HEIDENBLAD_AMPLICON_12P11_12_DN	22	0	1	1
AMUNDSON_RESPONSE_TO_ARSENITE	218	0	1	1
FUNG_IL2_SIGNALING_2	11	0	1	1
FUNG_IL2_SIGNALING_1	10	0	1	1
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1	9	0	1	1
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES	7	0	1	1
SASAKI_TARGETS_OF_TP73_AND_TP63	12	0	1	1
YANAGIHARA_ESX1_TARGETS	29	0	1	1
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	27	0	1	1
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	39	0	1	1
TSUNODA_CISPLATIN_RESISTANCE_UP	15	0	1	1
TSUNODA_CISPLATIN_RESISTANCE_DN	48	0	1	1
MAINA_HYPOXIA_VHL_TARGETS_UP	6	0	1	1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	177	0	1	1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	158	0	1	1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	235	0	1	1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	513	0	1	1
LI_WILMS_TUMOR_ANAPLASTIC_UP	17	0	1	1
LI_WILMS_TUMOR_ANAPLASTIC_DN	5	0	1	1
BORLAK_LIVER_CANCER_EGF_UP	49	0	1	1
MANN_RESPONSE_TO_AMIFOSTINE_UP	19	0	1	1
MANN_RESPONSE_TO_AMIFOSTINE_DN	9	0	1	1
YAN_ESCAPE_FROM_ANOIKIS	23	0	1	1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	82	0	1	1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	113	0	1	1
WOOD_EBV_EBNA1_TARGETS_UP	110	0	1	1
WOOD_EBV_EBNA1_TARGETS_DN	47	0	1	1
MOHANKUMAR_HOXA1_TARGETS_UP	404	0	1	1
MOHANKUMAR_HOXA1_TARGETS_DN	165	0	1	1
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	56	0	1	1
MURATA_VIRULENCE_OF_H_PILORI	21	0	1	1
WANG_HCP_PROSTATE_CANCER	106	0	1	1
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP	7	0	1	1
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	40	0	1	1
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP	10	0	1	1
MAINA_VHL_TARGETS_UP	10	0	1	1
MAINA_VHL_TARGETS_DN	16	0	1	1
GRUETZMANN_PANCREATIC_CANCER_UP	355	0	1	1
GRUETZMANN_PANCREATIC_CANCER_DN	197	0	1	1
JAZAG_TGFB1_SIGNALING_UP	105	0	1	1
JAZAG_TGFB1_SIGNALING_DN	34	0	1	1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	107	0	1	1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	65	0	1	1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	29	0	1	1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	49	0	1	1
SIMBULAN_UV_RESPONSE_NORMAL_UP	9	0	1	1
SIMBULAN_UV_RESPONSE_NORMAL_DN	33	0	1	1
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	31	0	1	1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	21	0	1	1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	35	0	1	1
INAMURA_LUNG_CANCER_SCC_UP	13	0	1	1
INAMURA_LUNG_CANCER_SCC_DN	14	0	1	1
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	14	0	1	1
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	50	0	1	1
KIM_MYC_AMPLIFICATION_TARGETS_UP	200	0	1	1
KIM_MYC_AMPLIFICATION_TARGETS_DN	96	0	1	1
KIM_MYCN_AMPLIFICATION_TARGETS_UP	92	0	1	1
KIM_MYCN_AMPLIFICATION_TARGETS_DN	102	0	1	1
KIM_MYCL1_AMPLIFICATION_TARGETS_UP	14	0	1	1
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	19	0	1	1
TSAI_RESPONSE_TO_IONIZING_RADIATION	147	0	1	1
YANG_BREAST_CANCER_ESR1_UP	36	0	1	1
YANG_BREAST_CANCER_ESR1_DN	25	0	1	1
YANG_BREAST_CANCER_ESR1_LASER_UP	32	0	1	1
YANG_BREAST_CANCER_ESR1_LASER_DN	47	0	1	1
YANG_BREAST_CANCER_ESR1_BULK_UP	27	0	1	1
YANG_BREAST_CANCER_ESR1_BULK_DN	23	0	1	1
WANG_RESPONSE_TO_BEXAROTENE_UP	34	0	1	1
WANG_RESPONSE_TO_BEXAROTENE_DN	28	0	1	1
STANHILL_HRAS_TRANSFROMATION_UP	7	0	1	1
REN_MIF_TARGETS_DN	5	0	1	1
SEMBA_FHIT_TARGETS_UP	11	0	1	1
SEMBA_FHIT_TARGETS_DN	10	0	1	1
SHANK_TAL1_TARGETS_DN	10	0	1	1
HASINA_NOL7_TARGETS_UP	12	0	1	1
HASINA_NOL7_TARGETS_DN	13	0	1	1
KONDO_HYPOXIA	8	0	1	1
HOWLIN_PUBERTAL_MAMMARY_GLAND	64	0	1	1
KREPPEL_CD99_TARGETS_DN	7	0	1	1
HATADA_METHYLATED_IN_LUNG_CANCER_UP	371	0	1	1
HATADA_METHYLATED_IN_LUNG_CANCER_DN	35	0	1	1
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP	5	0	1	1
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP	5	0	1	1
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN	5	0	1	1
FURUKAWA_DUSP6_TARGETS_PCI35_UP	72	0	1	1
FURUKAWA_DUSP6_TARGETS_PCI35_DN	70	0	1	1
KARAKAS_TGFB1_SIGNALING	18	0	1	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	250	0	1	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	164	0	1	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	69	0	1	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	276	0	1	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	106	0	1	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	53	0	1	1
LIEN_BREAST_CARCINOMA_METAPLASTIC	33	0	1	1
SCHMAHL_PDGF_SIGNALING	9	0	1	1
TOMLINS_PROSTATE_CANCER_UP	39	0	1	1
TOMLINS_PROSTATE_CANCER_DN	40	0	1	1
TOMLINS_METASTASIS_UP	13	0	1	1
TOMLINS_METASTASIS_DN	20	0	1	1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	41	0	1	1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	43	0	1	1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	38	0	1	1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	33	0	1	1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	13	0	1	1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	20	0	1	1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	483	0	1	1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	587	0	1	1
HUI_MAPK14_TARGETS_UP	17	0	1	1
DIERICK_SEROTONIN_FUNCTION_GENES	6	0	1	1
THEODOROU_MAMMARY_TUMORIGENESIS	31	0	1	1
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION	13	0	1	1
SCHLESINGER_METHYLATED_IN_COLON_CANCER	10	0	1	1
JIANG_CORE_DUPLICON_GENES	12	0	1	1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	101	0	1	1
PUJANA_XPRSS_INT_NETWORK	168	0	1	1
PUJANA_BRCA1_PCC_NETWORK	1602	1	0.39277089648756	1
PUJANA_BRCA2_PCC_NETWORK	418	0	1	1
PUJANA_ATM_PCC_NETWORK	1368	1	0.339549886024054	1
PUJANA_CHEK2_PCC_NETWORK	759	0	1	1
PUJANA_BRCA_CENTERED_NETWORK	117	0	1	1
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	28	0	1	1
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	88	0	1	1
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS	12	0	1	1
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS	13	0	1	1
KHETCHOUMIAN_TRIM24_TARGETS_UP	46	0	1	1
KHETCHOUMIAN_TRIM24_TARGETS_DN	8	0	1	1
OHM_METHYLATED_IN_ADULT_CANCERS	27	0	1	1
OHM_EMBRYONIC_CARCINOMA_UP	6	0	1	1
OHM_EMBRYONIC_CARCINOMA_DN	8	0	1	1
ALCALA_APOPTOSIS	85	0	1	1
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	22	0	1	1
COWLING_MYCN_TARGETS	43	0	1	1
GROSS_HYPOXIA_VIA_HIF1A_ONLY	8	0	1	1
FALVELLA_SMOKERS_WITH_LUNG_CANCER	80	0	1	1
OZEN_MIR125B1_TARGETS	22	0	1	1
GALIE_TUMOR_ANGIOGENESIS	8	0	1	1
GALIE_TUMOR_STEMNESS_GENES	6	0	1	1
KAUFFMANN_MELANOMA_RELAPSE_UP	60	0	1	1
KAUFFMANN_MELANOMA_RELAPSE_DN	5	0	1	1
WILLIAMS_ESR1_TARGETS_UP	26	0	1	1
WILLIAMS_ESR1_TARGETS_DN	6	0	1	1
WILLIAMS_ESR2_TARGETS_UP	28	0	1	1
WILLIAMS_ESR2_TARGETS_DN	11	0	1	1
GROSS_ELK3_TARGETS_UP	27	0	1	1
GROSS_ELK3_TARGETS_DN	33	0	1	1
GROSS_HYPOXIA_VIA_ELK3_UP	207	0	1	1
GROSS_HYPOXIA_VIA_ELK3_DN	156	0	1	1
GROSS_HIF1A_TARGETS_UP	7	0	1	1
GROSS_HIF1A_TARGETS_DN	26	0	1	1
GROSS_HYPOXIA_VIA_HIF1A_UP	76	0	1	1
GROSS_HYPOXIA_VIA_HIF1A_DN	108	0	1	1
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	34	0	1	1
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	44	0	1	1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	143	0	1	1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	101	0	1	1
NUYTTEN_NIPP1_TARGETS_UP	762	0	1	1
NUYTTEN_NIPP1_TARGETS_DN	837	2	0.0246641349624123	1
NUYTTEN_EZH2_TARGETS_UP	1023	0	1	1
NUYTTEN_EZH2_TARGETS_DN	1007	1	0.267212818719462	1
INGRAM_SHH_TARGETS_UP	124	0	1	1
INGRAM_SHH_TARGETS_DN	60	0	1	1
MARTIN_NFKB_TARGETS_UP	44	0	1	1
MARTIN_NFKB_TARGETS_DN	10	0	1	1
MARTIN_VIRAL_GPCR_SIGNALING_UP	84	0	1	1
MARTIN_VIRAL_GPCR_SIGNALING_DN	51	0	1	1
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	812	0	1	1
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	642	1	0.176237866177131	1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	163	0	1	1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	96	1	0.0265515631429929	1
NAKAYAMA_FRA2_TARGETS	43	0	1	1
LOPEZ_MBD_TARGETS	943	0	1	1
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	16	0	1	1
ROPERO_HDAC2_TARGETS	107	0	1	1
GOUYER_TUMOR_INVASIVENESS	9	0	1	1
LIU_LIVER_CANCER	32	0	1	1
LIU_BREAST_CANCER	28	0	1	1
LIU_NASOPHARYNGEAL_CARCINOMA	68	0	1	1
LIU_COMMON_CANCER_GENES	61	0	1	1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	212	0	1	1
FREDERICK_PRKCI_TARGETS	10	0	1	1
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	20	0	1	1
WEI_MIR34A_TARGETS	145	0	1	1
WEI_MYCN_TARGETS_WITH_E_BOX	786	0	1	1
LIAO_HAVE_SOX4_BINDING_SITES	40	0	1	1
LIAO_METASTASIS	525	0	1	1
HASEGAWA_TUMORIGENESIS_BY_RET_C634R	8	0	1	1
TONG_INTERACT_WITH_PTTG1	57	0	1	1
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP	9	0	1	1
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	22	0	1	1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP	11	0	1	1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	30	0	1	1
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	21	0	1	1
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	26	0	1	1
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP	13	0	1	1
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	16	0	1	1
GOUYER_TATI_TARGETS_UP	10	0	1	1
GOUYER_TATI_TARGETS_DN	17	0	1	1
CAFFAREL_RESPONSE_TO_THC_UP	33	0	1	1
CAFFAREL_RESPONSE_TO_THC_DN	31	0	1	1
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	15	0	1	1
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	11	0	1	1
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP	5	0	1	1
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN	10	0	1	1
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP	8	0	1	1
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	13	0	1	1
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	33	0	1	1
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	58	0	1	1
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP	5	0	1	1
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN	8	0	1	1
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	0	1	1
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	46	0	1	1
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	18	0	1	1
WOTTON_RUNX_TARGETS_UP	21	0	1	1
WOTTON_RUNX_TARGETS_DN	29	0	1	1
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP	10	0	1	1
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN	8	0	1	1
FUJIWARA_PARK2_IN_LIVER_CANCER_UP	8	0	1	1
FUJIWARA_PARK2_IN_LIVER_CANCER_DN	6	0	1	1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	49	0	1	1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	163	0	1	1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	239	0	1	1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	374	0	1	1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	106	0	1	1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	107	0	1	1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	124	0	1	1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	16	0	1	1
RICKMAN_METASTASIS_UP	335	0	1	1
RICKMAN_METASTASIS_DN	255	0	1	1
FRIDMAN_SENESCENCE_UP	77	0	1	1
FRIDMAN_SENESCENCE_DN	12	0	1	1
FRIDMAN_IMMORTALIZATION_DN	33	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	156	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	462	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	110	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	52	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	441	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	403	1	0.119831644813334	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	14	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN	10	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP	6	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN	7	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP	11	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	33	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP	11	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN	7	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP	7	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN	5	0	1	1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	21	0	1	1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	45	0	1	1
KOYAMA_SEMA3B_TARGETS_UP	255	0	1	1
KOYAMA_SEMA3B_TARGETS_DN	351	0	1	1
RICKMAN_HEAD_AND_NECK_CANCER_A	102	0	1	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3	5	0	1	1
RICKMAN_HEAD_AND_NECK_CANCER_B	47	0	1	1
RICKMAN_HEAD_AND_NECK_CANCER_C	106	0	1	1
RICKMAN_HEAD_AND_NECK_CANCER_D	33	0	1	1
RICKMAN_HEAD_AND_NECK_CANCER_E	83	0	1	1
RICKMAN_HEAD_AND_NECK_CANCER_F	55	0	1	1
WU_CELL_MIGRATION	182	0	1	1
TAGHAVI_NEOPLASTIC_TRANSFORMATION	12	0	1	1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	34	0	1	1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	28	0	1	1
BALDWIN_PRKCI_TARGETS_UP	40	0	1	1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	69	0	1	1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	206	0	1	1
HE_PTEN_TARGETS_UP	17	0	1	1
HE_PTEN_TARGETS_DN	7	0	1	1
AMIT_DELAYED_EARLY_GENES	18	0	1	1
DEN_INTERACT_WITH_LCA5	26	0	1	1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	285	0	1	1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	167	0	1	1
BENPORATH_ES_1	378	0	1	1
BENPORATH_ES_2	40	0	1	1
BENPORATH_NANOG_TARGETS	982	1	0.262635547105705	1
BENPORATH_OCT4_TARGETS	286	0	1	1
BENPORATH_SOX2_TARGETS	730	1	0.204038250501643	1
BENPORATH_NOS_TARGETS	177	0	1	1
BENPORATH_SUZ12_TARGETS	1016	0	1	1
BENPORATH_EED_TARGETS	1041	0	1	1
BENPORATH_ES_WITH_H3K27ME3	1096	0	1	1
BENPORATH_PRC2_TARGETS	638	0	1	1
BENPORATH_MYC_TARGETS_WITH_EBOX	227	0	1	1
BENPORATH_MYC_MAX_TARGETS	767	0	1	1
BENPORATH_CYCLING_GENES	643	1	0.182665131168444	1
BENPORATH_PROLIFERATION	147	0	1	1
PETRETTO_CARDIAC_HYPERTROPHY	34	0	1	1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	195	0	1	1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	516	0	1	1
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	50	0	1	1
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	22	0	1	1
STARK_BRAIN_22Q11_DELETION	11	0	1	1
BENPORATH_ES_CORE_NINE	9	0	1	1
BENPORATH_ES_CORE_NINE_CORRELATED	100	0	1	1
PETRETTO_BLOOD_PRESSURE_UP	12	0	1	1
PETRETTO_BLOOD_PRESSURE_DN	8	0	1	1
PETRETTO_HEART_MASS_QTL_CIS_UP	32	0	1	1
PETRETTO_HEART_MASS_QTL_CIS_DN	24	0	1	1
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP	6	0	1	1
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN	10	0	1	1
AMIT_EGF_RESPONSE_20_HELA	12	0	1	1
AMIT_EGF_RESPONSE_40_HELA	42	0	1	1
AMIT_EGF_RESPONSE_60_HELA	46	0	1	1
AMIT_EGF_RESPONSE_120_HELA	68	0	1	1
AMIT_EGF_RESPONSE_240_HELA	59	0	1	1
AMIT_EGF_RESPONSE_480_HELA	163	0	1	1
AMIT_EGF_RESPONSE_20_MCF10A	12	0	1	1
AMIT_EGF_RESPONSE_40_MCF10A	17	0	1	1
AMIT_EGF_RESPONSE_60_MCF10A	39	0	1	1
AMIT_EGF_RESPONSE_120_MCF10A	41	0	1	1
AMIT_EGF_RESPONSE_240_MCF10A	21	0	1	1
AMIT_EGF_RESPONSE_480_MCF10A	43	0	1	1
AMIT_SERUM_RESPONSE_20_MCF10A	16	0	1	1
AMIT_SERUM_RESPONSE_40_MCF10A	31	0	1	1
AMIT_SERUM_RESPONSE_60_MCF10A	58	0	1	1
AMIT_SERUM_RESPONSE_120_MCF10A	65	0	1	1
AMIT_SERUM_RESPONSE_240_MCF10A	55	0	1	1
AMIT_SERUM_RESPONSE_480_MCF10A	37	0	1	1
GEORGES_CELL_CYCLE_MIR192_TARGETS	62	0	1	1
GEORGES_TARGETS_OF_MIR192_AND_MIR215	887	1	0.242395012269881	1
SHEN_SMARCA2_TARGETS_UP	428	1	0.121573479995033	1
SHEN_SMARCA2_TARGETS_DN	298	0	1	1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	106	0	1	1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	79	0	1	1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	27	0	1	1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	36	0	1	1
JEON_SMAD6_TARGETS_UP	24	0	1	1
JEON_SMAD6_TARGETS_DN	19	0	1	1
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	65	0	1	1
SUNG_METASTASIS_STROMA_UP	110	0	1	1
SUNG_METASTASIS_STROMA_DN	54	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_1	13	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	30	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	28	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	17	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_6	11	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	27	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	37	0	1	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	19	0	1	1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	221	0	1	1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	103	0	1	1
MORI_PRE_BI_LYMPHOCYTE_UP	81	0	1	1
MORI_PRE_BI_LYMPHOCYTE_DN	79	0	1	1
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	88	0	1	1
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	59	0	1	1
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	77	0	1	1
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	74	0	1	1
MORI_IMMATURE_B_LYMPHOCYTE_UP	49	0	1	1
MORI_IMMATURE_B_LYMPHOCYTE_DN	91	0	1	1
MORI_MATURE_B_LYMPHOCYTE_UP	92	0	1	1
MORI_MATURE_B_LYMPHOCYTE_DN	76	0	1	1
MORI_PLASMA_CELL_UP	52	0	1	1
MORI_PLASMA_CELL_DN	36	0	1	1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	110	0	1	1
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	17	0	1	1
COLLIS_PRKDC_SUBSTRATES	16	0	1	1
COLLIS_PRKDC_REGULATORS	12	0	1	1
TOMIDA_LUNG_CANCER_POOR_SURVIVAL	5	0	1	1
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	56	0	1	1
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	87	0	1	1
KAUFFMANN_DNA_REPAIR_GENES	227	0	1	1
KAUFFMANN_DNA_REPLICATION_GENES	145	0	1	1
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	38	0	1	1
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	12	0	1	1
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	26	0	1	1
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	21	0	1	1
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	37	0	1	1
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	11	0	1	1
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	74	0	1	1
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	56	0	1	1
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	130	0	1	1
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	152	0	1	1
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON	8	0	1	1
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	155	1	0.0440893327560019	1
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	45	0	1	1
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15	0	1	1
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	14	0	1	1
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	22	0	1	1
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	118	0	1	1
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	52	0	1	1
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	10	0	1	1
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	131	0	1	1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	331	0	1	1
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON	5	0	1	1
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	22	0	1	1
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON	7	0	1	1
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON	8	0	1	1
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	31	0	1	1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	149	0	1	1
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	16	0	1	1
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	17	0	1	1
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	93	0	1	1
WHITEHURST_PACLITAXEL_SENSITIVITY	38	0	1	1
STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS	11	0	1	1
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN	6	0	1	1
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP	5	0	1	1
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN	7	0	1	1
JI_METASTASIS_REPRESSED_BY_STK11	26	0	1	1
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	63	0	1	1
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	50	0	1	1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	74	0	1	1
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	31	0	1	1
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	26	0	1	1
DING_LUNG_CANCER_MUTATED_FREQUENTLY	12	0	1	1
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	100	0	1	1
ONDER_CDH1_TARGETS_2_UP	253	0	1	1
ONDER_CDH1_TARGETS_2_DN	467	1	0.125517961422077	1
ONDER_CDH1_TARGETS_1_UP	138	0	1	1
ONDER_CDH1_TARGETS_1_DN	170	0	1	1
ONDER_CDH1_TARGETS_3_UP	17	0	1	1
ONDER_CDH1_TARGETS_3_DN	59	0	1	1
ONDER_CDH1_SIGNALING_VIA_CTNNB1	83	0	1	1
ZEILSTRA_CD44_TARGETS_UP	8	0	1	1
ZEILSTRA_CD44_TARGETS_DN	9	0	1	1
CERVERA_SDHB_TARGETS_2	114	0	1	1
ROZANOV_MMP14_TARGETS_SUBSET	33	0	1	1
ROZANOV_MMP14_CORRELATED	11	0	1	1
ROZANOV_MMP14_TARGETS_UP	264	0	1	1
ROZANOV_MMP14_TARGETS_DN	35	0	1	1
LANDEMAINE_LUNG_METASTASIS	21	0	1	1
CERVERA_SDHB_TARGETS_1_UP	118	0	1	1
CERVERA_SDHB_TARGETS_1_DN	35	0	1	1
LE_EGR2_TARGETS_DN	106	0	1	1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	82	0	1	1
BYSTRYKH_SCP2_QTL	6	0	1	1
KENNY_CTNNB1_TARGETS_UP	50	0	1	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	20	0	1	1
NELSON_RESPONSE_TO_ANDROGEN_DN	17	0	1	1
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	77	0	1	1
BYSTROEM_CORRELATED_WITH_IL5_DN	55	0	1	1
SWEET_KRAS_TARGETS_DN	64	0	1	1
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	200	0	1	1
ROSS_AML_WITH_PML_RARA_FUSION	80	0	1	1
LEI_HOXC8_TARGETS_UP	13	0	1	1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	15	0	1	1
LEE_LIVER_CANCER_CIPROFIBRATE_DN	66	0	1	1
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	158	0	1	1
STANELLE_E2F1_TARGETS	28	0	1	1
CHESLER_BRAIN_D6MIT150_QTL_CIS	6	0	1	1
SHIPP_DLBCL_CURED_VS_FATAL_DN	43	0	1	1
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	15	0	1	1
UEDA_CENTRAL_CLOCK	88	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	7	0	1	1
GOLUB_ALL_VS_AML_UP	24	0	1	1
HOUSTIS_ROS	36	0	1	1
BASSO_B_LYMPHOCYTE_NETWORK	146	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	131	0	1	1
SCHUHMACHER_MYC_TARGETS_DN	8	0	1	1
LEI_HOXC8_TARGETS_DN	17	0	1	1
CHESLER_BRAIN_QTL_CIS	72	0	1	1
ROSS_AML_WITH_CBFB_MYH11_FUSION	51	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN	10	0	1	1
FERRANDO_TAL1_NEIGHBORS	18	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	158	0	1	1
LEE_LIVER_CANCER_MYC_TGFA_DN	65	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	25	0	1	1
GOLDRATH_HOMEOSTATIC_PROLIFERATION	146	0	1	1
LAMB_CCND1_TARGETS	20	0	1	1
GNATENKO_PLATELET_SIGNATURE	43	0	1	1
KIM_GERMINAL_CENTER_T_HELPER_UP	64	0	1	1
SHEPARD_BMYB_MORPHOLINO_DN	201	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	67	0	1	1
LEE_LIVER_CANCER_ACOX1_DN	65	0	1	1
SMITH_TERT_TARGETS_UP	144	0	1	1
LEE_LIVER_CANCER_MYC_UP	54	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	17	0	1	1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	67	0	1	1
DER_IFN_ALPHA_RESPONSE_UP	74	0	1	1
KANNAN_TP53_TARGETS_UP	58	0	1	1
WELCH_GATA1_TARGETS	25	0	1	1
FRASOR_RESPONSE_TO_ESTRADIOL_UP	35	0	1	1
LEE_LIVER_CANCER_MYC_TGFA_UP	61	0	1	1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	40	0	1	1
DORSAM_HOXA9_TARGETS_UP	35	0	1	1
DER_IFN_BETA_RESPONSE_DN	8	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	26	0	1	1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	57	0	1	1
SHEPARD_BMYB_TARGETS	76	0	1	1
KANNAN_TP53_TARGETS_DN	21	0	1	1
CHANG_POU5F1_TARGETS_UP	15	0	1	1
CHANG_POU5F1_TARGETS_DN	8	0	1	1
SANA_TNF_SIGNALING_DN	85	0	1	1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	384	0	1	1
WILLERT_WNT_SIGNALING	21	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1	8	0	1	1
KENNY_CTNNB1_TARGETS_DN	52	0	1	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP	10	0	1	1
CHESLER_BRAIN_QTL_TRANS	6	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP	12	0	1	1
BECKER_TAMOXIFEN_RESISTANCE_UP	54	0	1	1
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	188	0	1	1
KIM_GERMINAL_CENTER_T_HELPER_DN	12	0	1	1
RADAEVA_RESPONSE_TO_IFNA1_UP	48	0	1	1
PEART_HDAC_PROLIFERATION_CLUSTER_UP	54	0	1	1
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	38	0	1	1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	19	0	1	1
YAGI_AML_RELAPSE_PROGNOSIS	35	0	1	1
SHIPP_DLBCL_CURED_VS_FATAL_UP	39	0	1	1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	87	0	1	1
LEE_LIVER_CANCER_ACOX1_UP	65	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN	9	0	1	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12	0	1	1
UEDA_PERIFERAL_CLOCK	168	0	1	1
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	37	0	1	1
CHEN_LUNG_CANCER_SURVIVAL	27	0	1	1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	62	0	1	1
WIELAND_UP_BY_HBV_INFECTION	99	0	1	1
SHEPARD_BMYB_MORPHOLINO_UP	210	0	1	1
GOLUB_ALL_VS_AML_DN	23	0	1	1
DISTECHE_ESCAPED_FROM_X_INACTIVATION	13	0	1	1
DER_IFN_BETA_RESPONSE_UP	103	0	1	1
MANALO_HYPOXIA_DN	292	0	1	1
CHESLER_BRAIN_HIGHEST_EXPRESSION	42	0	1	1
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	27	0	1	1
LEE_LIVER_CANCER_MYC_E2F1_DN	64	0	1	1
BYSTROEM_CORRELATED_WITH_IL5_UP	37	0	1	1
CHESLER_BRAIN_D6MIT150_QTL_TRANS	9	0	1	1
NELSON_RESPONSE_TO_ANDROGEN_UP	84	0	1	1
LIN_APC_TARGETS	70	0	1	1
VANTVEER_BREAST_CANCER_METASTASIS_DN	132	0	1	1
BROCKE_APOPTOSIS_REVERSED_BY_IL6	145	0	1	1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	60	0	1	1
FRASOR_RESPONSE_TO_ESTRADIOL_DN	77	0	1	1
CHEOK_RESPONSE_TO_HD_MTX_DN	22	0	1	1
TENEDINI_MEGAKARYOCYTE_MARKERS	61	0	1	1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	307	0	1	1
SMITH_LIVER_CANCER	47	0	1	1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	58	0	1	1
ROSS_AML_WITH_MLL_FUSIONS	79	0	1	1
GRANDVAUX_IRF3_TARGETS_UP	14	0	1	1
LEE_LIVER_CANCER_MYC_E2F1_UP	56	0	1	1
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	48	0	1	1
LE_EGR2_TARGETS_UP	109	0	1	1
FERNANDEZ_BOUND_BY_MYC	180	0	1	1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	152	0	1	1
ROSS_AML_OF_FAB_M7_TYPE	70	0	1	1
MOOTHA_VOXPHOS	87	0	1	1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	50	0	1	1
DER_IFN_GAMMA_RESPONSE_DN	9	0	1	1
SANA_RESPONSE_TO_IFNG_UP	75	0	1	1
SANA_TNF_SIGNALING_UP	82	0	1	1
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	48	0	1	1
SCHUHMACHER_MYC_TARGETS_UP	80	0	1	1
SWEET_KRAS_TARGETS_UP	83	0	1	1
CHEOK_RESPONSE_TO_HD_MTX_UP	21	0	1	1
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	19	0	1	1
OKUMURA_INFLAMMATORY_RESPONSE_LPS	176	0	1	1
SMITH_TERT_TARGETS_DN	87	0	1	1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	44	0	1	1
LEE_LIVER_CANCER_DENA_DN	74	0	1	1
SANA_RESPONSE_TO_IFNG_DN	86	0	1	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	20	0	1	1
LEE_LIVER_CANCER_MYC_DN	63	0	1	1
LEE_LIVER_CANCER_CIPROFIBRATE_UP	60	0	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	20	0	1	1
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	44	0	1	1
LU_IL4_SIGNALING	89	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	765	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1	8	0	1	1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	23	0	1	1
FERRANDO_LYL1_NEIGHBORS	15	0	1	1
VANTVEER_BREAST_CANCER_METASTASIS_UP	65	0	1	1
COLLER_MYC_TARGETS_UP	24	0	1	1
MANALO_HYPOXIA_UP	202	0	1	1
REN_BOUND_BY_E2F	61	0	1	1
DORSAM_HOXA9_TARGETS_DN	32	0	1	1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	552	1	0.148823309161879	1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	45	0	1	1
GRANDVAUX_IRF3_TARGETS_DN	18	0	1	1
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE	11	0	1	1
RADAEVA_RESPONSE_TO_IFNA1_DN	10	0	1	1
BECKER_TAMOXIFEN_RESISTANCE_DN	53	0	1	1
PEART_HDAC_PROLIFERATION_CLUSTER_DN	74	0	1	1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	50	0	1	1
SASAKI_ADULT_T_CELL_LEUKEMIA	163	0	1	1
COLLER_MYC_TARGETS_DN	7	0	1	1
LEE_LIVER_CANCER_E2F1_DN	64	0	1	1
LEE_LIVER_CANCER_DENA_UP	60	0	1	1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	24	0	1	1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	40	0	1	1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	64	0	1	1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	563	1	0.156254836639079	1
GOLDRATH_IMMUNE_MEMORY	64	0	1	1
LEE_LIVER_CANCER_E2F1_UP	63	0	1	1
ROSS_AML_WITH_AML1_ETO_FUSION	76	0	1	1
BHATTACHARYA_EMBRYONIC_STEM_CELL	82	0	1	1
OSAWA_TNF_TARGETS	10	0	1	1
DER_IFN_GAMMA_RESPONSE_UP	71	0	1	1
HASLINGER_B_CLL_WITH_17P13_DELETION	21	0	1	1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	75	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD1_UP	45	0	1	1
ABBUD_LIF_SIGNALING_1_DN	27	0	1	1
SANSOM_APC_TARGETS_UP	129	0	1	1
NAKAJIMA_EOSINOPHIL	25	0	1	1
BROWN_MYELOID_CELL_DEVELOPMENT_UP	158	0	1	1
NADLER_OBESITY_UP	59	0	1	1
SANSOM_APC_TARGETS_DN	340	0	1	1
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	74	0	1	1
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	86	0	1	1
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	0	1	1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	80	0	1	1
MA_MYELOID_DIFFERENTIATION_DN	42	0	1	1
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	79	0	1	1
VERNELL_RETINOBLASTOMA_PATHWAY_DN	23	0	1	1
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	18	0	1	1
CROMER_METASTASIS_UP	73	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	53	0	1	1
GUO_HEX_TARGETS_UP	74	0	1	1
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	22	0	1	1
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	136	0	1	1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	48	0	1	1
HEDVAT_ELF4_TARGETS_UP	12	0	1	1
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16	0	1	1
STOSSI_RESPONSE_TO_ESTRADIOL	46	0	1	1
YU_MYC_TARGETS_UP	43	0	1	1
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	76	0	1	1
ABBUD_LIF_SIGNALING_2_UP	12	0	1	1
PARK_HSC_MARKERS	43	0	1	1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	87	0	1	1
HOFMANN_CELL_LYMPHOMA_DN	40	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	67	0	1	1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	470	0	1	1
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	42	0	1	1
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	40	0	1	1
STONER_ESOPHAGEAL_CARCINOGENESIS_DN	6	0	1	1
HASLINGER_B_CLL_WITH_13Q14_DELETION	23	0	1	1
HOFMANN_CELL_LYMPHOMA_UP	49	0	1	1
GUO_HEX_TARGETS_DN	63	0	1	1
HSIAO_LIVER_SPECIFIC_GENES	249	0	1	1
GILDEA_METASTASIS	29	0	1	1
ZHAN_MULTIPLE_MYELOMA_SPIKED	24	0	1	1
MUNSHI_MULTIPLE_MYELOMA_DN	10	0	1	1
ASTIER_INTEGRIN_SIGNALING	55	0	1	1
ZHAN_MULTIPLE_MYELOMA_LB_UP	45	0	1	1
HASLINGER_B_CLL_WITH_11Q23_DELETION	22	0	1	1
LEI_MYB_TARGETS	320	0	1	1
BROWN_MYELOID_CELL_DEVELOPMENT_DN	126	0	1	1
ROETH_TERT_TARGETS_DN	9	0	1	1
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	80	0	1	1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	164	0	1	1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	85	0	1	1
HALMOS_CEBPA_TARGETS_DN	44	0	1	1
NADLER_OBESITY_DN	50	0	1	1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	86	0	1	1
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	29	0	1	1
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	30	0	1	1
GALE_APL_WITH_FLT3_MUTATED_DN	16	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	91	0	1	1
NADLER_HYPERGLYCEMIA_AT_OBESITY	58	0	1	1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	28	0	1	1
ZHAN_MULTIPLE_MYELOMA_PR_UP	45	0	1	1
HALMOS_CEBPA_TARGETS_UP	49	0	1	1
YU_MYC_TARGETS_DN	57	0	1	1
NUMATA_CSF3_SIGNALING_VIA_STAT3	20	0	1	1
ZHAN_MULTIPLE_MYELOMA_UP	60	0	1	1
LENAOUR_DENDRITIC_CELL_MATURATION_UP	115	0	1	1
TAVOR_CEBPA_TARGETS_DN	32	0	1	1
LENAOUR_DENDRITIC_CELL_MATURATION_DN	129	0	1	1
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	44	0	1	1
HADDAD_B_LYMPHOCYTE_PROGENITOR	278	1	0.0810051022645598	1
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	43	0	1	1
GREENBAUM_E2A_TARGETS_DN	19	0	1	1
NGUYEN_NOTCH1_TARGETS_UP	27	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD2_UP	45	0	1	1
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	23	0	1	1
ABBUD_LIF_SIGNALING_1_UP	40	0	1	1
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	26	0	1	1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	75	0	1	1
GERY_CEBP_TARGETS	128	0	1	1
VERHAAK_AML_WITH_NPM1_MUTATED_UP	184	0	1	1
KANG_IMMORTALIZED_BY_TERT_UP	88	0	1	1
BASSO_CD40_SIGNALING_DN	70	0	1	1
ZHAN_MULTIPLE_MYELOMA_MF_UP	46	0	1	1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	162	0	1	1
JAIN_NFKB_SIGNALING	73	0	1	1
ROETH_TERT_TARGETS_UP	14	0	1	1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	131	0	1	1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	182	0	0.999999999999999	1
STAEGE_EWING_FAMILY_TUMOR	30	0	1	1
GALE_APL_WITH_FLT3_MUTATED_UP	59	0	1	1
AFFAR_YY1_TARGETS_UP	194	0	1	1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	226	0	1	1
AFFAR_YY1_TARGETS_DN	248	0	1	1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	48	0	1	1
VERNELL_RETINOBLASTOMA_PATHWAY_UP	70	0	1	1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	184	0	1	1
KANG_IMMORTALIZED_BY_TERT_DN	100	0	1	1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	68	1	0.020031453003545	1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	19	0	1	1
NGUYEN_NOTCH1_TARGETS_DN	82	0	1	1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	358	0	1	1
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	65	0	1	1
PETROVA_PROX1_TARGETS_DN	57	0	1	1
HOEGERKORP_CD44_TARGETS_DIRECT_DN	14	0	1	1
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	29	0	1	1
XU_RESPONSE_TO_TRETINOIN_UP	16	0	1	1
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	20	0	1	1
MENSE_HYPOXIA_UP	96	0	1	1
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	21	0	1	1
ZHAN_V2_LATE_DIFFERENTIATION_GENES	43	0	1	1
DORSEY_GAB2_TARGETS	30	0	1	1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	63	0	1	1
NAKAJIMA_MAST_CELL	46	0	1	1
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	25	0	1	1
ZHAN_MULTIPLE_MYELOMA_MS_UP	48	0	1	1
MA_MYELOID_DIFFERENTIATION_UP	37	0	1	1
RADMACHER_AML_PROGNOSIS	79	0	1	1
CROMER_METASTASIS_DN	77	0	1	1
NOUZOVA_METHYLATED_IN_APL	61	0	1	1
ZHAN_MULTIPLE_MYELOMA_HP_UP	47	1	0.0136612924292907	1
XU_RESPONSE_TO_TRETINOIN_DN	11	0	1	1
TAVOR_CEBPA_TARGETS_UP	49	0	1	1
YAGI_AML_SURVIVAL	122	0	1	1
XU_CREBBP_TARGETS_UP	20	0	1	1
VERHAAK_AML_WITH_NPM1_MUTATED_DN	247	0	1	1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	28	0	1	1
APPEL_IMATINIB_RESPONSE	33	0	1	1
YAGI_AML_FAB_MARKERS	193	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	52	0	1	1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	175	0	1	1
ABBUD_LIF_SIGNALING_2_DN	6	0	1	1
XU_CREBBP_TARGETS_DN	38	0	1	1
IGLESIAS_E2F_TARGETS_DN	13	0	1	1
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP	12	0	1	1
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	25	0	1	1
IGLESIAS_E2F_TARGETS_UP	134	0	1	1
MUNSHI_MULTIPLE_MYELOMA_UP	77	0	1	1
KAMMINGA_EZH2_TARGETS	41	0	1	1
ZHAN_MULTIPLE_MYELOMA_DN	41	0	1	1
BASSO_CD40_SIGNALING_UP	101	0	1	1
HASLINGER_B_CLL_WITH_6Q21_DELETION	19	0	1	1
HANSON_HRAS_SIGNALING_VIA_NFKB	19	0	1	1
FAELT_B_CLL_WITH_VH3_21_DN	48	0	1	1
GREENBAUM_E2A_TARGETS_UP	31	0	1	1
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	15	0	1	1
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	134	0	1	1
BRUNO_HEMATOPOIESIS	66	0	1	1
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	80	0	1	1
PETROVA_PROX1_TARGETS_UP	25	0	1	1
HOEGERKORP_CD44_TARGETS_DIRECT_UP	26	0	1	1
KUMAR_TARGETS_OF_MLL_AF9_FUSION	396	0	1	1
FAELT_B_CLL_WITH_VH3_21_UP	42	0	1	1
SESTO_RESPONSE_TO_UV_C8	71	0	1	1
KIM_HYPOXIA	19	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D9	25	0	1	1
LIANG_SILENCED_BY_METHYLATION_2	55	0	1	1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	433	0	1	1
LY_AGING_PREMATURE_DN	30	0	1	1
MARTINEZ_RESPONSE_TO_TRABECTEDIN	50	0	1	1
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	35	0	1	1
BROWNE_HCMV_INFECTION_20HR_UP	232	0	1	1
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	84	0	1	1
URS_ADIPOCYTE_DIFFERENTIATION_UP	67	0	1	1
LEE_AGING_NEOCORTEX_DN	63	0	1	1
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	99	0	1	1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	406	0	1	1
TRAYNOR_RETT_SYNDROM_UP	38	0	1	1
MCCLUNG_DELTA_FOSB_TARGETS_8WK	49	0	1	1
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	25	0	1	1
BROWNE_HCMV_INFECTION_16HR_UP	220	1	0.0672954836227527	1
MODY_HIPPOCAMPUS_POSTNATAL	56	0	1	1
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS	10	0	1	1
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	42	0	1	1
BURTON_ADIPOGENESIS_10	30	0	1	1
ABE_VEGFA_TARGETS_2HR	33	0	1	1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	21	0	1	1
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	70	0	1	1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	384	0	1	1
IVANOVA_HEMATOPOIESIS_MATURE_CELL	287	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G3	14	0	1	1
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	35	0	1	1
WEBER_METHYLATED_IN_COLON_CANCER	18	0	1	1
KAAB_FAILED_HEART_ATRIUM_DN	147	0	1	1
SU_PANCREAS	45	0	1	1
RUAN_RESPONSE_TO_TROGLITAZONE_UP	24	0	1	1
WU_HBX_TARGETS_2_DN	14	0	1	1
ZAMORA_NOS2_TARGETS_UP	52	0	1	1
JIANG_AGING_CEREBRAL_CORTEX_UP	33	0	1	1
WEIGEL_OXIDATIVE_STRESS_RESPONSE	33	0	1	1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	292	1	0.0844524808704914	1
BRACHAT_RESPONSE_TO_CISPLATIN	23	0	1	1
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	503	0	1	1
LU_AGING_BRAIN_DN	151	0	1	1
RUAN_RESPONSE_TO_TNF_UP	9	0	1	1
WHITESIDE_CISPLATIN_RESISTANCE_UP	11	0	1	1
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	63	0	1	1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	60	0	1	1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	214	0	1	1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	36	0	1	1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	36	0	1	1
ZHOU_TNF_SIGNALING_4HR	53	0	1	1
MARCHINI_TRABECTEDIN_RESISTANCE_UP	19	0	1	1
GENTILE_UV_LOW_DOSE_UP	25	0	1	1
BLALOCK_ALZHEIMERS_DISEASE_DN	1241	0	1	1
BROWNE_HCMV_INFECTION_16HR_DN	84	0	1	1
WESTON_VEGFA_TARGETS_6HR	54	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	14	0	1	1
RAMALHO_STEMNESS_DN	72	0	1	1
ONGUSAHA_TP53_TARGETS	35	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D4	54	0	1	1
RHODES_CANCER_META_SIGNATURE	65	0	1	1
LIAN_LIPA_TARGETS_6M	78	0	1	1
WU_HBX_TARGETS_1_DN	22	0	1	1
HARRIS_HYPOXIA	80	0	1	1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	38	0	1	1
SU_SALIVARY_GLAND	14	0	1	1
BROWNE_HCMV_INFECTION_10HR_DN	56	0	1	1
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	87	0	1	1
HENDRICKS_SMARCA4_TARGETS_UP	53	0	1	1
ZHENG_RESPONSE_TO_ARSENITE_DN	12	0	1	1
MURAKAMI_UV_RESPONSE_6HR_DN	21	0	1	1
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	42	0	1	1
RAMALHO_STEMNESS_UP	194	0	1	1
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	14	0	1	1
MCDOWELL_ACUTE_LUNG_INJURY_UP	43	0	1	1
SESTO_RESPONSE_TO_UV_C4	20	0	1	1
WANG_SMARCE1_TARGETS_DN	375	0	1	1
SU_TESTIS	79	0	1	1
TRAYNOR_RETT_SYNDROM_DN	14	0	1	1
SESTO_RESPONSE_TO_UV_C6	38	0	1	1
MCCLUNG_CREB1_TARGETS_DN	56	0	1	1
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	142	0	1	1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	17	0	1	1
SESTO_RESPONSE_TO_UV_C2	54	0	1	1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	254	0	1	1
HU_GENOTOXIC_DAMAGE_24HR	34	0	1	1
CUI_TCF21_TARGETS_UP	36	0	1	1
HEDENFALK_BREAST_CANCER_BRACX_UP	19	0	1	1
GEISS_RESPONSE_TO_DSRNA_DN	15	0	1	1
CUI_TCF21_TARGETS_2_DN	846	1	0.23827171254905	1
VIETOR_IFRD1_TARGETS	23	0	1	1
PAL_PRMT5_TARGETS_UP	203	0	1	1
VARELA_ZMPSTE24_TARGETS_DN	42	0	1	1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	46	0	1	1
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	17	0	1	1
HEDENFALK_BREAST_CANCER_BRACX_DN	20	0	1	1
JIANG_AGING_HYPOTHALAMUS_DN	35	0	1	1
CHANG_IMMORTALIZED_BY_HPV31_DN	60	0	1	1
BROWNE_HCMV_INFECTION_24HR_DN	143	0	1	1
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8	10	0	1	1
CHIBA_RESPONSE_TO_TSA_UP	51	0	1	1
RAMASWAMY_METASTASIS_DN	58	0	1	1
MODY_HIPPOCAMPUS_NEONATAL	33	0	1	1
MCCLUNG_COCAINE_REWARD_5D	73	0	1	1
KAYO_AGING_MUSCLE_UP	237	0	1	1
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	15	0	1	1
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN	11	0	1	1
BROWNE_HCMV_INFECTION_14HR_DN	289	0	1	1
DELASERNA_MYOD_TARGETS_DN	57	0	1	1
YAMAZAKI_TCEB3_TARGETS_UP	167	0	1	1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	43	0	1	1
JIANG_VHL_TARGETS	88	0	1	1
MACLACHLAN_BRCA1_TARGETS_DN	16	0	1	1
LEE_AGING_CEREBELLUM_DN	70	0	1	1
EHRLICH_ICF_SYNDROM_UP	11	0	1	1
BROWNE_INTERFERON_RESPONSIVE_GENES	67	0	1	1
MCCLUNG_DELTA_FOSB_TARGETS_2WK	49	0	1	1
CUI_TCF21_TARGETS_DN	32	0	1	1
SU_THYMUS	20	0	1	1
KANG_FLUOROURACIL_RESISTANCE_DN	16	0	1	1
BROWNE_HCMV_INFECTION_8HR_UP	101	0	1	1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	69	0	1	1
JI_RESPONSE_TO_FSH_DN	53	0	1	1
WESTON_VEGFA_TARGETS_12HR	30	0	1	1
KRASNOSELSKAYA_ILF3_TARGETS_UP	39	0	1	1
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	28	0	1	1
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	50	0	1	1
BAELDE_DIABETIC_NEPHROPATHY_UP	88	0	1	1
LINDVALL_IMMORTALIZED_BY_TERT_UP	69	0	1	1
WU_HBX_TARGETS_3_UP	18	0	1	1
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	216	0	1	1
MURAKAMI_UV_RESPONSE_6HR_UP	34	0	1	1
BROWNE_HCMV_INFECTION_20HR_DN	100	0	1	1
SIMBULAN_PARP1_TARGETS_UP	30	0	1	1
ULE_SPLICING_VIA_NOVA2	43	0	1	1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	38	0	1	1
IVANOVA_HEMATOPOIESIS_STEM_CELL	189	0	1	1
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	46	0	1	1
MEDINA_SMARCA4_TARGETS	37	0	1	1
KANG_FLUOROURACIL_RESISTANCE_UP	21	0	1	1
MAHAJAN_RESPONSE_TO_IL1A_DN	68	0	1	1
RUAN_RESPONSE_TO_TNF_DN	78	0	1	1
BLALOCK_ALZHEIMERS_DISEASE_UP	1655	1	0.411484219860048	1
DELASERNA_MYOD_TARGETS_UP	83	0	1	1
BURTON_ADIPOGENESIS_12	31	0	1	1
LEONARD_HYPOXIA	43	0	1	1
KAYO_AGING_MUSCLE_DN	123	0	1	1
KAAB_FAILED_HEART_ATRIUM_UP	35	0	1	1
INGA_TP53_TARGETS	16	0	1	1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	61	0	1	1
DASU_IL6_SIGNALING_SCAR_UP	31	0	1	1
LINDVALL_IMMORTALIZED_BY_TERT_DN	74	0	1	1
DAZARD_RESPONSE_TO_UV_SCC_DN	112	0	1	1
CHIBA_RESPONSE_TO_TSA	45	0	1	1
RODWELL_AGING_KIDNEY_DN	142	0	1	1
YIH_RESPONSE_TO_ARSENITE_C2	14	0	1	1
KANG_DOXORUBICIN_RESISTANCE_UP	54	0	1	1
BROWNE_HCMV_INFECTION_48HR_DN	473	0	1	1
BROWNE_HCMV_INFECTION_48HR_UP	178	1	0.0543696445809265	1
BURTON_ADIPOGENESIS_5	113	0	1	1
WESTON_VEGFA_TARGETS	100	0	1	1
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	102	0	1	1
BROWNE_HCMV_INFECTION_8HR_DN	46	0	1	1
APRELIKOVA_BRCA1_TARGETS	43	0	1	1
VERRECCHIA_RESPONSE_TO_TGFB1_C2	21	0	1	1
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	94	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	33	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D5	36	0	1	1
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	24	0	1	1
RHODES_UNDIFFERENTIATED_CANCER	67	0	1	1
BROWNE_HCMV_INFECTION_14HR_UP	155	0	1	1
YAMAZAKI_TCEB3_TARGETS_DN	198	0	1	1
LEE_CALORIE_RESTRICTION_MUSCLE_UP	35	0	1	1
MACLACHLAN_BRCA1_TARGETS_UP	20	0	1	1
VERRECCHIA_RESPONSE_TO_TGFB1_C1	19	0	1	1
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	19	0	1	1
LEE_AGING_MUSCLE_DN	37	0	1	1
ZHANG_PROLIFERATING_VS_QUIESCENT	50	0	1	1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	66	0	1	1
VERRECCHIA_RESPONSE_TO_TGFB1_C5	21	0	1	1
GERHOLD_ADIPOGENESIS_DN	60	0	1	1
LU_AGING_BRAIN_UP	262	0	1	1
BURTON_ADIPOGENESIS_3	93	0	1	1
DAZARD_RESPONSE_TO_UV_NHEK_UP	219	0	1	1
LIAN_LIPA_TARGETS_3M	63	0	1	1
ZHU_CMV_ALL_UP	107	0	1	1
BURTON_ADIPOGENESIS_8	77	0	1	1
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	21	0	1	1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	14	0	1	1
BURTON_ADIPOGENESIS_2	70	0	1	1
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	54	0	1	1
XU_GH1_EXOGENOUS_TARGETS_UP	55	0	1	1
ZHU_CMV_8_HR_DN	49	0	1	1
ZHU_CMV_24_HR_DN	83	0	1	1
WU_HBX_TARGETS_3_DN	12	0	1	1
SU_KIDNEY	15	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D2	37	0	1	1
PAL_PRMT5_TARGETS_DN	29	0	1	1
VISALA_AGING_LYMPHOCYTE_DN	19	0	1	1
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	47	0	1	1
CHEN_ETV5_TARGETS_SERTOLI	25	0	1	1
BROWNE_HCMV_INFECTION_18HR_DN	178	0	1	1
MOREIRA_RESPONSE_TO_TSA_UP	27	0	1	1
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	22	0	1	1
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	98	0	1	1
YIH_RESPONSE_TO_ARSENITE_C4	17	0	1	1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	27	0	1	1
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	16	0	1	1
ZHENG_RESPONSE_TO_ARSENITE_UP	15	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G4	19	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D7	37	0	1	1
EHRLICH_ICF_SYNDROM_DN	13	0	1	1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	258	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D6	34	0	1	1
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	37	0	1	1
BROWNE_HCMV_INFECTION_18HR_UP	172	1	0.0522143208514458	1
LEE_AGING_NEOCORTEX_UP	73	0	1	1
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	66	0	1	1
BURTON_ADIPOGENESIS_PEAK_AT_24HR	45	0	1	1
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	30	0	1	1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	21	0	1	1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	25	0	1	1
GENTILE_UV_HIGH_DOSE_DN	285	0	1	1
HENDRICKS_SMARCA4_TARGETS_DN	48	0	1	1
HAN_JNK_SINGALING_UP	34	0	1	1
KANG_DOXORUBICIN_RESISTANCE_DN	19	0	1	1
SESTO_RESPONSE_TO_UV_C0	108	0	1	1
MCLACHLAN_DENTAL_CARIES_DN	81	0	1	1
BURTON_ADIPOGENESIS_PEAK_AT_2HR	46	0	1	1
CHEN_PDGF_TARGETS	18	0	1	1
MCCLUNG_CREB1_TARGETS_UP	100	0	1	1
LEE_AGING_CEREBELLUM_UP	81	0	1	1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	59	0	1	1
TSENG_IRS1_TARGETS_DN	133	0	1	1
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	215	0	1	1
RODWELL_AGING_KIDNEY_UP	478	0	1	1
MCCLUNG_COCAIN_REWARD_4WK	72	0	1	1
ZHOU_TNF_SIGNALING_30MIN	53	0	1	1
WELCSH_BRCA1_TARGETS_UP	199	0	1	1
JACKSON_DNMT1_TARGETS_UP	83	0	1	1
CHANG_IMMORTALIZED_BY_HPV31_UP	68	0	1	1
MODY_HIPPOCAMPUS_PRENATAL	44	0	1	1
BURTON_ADIPOGENESIS_4	45	0	1	1
ZHU_CMV_ALL_DN	118	0	1	1
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	133	0	1	1
GENTILE_UV_HIGH_DOSE_UP	21	0	1	1
SU_LIVER	57	0	1	1
CHIBA_RESPONSE_TO_TSA_DN	21	0	1	1
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	81	0	1	1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	165	0	1	1
LIANG_SILENCED_BY_METHYLATION_UP	32	0	1	1
SONG_TARGETS_OF_IE86_CMV_PROTEIN	55	0	1	1
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	62	0	1	1
CUI_TCF21_TARGETS_2_UP	417	0	1	1
SESTO_RESPONSE_TO_UV_C1	73	0	1	1
LY_AGING_MIDDLE_UP	14	0	1	1
WENG_POR_TARGETS_GLOBAL_UP	21	0	1	1
WU_HBX_TARGETS_1_UP	15	0	1	1
GEISS_RESPONSE_TO_DSRNA_UP	39	0	1	1
ABE_VEGFA_TARGETS	19	0	1	1
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	36	0	1	1
BURTON_ADIPOGENESIS_1	31	0	1	1
LIANG_SILENCED_BY_METHYLATION_DN	11	0	1	1
MOREIRA_RESPONSE_TO_TSA_DN	18	0	1	1
WENG_POR_TARGETS_GLOBAL_DN	24	0	1	1
BURTON_ADIPOGENESIS_7	48	0	1	1
BROWNE_HCMV_INFECTION_10HR_UP	94	0	1	1
LIU_SMARCA4_TARGETS	47	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D1	17	0	1	1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	271	0	1	1
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	14	0	1	1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	18	0	1	1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	45	0	1	1
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	24	0	1	1
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4	11	0	1	1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	41	0	1	1
WHITESIDE_CISPLATIN_RESISTANCE_DN	13	0	1	1
BURTON_ADIPOGENESIS_PEAK_AT_0HR	64	0	1	1
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	49	0	1	1
JACKSON_DNMT1_TARGETS_DN	21	0	1	1
DAZARD_RESPONSE_TO_UV_NHEK_DN	295	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	18	0	1	1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	17	0	1	1
KALMA_E2F1_TARGETS	11	0	1	1
VERRECCHIA_RESPONSE_TO_TGFB1_C4	11	0	1	1
ZHU_CMV_24_HR_UP	83	0	1	1
BURTON_ADIPOGENESIS_11	49	0	1	1
BROWNE_HCMV_INFECTION_12HR_UP	109	0	1	1
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	551	0	1	1
RAMASWAMY_METASTASIS_UP	65	0	1	1
DAZARD_RESPONSE_TO_UV_SCC_UP	106	0	1	1
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	93	0	1	1
JIANG_HYPOXIA_NORMAL	199	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	30	0	1	1
ABE_INNER_EAR	43	0	1	1
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	23	0	1	1
TSENG_IRS1_TARGETS_UP	114	0	1	1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	17	0	1	1
XU_GH1_AUTOCRINE_TARGETS_UP	187	0	1	1
XU_GH1_EXOGENOUS_TARGETS_DN	103	0	1	1
BAELDE_DIABETIC_NEPHROPATHY_DN	433	1	0.131341071438651	1
BROWNE_HCMV_INFECTION_6HR_UP	62	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G1	61	0	1	1
LY_AGING_OLD_DN	56	0	1	1
WENG_POR_DOSAGE	24	0	1	1
MURAKAMI_UV_RESPONSE_24HR	20	0	1	1
SEMENZA_HIF1_TARGETS	36	0	1	1
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	52	0	1	1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	181	0	1	1
VARELA_ZMPSTE24_TARGETS_UP	43	0	1	1
YIH_RESPONSE_TO_ARSENITE_C3	31	0	1	1
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	45	0	1	1
CHENG_RESPONSE_TO_NICKEL_ACETATE	42	0	1	1
TSENG_ADIPOGENIC_POTENTIAL_DN	46	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G6	142	0	1	1
XU_GH1_AUTOCRINE_TARGETS_DN	131	0	1	1
SESTO_RESPONSE_TO_UV_C7	70	0	1	1
KAAB_FAILED_HEART_VENTRICLE_DN	44	0	1	1
JIANG_HYPOXIA_CANCER	57	0	1	1
ZAMORA_NOS2_TARGETS_DN	79	0	1	1
YIH_RESPONSE_TO_ARSENITE_C1	22	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	157	0	1	1
BURTON_ADIPOGENESIS_PEAK_AT_8HR	39	0	1	1
SIMBULAN_PARP1_TARGETS_DN	17	0	1	1
SAFFORD_T_LYMPHOCYTE_ANERGY	87	1	0.0254217083006248	1
WU_HBX_TARGETS_2_UP	23	0	1	1
SESTO_RESPONSE_TO_UV_C5	46	0	1	1
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	18	0	1	1
LY_AGING_MIDDLE_DN	16	0	1	1
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	25	0	1	1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	412	0	1	1
WENG_POR_TARGETS_LIVER_UP	42	0	1	1
HU_GENOTOXIC_DAMAGE_4HR	35	0	1	1
MCDOWELL_ACUTE_LUNG_INJURY_DN	46	0	1	1
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	21	0	1	1
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	47	0	1	1
GENTILE_UV_LOW_DOSE_DN	62	0	1	1
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	16	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	19	0	1	1
GENTILE_UV_RESPONSE_CLUSTER_D8	37	0	1	1
BROWNE_HCMV_INFECTION_24HR_UP	143	0	1	1
WANG_SMARCE1_TARGETS_UP	287	0	1	1
SESTO_RESPONSE_TO_UV_C3	22	0	1	1
HAN_JNK_SINGALING_DN	38	0	1	1
KRASNOSELSKAYA_ILF3_TARGETS_DN	46	0	1	1
GENTILE_RESPONSE_CLUSTER_D3	53	0	1	1
JI_RESPONSE_TO_FSH_UP	68	0	1	1
LEE_CALORIE_RESTRICTION_MUSCLE_DN	44	0	1	1
ABE_VEGFA_TARGETS_30MIN	29	0	1	1
BROWNE_HCMV_INFECTION_6HR_DN	162	0	1	1
LEE_AGING_MUSCLE_UP	37	0	1	1
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	14	0	1	1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN	9	0	1	1
SASSON_FSH_RESPONSE	9	0	1	1
CHEN_ETV5_TARGETS_TESTIS	24	0	1	1
ZHU_CMV_8_HR_UP	41	0	1	1
WELCSH_BRCA1_TARGETS_DN	140	0	1	1
DASU_IL6_SIGNALING_SCAR_DN	16	0	1	1
JIANG_AGING_CEREBRAL_CORTEX_DN	49	0	1	1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	269	0	1	1
BURTON_ADIPOGENESIS_9	82	0	1	1
URS_ADIPOCYTE_DIFFERENTIATION_DN	30	0	1	1
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN	14	0	1	1
BROWNE_HCMV_INFECTION_12HR_DN	98	0	1	1
MAHAJAN_RESPONSE_TO_IL1A_UP	78	0	1	1
JIANG_AGING_HYPOTHALAMUS_UP	48	0	1	1
KYNG_RESPONSE_TO_H2O2	69	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G2	30	0	1	1
VERRECCHIA_RESPONSE_TO_TGFB1_C3	14	0	1	1
WESTON_VEGFA_TARGETS_3HR	68	0	1	1
TSENG_ADIPOGENIC_POTENTIAL_UP	30	0	1	1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	31	0	1	1
MCLACHLAN_DENTAL_CARIES_UP	240	0	1	1
GERHOLD_ADIPOGENESIS_UP	47	0	1	1
WENG_POR_TARGETS_LIVER_DN	22	0	1	1
SU_PLACENTA	27	0	1	1
BURTON_ADIPOGENESIS_6	186	0	1	1
SUZUKI_RESPONSE_TO_TSA	18	0	1	1
BURTON_ADIPOGENESIS_PEAK_AT_16HR	40	0	1	1
MARCHINI_TRABECTEDIN_RESISTANCE_DN	46	0	1	1
BILD_MYC_ONCOGENIC_SIGNATURE	202	0	1	1
BILD_E2F3_ONCOGENIC_SIGNATURE	238	0	1	1
BILD_HRAS_ONCOGENIC_SIGNATURE	246	0	1	1
BILD_SRC_ONCOGENIC_SIGNATURE	57	0	1	1
BILD_CTNNB1_ONCOGENIC_SIGNATURE	74	0	1	1
DOUGLAS_BMI1_TARGETS_UP	553	0	1	1
DOUGLAS_BMI1_TARGETS_DN	310	0	1	1
KRIGE_AMINO_ACID_DEPRIVATION	29	0	1	1
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	895	1	0.24357044610047	1
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	905	0	1	1
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	731	1	0.202453093282447	1
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	999	0	1	1
GHO_ATF5_TARGETS_UP	13	0	1	1
GHO_ATF5_TARGETS_DN	16	0	1	1
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	92	0	1	1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	262	0	1	1
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	15	0	1	1
LI_CYTIDINE_ANALOG_PATHWAY	17	0	1	1
KIM_LRRC3B_TARGETS	30	0	1	1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	76	0	1	1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	68	0	1	1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	131	0	1	1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	20	0	1	1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	35	0	1	1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	400	1	0.117716344813584	1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	378	0	1	1
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP	10	0	1	1
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN	7	0	1	1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	514	0	1	1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	439	0	1	1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	697	1	0.195413946462737	1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	292	0	1	1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	471	0	1	1
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP	10	0	1	1
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN	9	0	1	1
SINGH_NFE2L2_TARGETS	14	0	1	1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	64	0	1	1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	49	0	1	1
LOPES_METHYLATED_IN_COLON_CANCER_UP	28	0	1	1
LOPES_METHYLATED_IN_COLON_CANCER_DN	27	0	1	1
HARRIS_BRAIN_CANCER_PROGENITORS	43	0	1	1
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	21	0	1	1
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	18	0	1	1
BAFNA_MUC4_TARGETS_UP	4	0	1	1
HOWLIN_CITED1_TARGETS_1_UP	35	0	1	1
HOWLIN_CITED1_TARGETS_1_DN	37	0	1	1
HOWLIN_CITED1_TARGETS_2_UP	18	0	1	1
HOWLIN_CITED1_TARGETS_2_DN	16	0	1	1
HILLION_HMGA1_TARGETS	90	0	1	1
HILLION_HMGA1B_TARGETS	91	0	1	1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	75	0	1	1
LEIN_NEURON_MARKERS	67	0	1	1
LEIN_ASTROCYTE_MARKERS	43	0	1	1
LEIN_OLIGODENDROCYTE_MARKERS	75	0	1	1
LEIN_CHOROID_PLEXUS_MARKERS	103	0	1	1
LEIN_MIDBRAIN_MARKERS	81	0	1	1
LEIN_PONS_MARKERS	91	0	1	1
LEIN_MEDULLA_MARKERS	85	0	1	1
LEIN_CEREBELLUM_MARKERS	83	1	0.0251597539205624	1
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	17	0	1	1
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	37	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_T4	95	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_T7	97	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_P2	74	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_P3	158	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_P4	101	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_P6	90	0	1	1
GAVIN_FOXP3_TARGETS_CLUSTER_P7	90	0	1	1
GAVIN_PDE3B_TARGETS	22	0	1	1
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	19	0	1	1
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN	5	0	1	1
ZHENG_BOUND_BY_FOXP3	484	0	1	1
MARSON_BOUND_BY_FOXP3_STIMULATED	922	0	1	1
MARSON_BOUND_BY_FOXP3_UNSTIMULATED	1116	0	1	1
MARSON_BOUND_BY_E2F4_UNSTIMULATED	632	0	1	1
MARSON_FOXP3_TARGETS_STIMULATED_UP	30	0	1	1
MARSON_FOXP3_TARGETS_STIMULATED_DN	10	0	1	1
MARSON_FOXP3_CORE_DIRECT_TARGETS	18	0	1	1
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	193	0	1	1
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN	12	0	1	1
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	12	0	1	1
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	39	0	1	1
ZHENG_FOXP3_TARGETS_UP	26	0	1	1
ZHENG_FOXP3_TARGETS_DN	7	0	1	1
SANSOM_APC_TARGETS	201	0	1	1
SANSOM_APC_MYC_TARGETS	235	0	1	1
SANSOM_APC_TARGETS_REQUIRE_MYC	220	0	1	1
SANSOM_WNT_PATHWAY_REQUIRE_MYC	62	0	1	1
YEGNASUBRAMANIAN_PROSTATE_CANCER	130	0	1	1
RIGGINS_TAMOXIFEN_RESISTANCE_UP	67	0	1	1
RIGGINS_TAMOXIFEN_RESISTANCE_DN	219	1	0.0652106656002794	1
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	21	0	1	1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	30	0	1	1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	41	0	1	1
STEIN_ESRRA_TARGETS_UP	379	0	1	1
STEIN_ESRRA_TARGETS_DN	102	0	1	1
WANG_LSD1_TARGETS_UP	23	0	1	1
WANG_LSD1_TARGETS_DN	37	0	1	1
FOSTER_TOLERANT_MACROPHAGE_UP	161	0	1	1
FOSTER_TOLERANT_MACROPHAGE_DN	410	0	1	1
TESAR_ALK_TARGETS_EPISC_3D_UP	7	0	1	1
TESAR_ALK_TARGETS_EPISC_4D_UP	6	0	1	1
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP	5	0	1	1
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN	5	0	1	1
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN	8	0	1	1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	17	0	1	1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	12	0	1	1
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	24	0	1	1
JEPSEN_SMRT_TARGETS	32	0	1	1
KYNG_DNA_DAMAGE_BY_4NQO	33	0	1	1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	77	0	1	1
KYNG_DNA_DAMAGE_BY_UV	56	0	1	1
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	15	0	1	1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	60	0	1	1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	80	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD	12	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	37	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	29	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	31	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	23	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS	12	0	1	1
KYNG_DNA_DAMAGE_DN	181	0	1	1
KYNG_DNA_DAMAGE_UP	207	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	53	0	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	17	0	1	1
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	94	0	1	1
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	192	0	1	1
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	25	0	1	1
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3	4	0	1	1
KONDO_EZH2_TARGETS	225	0	1	1
ZHANG_GATA6_TARGETS_UP	14	0	1	1
ZHANG_GATA6_TARGETS_DN	64	0	1	1
MCGOWAN_RSP6_TARGETS_UP	19	0	1	1
MCGOWAN_RSP6_TARGETS_DN	5	0	1	1
KANG_CISPLATIN_RESISTANCE_UP	21	0	1	1
KANG_CISPLATIN_RESISTANCE_DN	8	0	1	1
STEARMAN_TUMOR_FIELD_EFFECT_UP	37	0	1	1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	126	0	1	1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	61	0	1	1
HELLER_SILENCED_BY_METHYLATION_UP	275	0	1	1
HELLER_SILENCED_BY_METHYLATION_DN	106	0	1	1
HELLER_HDAC_TARGETS_UP	309	0	1	1
HELLER_HDAC_TARGETS_DN	288	0	1	1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	446	0	1	1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	275	0	1	1
CLAUS_PGR_POSITIVE_MENINGIOMA_UP	10	0	1	1
CLAUS_PGR_POSITIVE_MENINGIOMA_DN	12	0	1	1
WONG_MITOCHONDRIA_GENE_MODULE	217	0	1	1
WONG_PROTEASOME_GENE_MODULE	49	0	1	1
COATES_MACROPHAGE_M1_VS_M2_UP	85	0	1	1
COATES_MACROPHAGE_M1_VS_M2_DN	81	0	1	1
LEE_METASTASIS_AND_RNA_PROCESSING_UP	16	0	1	1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	73	0	1	1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	45	0	1	1
LIN_MELANOMA_COPY_NUMBER_UP	71	0	1	1
LIN_MELANOMA_COPY_NUMBER_DN	41	0	1	1
MARTINEZ_RB1_TARGETS_UP	677	0	1	1
MARTINEZ_RB1_TARGETS_DN	550	0	1	1
MARTINEZ_TP53_TARGETS_UP	610	0	1	1
MARTINEZ_TP53_TARGETS_DN	596	0	1	1
MARTINEZ_RB1_AND_TP53_TARGETS_UP	608	0	1	1
MARTINEZ_RB1_AND_TP53_TARGETS_DN	593	0	1	1
FINETTI_BREAST_CANCER_KINOME_RED	16	0	1	1
FINETTI_BREAST_CANCER_KINOME_GREEN	16	0	1	1
FINETTI_BREAST_CANCERS_KINOME_BLUE	21	0	1	1
FINETTI_BREAST_CANCERS_KINOME_GRAY	15	0	1	1
MASSARWEH_TAMOXIFEN_RESISTANCE_UP	561	0	1	1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	239	0	1	1
MASSARWEH_RESPONSE_TO_ESTRADIOL	61	0	1	1
WALLACE_PROSTATE_CANCER_UP	19	0	1	1
WALLACE_PROSTATE_CANCER_DN	6	0	1	1
WALLACE_PROSTATE_CANCER_RACE_UP	286	0	1	1
WALLACE_PROSTATE_CANCER_RACE_DN	84	0	1	1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	180	0	1	1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	154	0	1	1
OUILLETTE_CLL_13Q14_DELETION_UP	73	0	1	1
OUILLETTE_CLL_13Q14_DELETION_DN	53	0	1	1
YOKOE_CANCER_TESTIS_ANTIGENS	33	0	1	1
MARZEC_IL2_SIGNALING_UP	113	0	1	1
MARZEC_IL2_SIGNALING_DN	36	0	1	1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	189	0	1	1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	350	0	1	1
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	171	0	1	1
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	121	0	1	1
DER_IFN_ALPHA_RESPONSE_DN	4	0	1	1
CAMPS_COLON_CANCER_COPY_NUMBER_UP	88	0	1	1
CAMPS_COLON_CANCER_COPY_NUMBER_DN	67	0	1	1
RIZKI_TUMOR_INVASIVENESS_3D_UP	209	0	1	1
RIZKI_TUMOR_INVASIVENESS_3D_DN	259	1	0.0724345076685805	1
RIZKI_TUMOR_INVASIVENESS_2D_UP	69	0	1	1
RIZKI_TUMOR_INVASIVENESS_2D_DN	62	0	1	1
FUJII_YBX1_TARGETS_UP	42	0	1	1
FUJII_YBX1_TARGETS_DN	194	0	1	1
OSADA_ASCL1_TARGETS_UP	46	0	1	1
OSADA_ASCL1_TARGETS_DN	24	0	1	1
CHENG_IMPRINTED_BY_ESTRADIOL	108	0	1	1
DE_YY1_TARGETS_UP	19	0	1	1
DE_YY1_TARGETS_DN	93	0	1	1
MCCABE_BOUND_BY_HOXC6	442	0	1	1
POS_RESPONSE_TO_HISTAMINE_UP	12	0	1	1
POS_RESPONSE_TO_HISTAMINE_DN	11	0	1	1
POS_HISTAMINE_RESPONSE_NETWORK	32	0	1	1
DAIRKEE_CANCER_PRONE_RESPONSE_E2	28	0	1	1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	51	0	1	1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	117	0	1	1
YAMASHITA_SILENCED_BY_METHYLATION	7	0	1	1
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	61	0	1	1
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	19	0	1	1
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	20	0	1	1
OUYANG_PROSTATE_CANCER_MARKERS	20	0	1	1
RIGGI_EWING_SARCOMA_PROGENITOR_UP	421	0	1	1
RIGGI_EWING_SARCOMA_PROGENITOR_DN	184	0	1	1
GAUTSCHI_SRC_SIGNALING	8	0	1	1
VICENT_METASTASIS_UP	14	0	1	1
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	107	0	1	1
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	36	0	1	1
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	47	0	1	1
ENGELMANN_CANCER_PROGENITORS_UP	48	0	1	1
ENGELMANN_CANCER_PROGENITORS_DN	69	0	1	1
WORSCHECH_TUMOR_REJECTION_UP	59	0	1	1
WORSCHECH_TUMOR_REJECTION_DN	10	0	1	1
HUANG_FOXA2_TARGETS_UP	47	0	1	1
HUANG_FOXA2_TARGETS_DN	38	0	0.999999999999999	1
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	20	0	1	1
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	20	0	1	1
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	24	0	1	1
MCCABE_HOXC6_TARGETS_UP	10	0	1	1
MCCABE_HOXC6_TARGETS_DN	21	0	1	1
TING_SILENCED_BY_DICER	30	0	1	1
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1	12	0	1	1
MCCABE_HOXC6_TARGETS_CANCER_UP	30	0	1	1
MCCABE_HOXC6_TARGETS_CANCER_DN	20	0	1	1
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	65	0	1	1
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	57	0	1	1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	170	0	1	1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	348	0	1	1
ACEVEDO_LIVER_CANCER_UP	967	0	1	1
ACEVEDO_LIVER_CANCER_DN	529	0	1	1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	855	0	1	1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	269	0	1	1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	277	0	1	1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	202	0	1	1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	126	0	1	1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	115	0	1	1
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	806	2	0.0149987459922115	1
MITSIADES_RESPONSE_TO_APLIDIN_UP	440	0	1	1
MITSIADES_RESPONSE_TO_APLIDIN_DN	247	0	1	1
HOQUE_METHYLATED_IN_CANCER	56	0	1	1
NADELLA_PRKAR1A_TARGETS_UP	9	0	1	1
NADELLA_PRKAR1A_TARGETS_DN	7	0	1	1
SAGIV_CD24_TARGETS_UP	22	0	1	1
SAGIV_CD24_TARGETS_DN	45	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	39	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	80	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	98	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	300	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	22	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	38	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP	6	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN	10	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP	5	0	1	1
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	27	0	1	1
SMID_BREAST_CANCER_LUMINAL_B_UP	166	0	1	1
SMID_BREAST_CANCER_LUMINAL_B_DN	549	0	1	1
SMID_BREAST_CANCER_LUMINAL_A_UP	85	0	1	1
SMID_BREAST_CANCER_LUMINAL_A_DN	18	0	1	1
SMID_BREAST_CANCER_ERBB2_UP	139	0	1	1
SMID_BREAST_CANCER_ERBB2_DN	5	0	1	1
SMID_BREAST_CANCER_NORMAL_LIKE_UP	459	0	1	1
SMID_BREAST_CANCER_NORMAL_LIKE_DN	6	0	1	1
SMID_BREAST_CANCER_BASAL_UP	635	0	1	1
SMID_BREAST_CANCER_BASAL_DN	691	0	1	1
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	9	0	1	1
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN	10	0	1	1
ITO_PTTG1_TARGETS_UP	12	0	1	1
ITO_PTTG1_TARGETS_DN	9	0	1	1
LE_SKI_TARGETS_UP	17	0	1	1
LE_SKI_TARGETS_DN	6	0	1	1
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	31	0	1	1
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	21	0	1	1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	231	0	1	1
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	497	0	1	1
GALI_TP53_TARGETS_APOPTOTIC_UP	8	0	1	1
GALI_TP53_TARGETS_APOPTOTIC_DN	6	0	1	1
MOSERLE_IFNA_RESPONSE	31	0	1	1
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	42	0	1	1
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	20	0	1	1
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN	5	0	1	1
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP	6	0	1	1
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	42	0	1	1
WEBER_METHYLATED_HCP_IN_SPERM_DN	28	0	1	1
WEBER_METHYLATED_HCP_IN_SPERM_UP	20	0	1	1
BASSO_HAIRY_CELL_LEUKEMIA_UP	78	0	1	1
BASSO_HAIRY_CELL_LEUKEMIA_DN	5	0	1	1
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	442	0	1	1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	127	0	1	1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	106	0	1	1
ZHANG_BREAST_CANCER_PROGENITORS_UP	430	0	1	1
ZHANG_BREAST_CANCER_PROGENITORS_DN	137	0	1	1
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	24	0	1	1
BERNARD_PPAPDC1B_TARGETS_UP	37	0	1	1
BERNARD_PPAPDC1B_TARGETS_DN	56	0	1	1
GAURNIER_PSMD4_TARGETS	70	0	1	1
EHLERS_ANEUPLOIDY_UP	40	0	1	1
EHLERS_ANEUPLOIDY_DN	12	0	1	1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	247	0	1	1
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	59	0	1	1
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	20	0	1	1
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	22	0	1	1
JONES_TCOF1_TARGETS	5	0	1	1
AUJLA_IL22_AND_IL17A_SIGNALING	11	0	1	1
ZHENG_IL22_SIGNALING_UP	59	0	1	1
ZHENG_IL22_SIGNALING_DN	38	0	1	1
BOCHKIS_FOXA2_TARGETS	426	1	0.108312489476845	1
HONMA_DOCETAXEL_RESISTANCE	35	0	1	1
WILENSKY_RESPONSE_TO_DARAPLADIB	28	0	1	1
MATZUK_OVULATION	15	0	1	1
MATZUK_CUMULUS_EXPANSION	9	0	1	1
MATZUK_FERTILIZATION	8	0	1	1
MATZUK_MATERNAL_EFFECT	9	0	1	1
MATZUK_IMPLANTATION_AND_UTERINE	22	0	1	1
MATZUK_POSTIMPLANTATION_AND_POSTPARTUM	14	0	1	1
MATZUK_STEROIDOGENESIS	7	0	1	1
MATZUK_MEIOTIC_AND_DNA_REPAIR	39	0	1	1
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	29	0	1	1
MATZUK_EMBRYONIC_GERM_CELL	18	0	1	1
MATZUK_EARLY_ANTRAL_FOLLICLE	13	0	1	1
MATZUK_LUTEAL_GENES	8	0	1	1
MATZUK_PREOVULATORY_FOLLICLE	10	0	1	1
MATZUK_MALE_REPRODUCTION_SERTOLI	28	0	1	1
MATZUK_SPERMATOGONIA	22	0	1	1
MATZUK_SPERMATOCYTE	72	0	1	1
MATZUK_SPERMATID_DIFFERENTIATION	37	0	1	1
MATZUK_SPERMATOZOA	114	0	1	1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	92	0	1	1
CHUNG_BLISTER_CYTOTOXICITY_UP	134	0	1	1
CHUNG_BLISTER_CYTOTOXICITY_DN	46	0	1	1
WHITEFORD_PEDIATRIC_CANCER_MARKERS	116	0	1	1
GRADE_COLON_AND_RECTAL_CANCER_UP	289	0	1	1
GRADE_COLON_AND_RECTAL_CANCER_DN	100	0	1	1
GRADE_COLON_VS_RECTAL_CANCER_UP	36	0	1	1
GRADE_COLON_VS_RECTAL_CANCER_DN	56	0	1	1
BOQUEST_STEM_CELL_UP	259	0	1	1
BOQUEST_STEM_CELL_DN	214	0	1	1
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	424	0	1	1
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	31	0	1	1
NAKAMURA_METASTASIS	46	0	1	1
NAKAMURA_METASTASIS_MODEL_UP	41	0	1	1
NAKAMURA_METASTASIS_MODEL_DN	43	0	1	1
GRATIAS_RETINOBLASTOMA_16Q24	18	0	1	1
WEST_ADRENOCORTICAL_TUMOR_UP	296	0	1	1
WEST_ADRENOCORTICAL_TUMOR_DN	537	0	1	1
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	20	0	1	1
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	25	0	1	1
DONATO_CELL_CYCLE_TRETINOIN	6	0	1	1
CHO_NR4A1_TARGETS	31	0	1	1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	119	0	1	1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	127	0	1	1
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	23	0	1	1
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN	8	0	1	1
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	27	0	1	1
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN	7	0	1	1
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA	10	0	1	1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	194	0	1	1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	259	0	1	1
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP	7	0	1	1
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	12	0	1	1
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	110	0	1	1
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	75	0	1	1
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	147	0	1	1
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	18	0	1	1
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	22	0	1	1
LU_TUMOR_ENDOTHELIAL_MARKERS_DN	5	0	1	1
LU_TUMOR_ANGIOGENESIS_UP	25	0	1	1
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	20	0	1	1
CHEN_HOXA5_TARGETS_6HR_UP	10	0	1	1
CHEN_HOXA5_TARGETS_6HR_DN	6	0	1	1
CHEN_HOXA5_TARGETS_9HR_UP	222	0	1	1
CHEN_HOXA5_TARGETS_9HR_DN	42	0	1	1
LIN_NPAS4_TARGETS_UP	166	0	1	1
LIN_NPAS4_TARGETS_DN	67	0	1	1
CADWELL_ATG16L1_TARGETS_UP	102	0	1	1
CADWELL_ATG16L1_TARGETS_DN	62	0	1	1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	64	0	1	1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	58	0	1	1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	51	0	1	1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	40	0	1	1
CONRAD_STEM_CELL	39	0	1	1
CONRAD_GERMLINE_STEM_CELL	13	0	1	1
THUM_MIR21_TARGETS_HEART_DISEASE_UP	18	0	1	1
THUM_MIR21_TARGETS_HEART_DISEASE_DN	9	0	1	1
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	32	0	1	1
HUANG_DASATINIB_RESISTANCE_UP	80	0	1	1
HUANG_DASATINIB_RESISTANCE_DN	68	0	1	1
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	15	0	1	1
MATTHEWS_AP1_TARGETS	15	0	1	1
QI_PLASMACYTOMA_UP	253	1	0.0665538513888592	1
QI_PLASMACYTOMA_DN	98	0	1	1
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	77	0	1	1
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	52	0	1	1
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	30	0	1	1
HUPER_BREAST_BASAL_VS_LUMINAL_UP	53	0	1	1
HUPER_BREAST_BASAL_VS_LUMINAL_DN	58	0	1	1
MALONEY_RESPONSE_TO_17AAG_UP	39	0	1	1
MALONEY_RESPONSE_TO_17AAG_DN	77	0	1	1
CUI_GLUCOSE_DEPRIVATION	60	0	1	1
BLUM_RESPONSE_TO_SALIRASIB_UP	245	0	1	1
BLUM_RESPONSE_TO_SALIRASIB_DN	339	0	1	1
WINTER_HYPOXIA_METAGENE	237	0	1	1
ALONSO_METASTASIS_EMT_UP	35	0	1	1
ALONSO_METASTASIS_EMT_DN	5	0	1	1
ALONSO_METASTASIS_NEURAL_UP	18	0	1	1
ALONSO_METASTASIS_UP	190	0	1	1
ALONSO_METASTASIS_DN	25	0	1	1
CROMER_TUMORIGENESIS_UP	58	0	1	1
CROMER_TUMORIGENESIS_DN	49	0	1	1
KRISHNAN_FURIN_TARGETS_UP	8	0	1	1
KRISHNAN_FURIN_TARGETS_DN	9	0	1	1
MUELLER_PLURINET	297	0	1	1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	138	0	1	1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	248	0	1	1
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION	9	0	1	1
FIRESTEIN_CTNNB1_PATHWAY	32	0	1	1
FIRESTEIN_PROLIFERATION	166	0	1	1
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR	11	0	1	1
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR	14	0	1	1
ZHOU_PANCREATIC_BETA_CELL	11	0	1	1
ISHIKAWA_STING_SIGNALING	7	0	1	1
WANG_TUMOR_INVASIVENESS_UP	383	0	1	1
WANG_TUMOR_INVASIVENESS_DN	210	0	1	1
JIANG_TIP30_TARGETS_UP	46	0	1	1
JIANG_TIP30_TARGETS_DN	24	0	1	1
GRESHOCK_CANCER_COPY_NUMBER_UP	323	0	1	1
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	22	0	1	1
TSAI_RESPONSE_TO_RADIATION_THERAPY	32	0	1	1
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP	14	0	1	1
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN	8	0	1	1
MIKI_COEXPRESSED_WITH_CYP19A1	5	0	1	1
BEIER_GLIOMA_STEM_CELL_UP	38	0	1	1
BEIER_GLIOMA_STEM_CELL_DN	66	0	1	1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	159	0	1	1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	129	0	1	1
MOOTHA_HUMAN_MITODB_6_2002	428	0	1	1
MOOTHA_PGC	415	0	1	1
MOOTHA_TCA	15	0	1	1
LEE_LIVER_CANCER_SURVIVAL_DN	175	0	1	1
LEE_LIVER_CANCER_SURVIVAL_UP	180	0	1	1
MOOTHA_MITOCHONDRIA	446	0	1	1
MOOTHA_ROS	7	0	1	1
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP	13	0	1	1
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	26	0	1	1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	35	0	1	1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	32	0	1	1
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	28	0	1	1
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	35	0	1	1
BOYLAN_MULTIPLE_MYELOMA_D_UP	90	0	1	1
BOYLAN_MULTIPLE_MYELOMA_D_DN	77	0	1	1
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	136	0	1	1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	275	0	1	1
BOYLAN_MULTIPLE_MYELOMA_C_UP	49	0	1	1
BOYLAN_MULTIPLE_MYELOMA_C_DN	56	0	1	1
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	52	0	1	1
FERRARI_RESPONSE_TO_FENRETINIDE_UP	22	0	1	1
FERRARI_RESPONSE_TO_FENRETINIDE_DN	5	0	1	1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	76	0	1	1
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS	8	0	1	1
GU_PDEF_TARGETS_UP	71	0	1	1
GU_PDEF_TARGETS_DN	40	0	1	1
TOOKER_GEMCITABINE_RESISTANCE_UP	77	0	1	1
TOOKER_GEMCITABINE_RESISTANCE_DN	123	0	1	1
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	46	1	0.0125010563134495	1
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	38	0	1	1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	52	0	1	1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	30	0	1	1
VILIMAS_NOTCH1_TARGETS_UP	51	0	1	1
VILIMAS_NOTCH1_TARGETS_DN	24	0	1	1
SPIRA_SMOKERS_LUNG_CANCER_UP	39	0	1	1
SPIRA_SMOKERS_LUNG_CANCER_DN	15	0	1	1
LUDWICZEK_TREATING_IRON_OVERLOAD	7	0	1	1
JU_AGING_TERC_TARGETS_UP	6	0	1	1
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	14	0	1	1
WAGNER_APO2_SENSITIVITY	26	0	1	1
PALOMERO_GSI_SENSITIVITY_UP	7	0	1	1
PALOMERO_GSI_SENSITIVITY_DN	5	0	1	1
SOUCEK_MYC_TARGETS	12	0	1	1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	77	0	1	1
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	22	0	1	1
RAY_ALZHEIMERS_DISEASE	13	0	1	1
HUNSBERGER_EXERCISE_REGULATED_GENES	31	0	1	1
PIONTEK_PKD1_TARGETS_UP	37	0	1	1
PIONTEK_PKD1_TARGETS_DN	17	0	1	1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	49	0	1	1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	101	0	1	1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	23	0	1	1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	49	0	1	1
GOLDRATH_ANTIGEN_RESPONSE	355	1	0.0948270841062328	1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	114	0	1	1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	43	0	1	1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	144	0	1	1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	50	0	1	1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	61	0	1	1
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	48	0	1	1
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	62	0	1	1
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	61	0	1	1
MARSHALL_VIRAL_INFECTION_RESPONSE_UP	9	0	1	1
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	27	0	1	1
MARTINELLI_IMMATURE_NEUTROPHIL_UP	11	0	1	1
MARTINELLI_IMMATURE_NEUTROPHIL_DN	13	0	1	1
NICK_RESPONSE_TO_PROC_TREATMENT_DN	26	0	1	1
NUTT_GBM_VS_AO_GLIOMA_UP	46	0	1	1
NUTT_GBM_VS_AO_GLIOMA_DN	45	0	1	1
PARK_APL_PATHOGENESIS_UP	14	0	1	1
PARK_APL_PATHOGENESIS_DN	48	0	1	1
PARK_TRETINOIN_RESPONSE	12	0	1	1
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	30	0	1	1
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	23	0	1	1
ZHANG_INTERFERON_RESPONSE	22	0	1	1
WU_ALZHEIMER_DISEASE_UP	12	0	1	1
WU_ALZHEIMER_DISEASE_DN	19	0	1	1
MIZUKAMI_HYPOXIA_UP	12	0	1	1
MIZUKAMI_HYPOXIA_DN	6	0	1	1
YOSHIMURA_MAPK8_TARGETS_UP	1200	0	1	1
YOSHIMURA_MAPK8_TARGETS_DN	358	0	1	1
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	60	0	1	1
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	11	0	1	1
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	16	0	1	1
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15	0	1	1
RUIZ_TNC_TARGETS_UP	155	0	1	1
RUIZ_TNC_TARGETS_DN	143	0	1	1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	336	0	1	1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	318	0	1	1
RUTELLA_RESPONSE_TO_HGF_UP	419	0	1	1
RUTELLA_RESPONSE_TO_HGF_DN	235	0	1	1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	410	0	1	1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	244	0	1	1
SCHRAETS_MLL_TARGETS_UP	30	0	1	1
SCHRAETS_MLL_TARGETS_DN	31	0	1	1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	13	0	1	1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	33	0	1	1
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	79	0	1	1
VANASSE_BCL2_TARGETS_UP	27	0	1	1
VANASSE_BCL2_TARGETS_DN	59	0	1	1
VANTVEER_BREAST_CANCER_ESR1_UP	207	0	1	1
VANTVEER_BREAST_CANCER_ESR1_DN	267	0	1	1
VANTVEER_BREAST_CANCER_BRCA1_UP	41	0	1	1
VANTVEER_BREAST_CANCER_BRCA1_DN	47	0	1	1
WALLACE_JAK2_TARGETS_UP	23	0	1	1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	297	0	1	1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	235	0	1	1
SWEET_LUNG_CANCER_KRAS_UP	472	0	1	1
SWEET_LUNG_CANCER_KRAS_DN	412	0	1	1
SWEET_KRAS_ONCOGENIC_SIGNATURE	89	0	1	1
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	85	0	1	1
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	23	0	1	1
HINATA_NFKB_TARGETS_FIBROBLAST_UP	81	0	1	1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	28	0	1	1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	74	0	1	1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	153	0	1	1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	61	0	1	1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	64	0	1	1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	35	0	1	1
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	40	0	1	1
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	47	0	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	21	0	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	29	0	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP	10	0	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	20	0	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	23	0	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	23	0	1	1
LEE_EARLY_T_LYMPHOCYTE_UP	103	0	1	1
LEE_EARLY_T_LYMPHOCYTE_DN	57	0	1	1
LEE_INTRATHYMIC_T_PROGENITOR	20	0	1	1
LEE_DOUBLE_POLAR_THYMOCYTE	26	0	1	1
LEE_SP4_THYMOCYTE	15	0	1	1
LEE_RECENT_THYMIC_EMIGRANT	230	0	1	1
LEE_NAIVE_T_LYMPHOCYTE	20	0	1	1
LEE_DIFFERENTIATING_T_LYMPHOCYTE	187	0	1	1
LI_WILMS_TUMOR	27	0	1	1
FINAK_BREAST_CANCER_SDPP_SIGNATURE	25	0	1	1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	452	0	1	1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	197	0	1	1
BRUNEAU_SEPTATION_ATRIAL	5	0	1	1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	69	0	1	1
BRUNEAU_SEPTATION_VENTRICULAR	10	0	1	1
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS	8	0	1	1
MELLMAN_TUT1_TARGETS_UP	20	0	1	1
MELLMAN_TUT1_TARGETS_DN	47	0	1	1
HAN_SATB1_TARGETS_UP	422	0	1	1
HAN_SATB1_TARGETS_DN	387	0	1	1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	279	0	1	1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	336	0	1	1
CHEN_METABOLIC_SYNDROM_NETWORK	1223	0	1	1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	28	0	1	1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	67	0	1	1
MIKKELSEN_PLURIPOTENT_STATE_UP	10	0	1	1
MIKKELSEN_PLURIPOTENT_STATE_DN	8	0	1	1
MIKKELSEN_DEDIFFERENTIATED_STATE_UP	8	0	1	1
MIKKELSEN_DEDIFFERENTIATED_STATE_DN	7	0	1	1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY	10	0	1	1
ELLWOOD_MYC_TARGETS_UP	14	0	1	1
ELLWOOD_MYC_TARGETS_DN	43	0	1	1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	35	0	1	1
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	100	0	1	1
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	66	0	1	1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	80	0	1	1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	64	0	1	1
HSIAO_HOUSEKEEPING_GENES	394	0	1	1
MEISSNER_ES_ICP_WITH_H3K4ME3	31	0	1	1
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	14	0	1	1
MEISSNER_NPC_HCP_WITH_H3K27ME3	78	0	1	1
MEISSNER_NPC_ICP_WITH_H3K4ME3	19	0	1	1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	141	0	1	1
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	534	0	1	1
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	21	0	1	1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	265	0	1	1
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	30	0	1	1
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	1065	0	1	1
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	39	0	1	1
TAVAZOIE_METASTASIS	102	0	1	1
WENDT_COHESIN_TARGETS_UP	32	0	1	1
FERRANDO_HOX11_NEIGHBORS	23	0	1	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP	5	0	1	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	25	0	1	1
ZHAN_EARLY_DIFFERENTIATION_GENES_UP	7	0	1	1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	42	0	1	1
MILI_PSEUDOPODIA	48	0	1	1
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	83	0	1	1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	422	0	1	1
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	512	0	1	1
MILI_PSEUDOPODIA_HAPTOTAXIS_DN	669	0	1	1
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	87	0	1	1
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	17	0	1	1
CROONQUIST_IL6_DEPRIVATION_UP	17	0	1	1
CROONQUIST_IL6_DEPRIVATION_DN	95	0	1	1
CROONQUIST_STROMAL_STIMULATION_UP	56	0	1	1
CROONQUIST_STROMAL_STIMULATION_DN	12	0	1	1
CROONQUIST_NRAS_SIGNALING_UP	38	0	1	1
CROONQUIST_NRAS_SIGNALING_DN	70	0	1	1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	39	0	1	1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	98	0	1	1
IRITANI_MAD1_TARGETS_UP	13	0	1	1
IRITANI_MAD1_TARGETS_DN	46	0	1	1
ZHAN_LATE_DIFFERENTIATION_GENES_UP	32	0	1	1
ZHAN_LATE_DIFFERENTIATION_GENES_DN	17	0	1	1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	17	0	1	1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	29	0	1	1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	33	0	1	1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	16	0	1	1
ISHIDA_E2F_TARGETS	51	0	1	1
VALK_AML_CLUSTER_1	28	0	1	1
VALK_AML_CLUSTER_2	29	0	1	1
VALK_AML_CLUSTER_3	34	0	1	1
VALK_AML_CLUSTER_4	29	0	1	1
VALK_AML_CLUSTER_5	31	0	1	1
VALK_AML_CLUSTER_6	34	0	1	1
VALK_AML_CLUSTER_7	27	0	1	1
VALK_AML_CLUSTER_8	25	0	1	1
VALK_AML_CLUSTER_9	35	0	1	1
VALK_AML_CLUSTER_10	32	0	1	1
VALK_AML_CLUSTER_11	38	0	1	1
VALK_AML_CLUSTER_12	30	0	1	1
VALK_AML_CLUSTER_13	31	0	1	1
VALK_AML_CLUSTER_15	30	0	1	1
VALK_AML_CLUSTER_16	29	0	1	1
VALK_AML_WITH_T_8_21_TRANSLOCATION	5	0	1	1
VALK_AML_WITH_11Q23_REARRANGED	23	0	1	1
VALK_AML_WITH_EVI1	24	0	1	1
VALK_AML_WITH_CEBPA	35	0	1	1
VALK_AML_WITH_FLT3_ITD	40	0	1	1
JISON_SICKLE_CELL_DISEASE_UP	181	0	1	1
JISON_SICKLE_CELL_DISEASE_DN	181	0	1	1
POOLA_INVASIVE_BREAST_CANCER_UP	270	0	1	1
POOLA_INVASIVE_BREAST_CANCER_DN	132	0	1	1
DING_LUNG_CANCER_MUTATED_RECURRENTLY	6	0	1	1
DING_LUNG_CANCER_BY_MUTATION_RATE	20	0	1	1
TCGA_GLIOBLASTOMA_MUTATED	8	0	1	1
CHEN_LIVER_METABOLISM_QTL_CIS	94	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	116	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	40	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G2	27	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	190	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	53	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	27	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	66	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	19	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	40	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	15	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	52	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN	10	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	11	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	45	0	1	1
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	51	1	0.0123816676384249	1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	172	1	0.0472627696226497	1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	167	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	175	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	177	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	25	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	50	1	0.0162487311360611	1
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	73	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	25	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	85	0	1	1
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	190	0	1	1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	108	0	1	1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	136	0	1	1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	61	0	1	1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	70	0	1	1
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	73	0	1	1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	111	0	1	1
KAPOSI_LIVER_CANCER_MET_UP	18	0	1	1
KAPOSI_LIVER_CANCER_MET_DN	6	0	1	1
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	53	0	1	1
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	16	0	1	1
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	47	0	1	1
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	76	0	1	1
LEE_LIVER_CANCER_HEPATOBLAST	16	0	1	1
WANG_RECURRENT_LIVER_CANCER_UP	20	0	1	1
WANG_RECURRENT_LIVER_CANCER_DN	16	0	1	1
WOO_LIVER_CANCER_RECURRENCE_UP	104	0	1	1
WOO_LIVER_CANCER_RECURRENCE_DN	78	0	1	1
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP	11	0	1	1
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN	8	0	1	1
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	12	0	1	1
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN	11	0	1	1
YAGI_AML_WITH_T_8_21_TRANSLOCATION	364	0	1	1
YAGI_AML_WITH_INV_16_TRANSLOCATION	403	1	0.112231014932865	1
YAGI_AML_WITH_T_9_11_TRANSLOCATION	131	0	1	1
YAGI_AML_WITH_11Q23_REARRANGED	340	0	1	1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	342	0	1	1
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	60	0	1	1
MEISSNER_NPC_HCP_WITH_H3K4ME2	484	0	1	1
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	18	0	1	1
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	431	0	1	1
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	34	0	1	1
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	73	0	1	1
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	24	0	1	1
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	161	0	1	1
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	38	0	1	1
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	200	1	0.0525898606981543	1
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	65	0	1	1
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	126	0	1	1
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	103	0	1	1
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	80	0	1	1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	122	0	1	1
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	55	0	1	1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3	5	0	1	1
MIKKELSEN_IPS_LCP_WITH_H3K27ME3	10	0	1	1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	171	0	1	1
GLINSKY_CANCER_DEATH_UP	7	0	1	1
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	12	0	1	1
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	6	0	1	1
MARSON_FOXP3_TARGETS_UP	66	0	1	1
MARSON_FOXP3_TARGETS_DN	54	0	1	1
ONO_AML1_TARGETS_UP	24	0	1	1
ONO_AML1_TARGETS_DN	40	0	1	1
ONO_FOXP3_TARGETS_UP	23	0	1	1
ONO_FOXP3_TARGETS_DN	42	0	1	1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	66	0	1	1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	20	0	1	1
SCHOEN_NFKB_SIGNALING	34	0	1	1
NGO_MALIGNANT_GLIOMA_1P_LOH	14	0	1	1
YANAGISAWA_LUNG_CANCER_RECURRENCE	9	0	1	1
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	79	0	1	1
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	44	0	1	1
TSAI_DNAJB4_TARGETS_UP	13	0	1	1
TSAI_DNAJB4_TARGETS_DN	6	0	1	1
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	42	0	1	1
LI_PROSTATE_CANCER_EPIGENETIC	30	0	1	1
UROSEVIC_RESPONSE_TO_IMIQUIMOD	20	0	1	1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	44	0	1	1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	20	0	1	1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	75	0	1	1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	70	0	1	1
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	37	0	1	1
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	26	0	1	1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	66	0	1	1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	77	0	1	1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	16	0	1	1
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP	13	0	1	1
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN	10	0	1	1
WEBER_METHYLATED_ICP_IN_FIBROBLAST	20	0	1	1
WEBER_METHYLATED_ICP_IN_SPERM_UP	8	0	1	1
WEBER_METHYLATED_ICP_IN_SPERM_DN	12	0	1	1
WEBER_METHYLATED_LCP_IN_SPERM_UP	15	0	1	1
WEBER_METHYLATED_LCP_IN_SPERM_DN	8	0	1	1
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	57	0	1	1
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN	9	0	1	1
GYORFFY_DOXORUBICIN_RESISTANCE	39	0	1	1
GYORFFY_MITOXANTRONE_RESISTANCE	34	0	1	1
SYED_ESTRADIOL_RESPONSE	18	0	1	1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	31	0	1	1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN	14	0	1	1
STEIN_ESR1_TARGETS	82	0	1	1
STEIN_ESRRA_TARGETS	520	0	1	1
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18	0	1	1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	82	0	1	1
LOPEZ_EPITHELIOID_MESOTHELIOMA	17	0	1	1
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP	8	0	1	1
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	15	0	1	1
LOPEZ_MESOTHELIOMA_SURVIVAL_UP	12	0	1	1
LOPEZ_MESOTHELIOMA_SURVIVAL_DN	12	0	1	1
KORKOLA_CORRELATED_WITH_POU5F1	32	0	1	1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	23	0	1	1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	25	0	1	1
KOBAYASHI_EGFR_SIGNALING_24HR_UP	100	0	1	1
KOBAYASHI_EGFR_SIGNALING_24HR_DN	252	0	1	1
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	279	1	0.0851792677436491	1
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	118	0	1	1
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN	9	0	1	1
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	80	0	1	1
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	67	0	1	1
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	234	0	1	1
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	115	0	1	1
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	266	0	1	1
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	185	1	0.0549741115382877	1
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	29	0	1	1
CAIRO_HEPATOBLASTOMA_UP	211	0	1	1
CAIRO_HEPATOBLASTOMA_DN	265	0	1	1
CAIRO_HEPATOBLASTOMA_CLASSES_UP	605	0	1	1
CAIRO_HEPATOBLASTOMA_CLASSES_DN	210	0	1	1
CAIRO_LIVER_DEVELOPMENT_UP	165	0	1	1
CAIRO_LIVER_DEVELOPMENT_DN	221	0	1	1
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	16	0	1	1
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	12	0	1	1
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	55	0	1	1
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP	10	0	1	1
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN	9	0	1	1
GUTIERREZ_MULTIPLE_MYELOMA_UP	35	0	1	1
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2	12	0	1	1
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	162	0	1	1
HAHTOLA_CTCL_CUTANEOUS	26	0	1	1
HAHTOLA_CTCL_PATHOGENESIS	15	0	1	1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	36	0	1	1
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	60	0	1	1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	80	1	0.0250442241996524	1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	190	0	1	1
KYNG_NORMAL_AGING_UP	15	0	1	1
KYNG_NORMAL_AGING_DN	18	0	1	1
KYNG_WERNER_SYNDROM_UP	15	0	1	1
KYNG_WERNER_SYNDROM_DN	18	0	1	1
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	29	0	1	1
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	19	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA	9	0	1	1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	26	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD1_DN	45	0	1	1
ZHAN_MULTIPLE_MYELOMA_CD2_DN	47	0	1	1
ZHAN_MULTIPLE_MYELOMA_LB_DN	37	0	1	1
ZHAN_MULTIPLE_MYELOMA_HP_DN	46	0	1	1
ZHAN_MULTIPLE_MYELOMA_MF_DN	41	0	1	1
ZHAN_MULTIPLE_MYELOMA_MS_DN	44	0	1	1
ZHAN_MULTIPLE_MYELOMA_PR_DN	48	0	1	1
DANG_REGULATED_BY_MYC_UP	67	0	1	1
DANG_REGULATED_BY_MYC_DN	250	0	1	1
DANG_MYC_TARGETS_UP	129	0	1	1
DANG_MYC_TARGETS_DN	30	0	1	1
DANG_BOUND_BY_MYC	1046	0	1	1
DORN_ADENOVIRUS_INFECTION_12HR_UP	28	0	1	1
DORN_ADENOVIRUS_INFECTION_12HR_DN	33	0	1	1
DORN_ADENOVIRUS_INFECTION_24HR_UP	12	0	1	1
DORN_ADENOVIRUS_INFECTION_24HR_DN	42	0	1	1
DORN_ADENOVIRUS_INFECTION_32HR_UP	11	0	1	1
DORN_ADENOVIRUS_INFECTION_32HR_DN	38	0	1	1
DORN_ADENOVIRUS_INFECTION_48HR_UP	14	0	1	1
DORN_ADENOVIRUS_INFECTION_48HR_DN	39	0	1	1
TIAN_TNF_SIGNALING_VIA_NFKB	26	0	1	1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	22	0	1	1
WONG_EMBRYONIC_STEM_CELL_CORE	334	0	1	1
WONG_ADULT_TISSUE_STEM_MODULE	683	0	1	1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	75	0	1	1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	74	0	1	1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	88	0	1	1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	80	0	1	1
CHANDRAN_METASTASIS_UP	197	0	1	1
CHANDRAN_METASTASIS_DN	308	0	1	1
MIKKELSEN_ES_HCP_WITH_H3K27ME3	40	0	1	1
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	64	0	1	1
MIKKELSEN_ES_ICP_WITH_H3K27ME3	42	0	1	1
MIKKELSEN_ES_ICP_WITH_H3K4ME3	711	0	1	1
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	135	0	1	1
MIKKELSEN_ES_LCP_WITH_H3K27ME3	14	0	1	1
MIKKELSEN_ES_LCP_WITH_H3K4ME3	138	0	1	1
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3	7	0	1	1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	338	0	1	1
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	207	0	1	1
MIKKELSEN_NPC_ICP_WITH_H3K27ME3	12	0	1	1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	439	0	1	1
MIKKELSEN_NPC_WITH_LCP_H3K27ME3	9	0	1	1
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	58	0	1	1
MIKKELSEN_MEF_HCP_WITH_H3K27ME3	580	0	1	1
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	226	1	0.0585957642074406	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	73	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	69	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	56	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	13	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	15	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	29	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	75	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	71	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	50	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	75	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	69	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	99	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	79	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	176	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	143	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	35	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	77	0	1	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	183	0	1	1
SENGUPTA_EBNA1_ANTICORRELATED	143	0	1	1
YIH_RESPONSE_TO_ARSENITE_C5	11	0	1	1
MOOTHA_PYR	8	0	1	1
MOOTHA_FFA_OXYDATION	23	0	1	1
MOOTHA_GLUCONEOGENESIS	31	0	1	1
MOOTHA_GLYCOGEN_METABOLISM	20	0	1	1
MOOTHA_GLYCOLYSIS	21	0	1	1
LY_AGING_OLD_UP	7	0	1	1
NAKAMURA_ADIPOGENESIS_EARLY_UP	62	0	1	1
NAKAMURA_ADIPOGENESIS_EARLY_DN	37	0	1	1
NAKAMURA_ADIPOGENESIS_LATE_UP	97	0	1	1
NAKAMURA_ADIPOGENESIS_LATE_DN	36	0	1	1
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN	10	0	1	1
VERRECCHIA_RESPONSE_TO_TGFB1_C6	5	0	1	1
BAUS_TFF2_TARGETS_UP	31	0	1	1
BAUS_TFF2_TARGETS_DN	12	0	1	1
KAMMINGA_SENESCENCE	38	0	1	1
HO_LIVER_CANCER_VASCULAR_INVASION	12	0	1	1
GERHOLD_RESPONSE_TO_TZD_UP	6	0	1	1
GERHOLD_RESPONSE_TO_TZD_DN	13	0	1	1
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1	8	0	1	1
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2	8	0	1	1
MURAKAMI_UV_RESPONSE_1HR_UP	15	0	1	1
MURAKAMI_UV_RESPONSE_1HR_DN	10	0	1	1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	38	0	1	1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	45	0	1	1
VISALA_AGING_LYMPHOCYTE_UP	8	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G5	11	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G24	24	0	1	1
DAZARD_UV_RESPONSE_CLUSTER_G28	20	0	1	1
RUAN_RESPONSE_TO_TROGLITAZONE_DN	15	0	1	1
DASU_IL6_SIGNALING_UP	60	0	1	1
DASU_IL6_SIGNALING_DN	7	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN	9	0	1	1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP	9	0	1	1
HOFFMAN_CLOCK_TARGETS_UP	10	0	1	1
HOFFMAN_CLOCK_TARGETS_DN	10	0	1	1
WHITFIELD_CELL_CYCLE_LITERATURE	44	0	1	1
JIANG_HYPOXIA_VIA_VHL	19	0	1	1
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	51	0	1	1
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12	0	1	1
ONGUSAHA_BRCA1_TARGETS_UP	12	0	1	1
ONGUSAHA_BRCA1_TARGETS_DN	10	0	1	1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	86	0	1	1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	85	0	1	1
SASSON_RESPONSE_TO_FORSKOLIN_UP	88	0	1	1
SASSON_RESPONSE_TO_FORSKOLIN_DN	84	0	1	1
BAE_BRCA1_TARGETS_UP	72	0	1	1
BAE_BRCA1_TARGETS_DN	32	0	1	1
BROWNE_HCMV_INFECTION_30MIN_UP	53	0	1	1
BROWNE_HCMV_INFECTION_30MIN_DN	139	0	1	1
BROWNE_HCMV_INFECTION_1HR_UP	52	0	1	1
BROWNE_HCMV_INFECTION_1HR_DN	212	0	1	1
BROWNE_HCMV_INFECTION_2HR_UP	38	0	1	1
BROWNE_HCMV_INFECTION_2HR_DN	48	0	1	1
BROWNE_HCMV_INFECTION_4HR_UP	48	0	1	1
BROWNE_HCMV_INFECTION_4HR_DN	249	1	0.0725926052090352	1
WHITFIELD_CELL_CYCLE_G1_S	130	1	0.0373521021862568	1
WHITFIELD_CELL_CYCLE_S	149	1	0.0439311528704006	1
WHITFIELD_CELL_CYCLE_G2	169	0	1	1
WHITFIELD_CELL_CYCLE_G2_M	200	0	1	1
WHITFIELD_CELL_CYCLE_M_G1	129	0	1	1
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	71	0	1	1
KARLSSON_TGFB1_TARGETS_UP	122	0	1	1
KARLSSON_TGFB1_TARGETS_DN	194	0	1	1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	22	0	1	1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	31	0	1	1
WANG_METASTASIS_OF_BREAST_CANCER	14	0	1	1
LI_INDUCED_T_TO_NATURAL_KILLER_UP	315	1	0.0818099208377824	1
LI_INDUCED_T_TO_NATURAL_KILLER_DN	134	0	1	1
NOUSHMEHR_GBM_SOMATIC_MUTATED	9	0	1	1
NOUSHMEHR_GBM_GERMLINE_MUTATED	7	0	1	1
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	50	0	1	1
KAMIKUBO_MYELOID_CEBPA_NETWORK	29	0	1	1
KAMIKUBO_MYELOID_MN1_NETWORK	19	0	1	1
MARTENS_BOUND_BY_PML_RARA_FUSION	452	0	1	1
MARTENS_TRETINOIN_RESPONSE_UP	826	0	1	1
MARTENS_TRETINOIN_RESPONSE_DN	828	0	1	1
STAMBOLSKY_BOUND_BY_MUTATED_TP53	18	0	1	1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	49	0	1	1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	49	0	1	1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	79	0	1	1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	24	0	1	1
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	747	0	1	1
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	33	0	1	1
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP	672	0	1	1
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	85	0	1	1
KIM_ALL_DISORDERS_CALB1_CORR_UP	544	0	1	1
KIM_ALL_DISORDERS_CALB1_CORR_DN	34	0	1	1
KIM_ALL_DISORDERS_DURATION_CORR_UP	9	0	1	1
KIM_ALL_DISORDERS_DURATION_CORR_DN	145	0	1	1
VERHAAK_GLIOBLASTOMA_PRONEURAL	176	0	1	1
VERHAAK_GLIOBLASTOMA_NEURAL	128	0	1	1
VERHAAK_GLIOBLASTOMA_CLASSICAL	161	0	1	1
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	216	0	1	1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	242	0	1	1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	102	0	1	1
CHICAS_RB1_TARGETS_SENESCENT	548	0	1	1
CHICAS_RB1_TARGETS_LOW_SERUM	97	0	1	1
CHICAS_RB1_TARGETS_GROWING	240	0	1	1
CHICAS_RB1_TARGETS_CONFLUENT	552	0	1	1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	374	0	1	1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	360	0	1	1
QI_HYPOXIA	131	0	1	1
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	35	0	1	1
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	145	0	1	1
LU_EZH2_TARGETS_UP	283	0	1	1
LU_EZH2_TARGETS_DN	387	1	0.111970701626145	1
HOELZEL_NF1_TARGETS_UP	136	0	1	1
HOELZEL_NF1_TARGETS_DN	114	0	1	1
DEMAGALHAES_AGING_UP	54	0	1	1
DEMAGALHAES_AGING_DN	16	0	1	1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	227	0	1	1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	91	0	1	1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	322	0	1	1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	503	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	120	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	45	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	54	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN	9	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	166	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	39	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	108	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN	15	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP	12	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	46	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	138	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	35	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	114	0	1	1
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN	5	0	1	1
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	27	0	1	1
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	28	0	1	1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	129	0	1	1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	138	0	1	1
TSUTSUMI_FBXW8_TARGETS	9	0	1	1
LI_DCP2_BOUND_MRNA	85	0	1	1
WAGSCHAL_EHMT2_TARGETS_UP	18	0	1	1
SUBTIL_PROGESTIN_TARGETS	36	0	1	1
OHGUCHI_LIVER_HNF4A_TARGETS_UP	50	0	1	1
OHGUCHI_LIVER_HNF4A_TARGETS_DN	162	0	1	1
GABRIELY_MIR21_TARGETS	289	0	1	1
THILLAINADESAN_ZNF217_TARGETS_UP	41	0	1	1
THILLAINADESAN_ZNF217_TARGETS_DN	9	0	1	1
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	17	0	1	1
PHESSE_TARGETS_OF_APC_AND_MBD2_DN	11	0	1	1
CHYLA_CBFA2T3_TARGETS_UP	378	0	1	1
CHYLA_CBFA2T3_TARGETS_DN	232	0	1	1
FUKUSHIMA_TNFSF11_TARGETS	16	0	1	1
CARD_MIR302A_TARGETS	77	0	1	1
WIERENGA_STAT5A_TARGETS_UP	200	0	1	1
WIERENGA_STAT5A_TARGETS_DN	192	0	1	1
WIERENGA_STAT5A_TARGETS_GROUP1	125	0	1	1
WIERENGA_STAT5A_TARGETS_GROUP2	54	0	1	1
WIERENGA_PML_INTERACTOME	42	0	1	1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	82	1	0.0260930324810503	1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	116	0	1	1
KANG_AR_TARGETS_UP	17	0	1	1
KANG_AR_TARGETS_DN	18	0	1	1
PILON_KLF1_TARGETS_UP	494	0	1	1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	210	0	1	1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	88	0	1	1
BHAT_ESR1_TARGETS_VIA_AKT1_UP	277	0	1	1
BHAT_ESR1_TARGETS_VIA_AKT1_DN	82	0	1	1
JOHNSTONE_PARVB_TARGETS_1_UP	7	0	1	1
JOHNSTONE_PARVB_TARGETS_1_DN	59	0	1	1
JOHNSTONE_PARVB_TARGETS_2_UP	139	0	1	1
JOHNSTONE_PARVB_TARGETS_2_DN	333	0	1	1
JOHNSTONE_PARVB_TARGETS_3_UP	430	0	1	1
JOHNSTONE_PARVB_TARGETS_3_DN	838	0	1	1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	838	0	1	1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	529	0	1	1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	87	0	1	1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	261	0	1	1
BRUINS_UVC_RESPONSE_LATE	1074	0	1	1
BRUINS_UVC_RESPONSE_EARLY_LATE	305	0	1	1
BRUINS_UVC_RESPONSE_MIDDLE	97	0	1	1
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	36	0	1	1
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	35	0	1	1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	258	0	1	1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	225	0	1	1
IVANOVSKA_MIR106B_TARGETS	88	0	1	1
KIM_GLIS2_TARGETS_UP	85	0	1	1
KIM_GLIS2_TARGETS_DN	6	0	1	1
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP	7	0	1	1
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN	6	0	1	1
STEGER_ADIPOGENESIS_UP	21	0	1	1
STEGER_ADIPOGENESIS_DN	25	0	1	1
ZHU_SKIL_TARGETS_UP	19	0	1	1
ZHU_SKIL_TARGETS_DN	9	0	1	1
KIM_PTEN_TARGETS_UP	18	0	1	1
KIM_PTEN_TARGETS_DN	5	0	1	1
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS	6	0	1	1
MAEKAWA_ATF2_TARGETS	22	0	1	1
ISSAEVA_MLL2_TARGETS	60	0	1	1
LINSLEY_MIR16_TARGETS	206	0	1	1
CHENG_TAF7L_TARGETS	6	0	1	1
CHANGOLKAR_H2AFY_TARGETS_UP	50	0	1	1
CHANGOLKAR_H2AFY_TARGETS_DN	39	0	1	1
PASINI_SUZ12_TARGETS_UP	109	0	1	1
PASINI_SUZ12_TARGETS_DN	316	0	1	1
BAKKER_FOXO3_TARGETS_UP	53	0	1	1
BAKKER_FOXO3_TARGETS_DN	171	0	1	1
BERGER_MBD2_TARGETS	5	0	1	1
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	15	0	1	1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	81	0	1	1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	37	0	1	1
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	17	0	1	1
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	17	0	1	1
VANDESLUIS_NORMAL_EMBRYOS_UP	5	0	1	1
VANDESLUIS_NORMAL_EMBRYOS_DN	21	0	1	1
SUMI_HNF4A_TARGETS	28	0	1	1
WANG_NFKB_TARGETS	23	0	1	1
WANG_TNF_TARGETS	24	0	1	1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	123	0	1	1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	18	0	1	1
AZARE_STAT3_TARGETS	24	0	1	1
DELPUECH_FOXO3_TARGETS_UP	65	0	1	1
DELPUECH_FOXO3_TARGETS_DN	40	0	1	1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	56	0	1	1
KASLER_HDAC7_TARGETS_1_UP	183	0	1	1
KASLER_HDAC7_TARGETS_1_DN	17	0	1	1
KASLER_HDAC7_TARGETS_2_UP	7	0	1	1
KASLER_HDAC7_TARGETS_2_DN	31	0	1	1
DORMOY_ELAVL1_TARGETS	18	0	1	1
LEE_BMP2_TARGETS_UP	757	0	1	1
LEE_BMP2_TARGETS_DN	893	0	1	1
BILANGES_SERUM_SENSITIVE_GENES	79	0	1	1
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	68	0	1	1
BILANGES_RAPAMYCIN_SENSITIVE_GENES	36	0	1	1
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	68	0	1	1
BILANGES_SERUM_SENSITIVE_VIA_TSC1	21	0	1	1
BILANGES_SERUM_SENSITIVE_VIA_TSC2	31	0	1	1
BILANGES_SERUM_RESPONSE_TRANSLATION	34	0	1	1
KIM_TIAL1_TARGETS	32	0	1	1
DUAN_PRDM5_TARGETS	77	0	1	1
DALESSIO_TSA_RESPONSE	25	0	1	1
FEVR_CTNNB1_TARGETS_UP	684	0	1	1
FEVR_CTNNB1_TARGETS_DN	550	0	1	1
FARDIN_HYPOXIA_9	7	0	1	1
FARDIN_HYPOXIA_11	32	0	1	1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	20	0	1	1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	18	0	1	1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	267	0	1	1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	316	0	1	1
WINZEN_DEGRADED_VIA_KHSRP	99	0	1	1
VANLOO_SP3_TARGETS_UP	9	0	1	1
VANLOO_SP3_TARGETS_DN	88	0	1	1
YUAN_ZNF143_PARTNERS	22	0	1	1
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	831	0	1	1
RAFFEL_VEGFA_TARGETS_UP	9	0	1	1
RAFFEL_VEGFA_TARGETS_DN	5	0	1	1
TERAO_AOX4_TARGETS_HG_UP	28	0	1	1
TERAO_AOX4_TARGETS_HG_DN	6	0	1	1
TERAO_AOX4_TARGETS_SKIN_UP	30	0	1	1
TERAO_AOX4_TARGETS_SKIN_DN	23	0	1	1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	76	0	1	1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	163	0	1	1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	296	0	1	1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	401	0	1	1
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	570	0	1	1
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	1073	0	1	1
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	43	0	1	1
WACKER_HYPOXIA_TARGETS_OF_VHL	13	0	1	1
IKEDA_MIR1_TARGETS_UP	54	0	1	1
IKEDA_MIR1_TARGETS_DN	6	0	1	1
IKEDA_MIR133_TARGETS_UP	44	0	1	1
IKEDA_MIR133_TARGETS_DN	6	0	1	1
IKEDA_MIR30_TARGETS_UP	116	0	1	1
IKEDA_MIR30_TARGETS_DN	23	0	1	1
KUWANO_RNA_STABILIZED_BY_NO	7	0	1	1
LIU_TOPBP1_TARGETS	15	0	1	1
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	27	0	1	1
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	8	0	1	1
KATSANOU_ELAVL1_TARGETS_UP	155	0	1	1
KATSANOU_ELAVL1_TARGETS_DN	140	0	1	1
WANG_THOC1_TARGETS_UP	5	0	1	1
WANG_THOC1_TARGETS_DN	20	0	1	1
SERVITJA_ISLET_HNF1A_TARGETS_UP	169	0	1	1
SERVITJA_ISLET_HNF1A_TARGETS_DN	105	0	1	1
SERVITJA_LIVER_HNF1A_TARGETS_UP	137	0	1	1
SERVITJA_LIVER_HNF1A_TARGETS_DN	162	0	1	1
MADAN_DPPA4_TARGETS	58	0	1	1
KOHOUTEK_CCNT1_TARGETS	51	0	1	1
KOHOUTEK_CCNT2_TARGETS	56	0	1	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	46	0	1	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	20	0	1	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	107	0	1	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5	11	0	1	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	29	0	1	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	389	0	1	1
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	75	0	1	1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	146	0	1	1
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	29	0	1	1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	850	0	1	1
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	633	0	1	1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	146	0	1	1
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	12	0	1	1
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN	6	0	1	1
YANG_BCL3_TARGETS_UP	328	0	1	1
YANG_BCL3_TARGETS_DN	7	0	1	1
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	35	0	1	1
VERNOCHET_ADIPOGENESIS	19	0	1	1
IM_SREBF1A_TARGETS	5	0	1	1
GUO_TARGETS_OF_IRS1_AND_IRS2	96	0	1	1
HUANG_GATA2_TARGETS_UP	148	0	1	1
HUANG_GATA2_TARGETS_DN	74	0	1	1
LE_NEURONAL_DIFFERENTIATION_UP	18	0	1	1
LE_NEURONAL_DIFFERENTIATION_DN	19	0	1	1
STEINER_ERYTHROCYTE_MEMBRANE_GENES	14	0	1	1
PLASARI_TGFB1_TARGETS_1HR_UP	33	0	1	1
PLASARI_TGFB1_TARGETS_1HR_DN	5	0	1	1
PLASARI_TGFB1_TARGETS_10HR_UP	194	0	1	1
PLASARI_TGFB1_TARGETS_10HR_DN	251	0	1	1
PLASARI_NFIC_TARGETS_BASAL_UP	28	0	1	1
PLASARI_NFIC_TARGETS_BASAL_DN	20	0	1	1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	33	0	1	1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	108	0	1	1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	57	0	1	1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	32	0	1	1
WANG_MLL_TARGETS	291	0	1	1
SANDERSON_PPARA_TARGETS	15	0	1	1
KANG_GLIS3_TARGETS	35	0	1	1
DELACROIX_RARG_BOUND_MEF	365	0	1	1
DELACROIX_RAR_TARGETS_UP	48	0	1	1
DELACROIX_RAR_TARGETS_DN	24	0	1	1
DELACROIX_RAR_BOUND_ES	456	0	1	1
KRIEG_HYPOXIA_VIA_KDM3A	53	0	1	1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	195	0	1	1
KRIEG_HYPOXIA_NOT_VIA_KDM3A	728	0	1	1
MALIK_REPRESSED_BY_ESTROGEN	13	0	1	1
TIAN_BHLHA15_TARGETS	16	0	1	1
LIU_IL13_MEMORY_MODEL_UP	17	0	1	1
LIU_IL13_MEMORY_MODEL_DN	5	0	1	1
LIU_IL13_PRIMING_MODEL	15	0	1	1
ALFANO_MYC_TARGETS	237	0	1	1
FU_INTERACT_WITH_ALKBH8	13	0	1	1
SUZUKI_CTCFL_TARGETS_UP	12	0	1	1
REICHERT_MITOSIS_LIN9_TARGETS	27	0	1	1
GUILLAUMOND_KLF10_TARGETS_UP	49	0	1	1
GUILLAUMOND_KLF10_TARGETS_DN	31	0	1	1
FORTSCHEGGER_PHF8_TARGETS_UP	269	0	1	1
FORTSCHEGGER_PHF8_TARGETS_DN	772	0	1	1
BRIDEAU_IMPRINTED_GENES	65	0	1	1
PEDRIOLI_MIR31_TARGETS_UP	211	0	1	1
PEDRIOLI_MIR31_TARGETS_DN	402	0	1	1
PHONG_TNF_TARGETS_UP	63	0	1	1
PHONG_TNF_TARGETS_DN	8	0	1	1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	225	0	1	1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	163	0	1	1
PHONG_TNF_RESPONSE_NOT_VIA_P38	338	0	1	1
RATTENBACHER_BOUND_BY_CELF1	399	0	1	1
KINNEY_DNMT1_METHYLATION_TARGETS	13	0	1	1
ABDELMOHSEN_ELAVL4_TARGETS	16	0	1	1
ZHANG_ADIPOGENESIS_BY_BMP7	14	0	1	1
FOSTER_KDM1A_TARGETS_UP	255	0	1	1
FOSTER_KDM1A_TARGETS_DN	197	0	1	1
YU_BAP1_TARGETS	29	0	1	1
RAO_BOUND_BY_SALL4_ISOFORM_A	186	0	1	1
RAO_BOUND_BY_SALL4_ISOFORM_B	518	0	1	1
RAO_BOUND_BY_SALL4	227	0	1	1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	220	0	1	1
BOUDOUKHA_BOUND_BY_IGF2BP2	107	0	1	1
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	146	0	1	1
BOSCO_TH1_CYTOTOXIC_MODULE	110	0	1	1
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	75	0	1	1
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	64	0	1	1
PECE_MAMMARY_STEM_CELL_UP	136	0	1	1
PECE_MAMMARY_STEM_CELL_DN	139	0	1	1
ABRAMSON_INTERACT_WITH_AIRE	44	0	1	1
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	11	0	1	1
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	271	0	1	1
KUMAR_AUTOPHAGY_NETWORK	71	0	1	1
GENTLES_LEUKEMIC_STEM_CELL_UP	29	0	1	1
GENTLES_LEUKEMIC_STEM_CELL_DN	19	0	1	1
ROESSLER_LIVER_CANCER_METASTASIS_UP	106	0	1	1
ROESSLER_LIVER_CANCER_METASTASIS_DN	48	0	1	1
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	22	0	1	1
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN	12	0	1	1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	38	0	1	1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	16	0	1	1
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	28	0	1	1
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN	14	0	1	1
HOLLEMAN_DAUNORUBICIN_B_ALL_UP	10	0	1	1
HOLLEMAN_DAUNORUBICIN_B_ALL_DN	11	0	1	1
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	20	0	1	1
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN	11	0	1	1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	27	0	1	1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	20	0	1	1
HOLLEMAN_DAUNORUBICIN_ALL_UP	7	0	1	1
HOLLEMAN_DAUNORUBICIN_ALL_DN	8	0	1	1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	23	0	1	1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	26	0	1	1
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	118	0	1	1
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	64	0	1	1
LIM_MAMMARY_STEM_CELL_UP	476	1	0.145552697631361	1
LIM_MAMMARY_STEM_CELL_DN	415	0	1	1
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	58	0	1	1
LIM_MAMMARY_LUMINAL_PROGENITOR_DN	14	0	1	1
LIM_MAMMARY_LUMINAL_MATURE_UP	112	0	1	1
LIM_MAMMARY_LUMINAL_MATURE_DN	94	0	1	1
DURAND_STROMA_S_UP	280	0	1	1
DURAND_STROMA_NS_UP	158	0	1	1
SMIRNOV_RESPONSE_TO_IR_2HR_UP	53	0	1	1
SMIRNOV_RESPONSE_TO_IR_2HR_DN	57	0	1	1
SMIRNOV_RESPONSE_TO_IR_6HR_UP	166	0	1	1
SMIRNOV_RESPONSE_TO_IR_6HR_DN	114	0	1	1
GHANDHI_DIRECT_IRRADIATION_UP	98	0	1	1
GHANDHI_DIRECT_IRRADIATION_DN	34	0	1	1
GHANDHI_BYSTANDER_IRRADIATION_UP	79	0	1	1
GHANDHI_BYSTANDER_IRRADIATION_DN	11	0	1	1
WARTERS_RESPONSE_TO_IR_SKIN	78	0	1	1
WARTERS_IR_RESPONSE_5GY	50	0	1	1
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR	8	0	1	1
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	84	0	1	1
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	126	0	1	1
ZWANG_EGF_PERSISTENTLY_UP	31	0	1	1
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	510	1	0.14445056341035	1
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	51	0	1	1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	217	0	1	1
ZWANG_DOWN_BY_2ND_EGF_PULSE	254	0	1	1
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	1597	0	1	1
ZWANG_EGF_INTERVAL_UP	93	0	1	1
ZWANG_EGF_INTERVAL_DN	207	0	1	1
ZWANG_EGF_PERSISTENTLY_DN	58	0	1	1
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	17	0	1	1
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	5	0	1	1
HORTON_SREBF_TARGETS	24	0	1	1
HECKER_IFNB1_TARGETS	93	0	1	1
NABA_COLLAGENS	44	0	1	1
NABA_ECM_GLYCOPROTEINS	193	0	1	1
NABA_ECM_REGULATORS	235	0	1	1
NABA_ECM_AFFILIATED	161	0	1	1
NABA_PROTEOGLYCANS	35	0	1	1
NABA_SECRETED_FACTORS	332	0	1	1
NABA_CORE_MATRISOME	272	0	1	1
NABA_MATRISOME_ASSOCIATED	728	0	1	1
NABA_BASEMENT_MEMBRANES	40	0	1	1
NABA_MATRISOME	1000	0	1	1
FARMER_BREAST_CANCER_CLUSTER_6	14	0	1	1
FARMER_BREAST_CANCER_CLUSTER_5	19	0	1	1
FARMER_BREAST_CANCER_CLUSTER_4	19	0	1	1
FARMER_BREAST_CANCER_CLUSTER_3	16	0	1	1
EPPERT_LSC_R	39	0	1	1
EPPERT_HSC_R	119	0	1	1
EPPERT_PROGENITOR	136	0	1	1
EPPERT_CE_HSC_LSC	40	0	1	1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	82	0	1	1
MACAEVA_PBMC_RESPONSE_TO_IR	100	0	1	1
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	311	0	1	1
FISCHER_G1_S_CELL_CYCLE	196	0	1	1
FISCHER_G2_M_CELL_CYCLE	236	0	1	1
FISCHER_DREAM_TARGETS	960	1	0.258049510222912	1
GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	1006	0	1	1
GRYDER_PAX3FOXO1_TOP_ENHANCERS	441	0	1	1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	436	0	1	1
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	175	0	1	1
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1	62	0	1	1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	343	0	1	1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	273	0	1	1
VILLANUEVA_LIVER_CANCER_KRT19_UP	172	0	1	1
VILLANUEVA_LIVER_CANCER_KRT19_DN	63	0	1	1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP	14	0	1	1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	21	0	1	1
ANDERSEN_LIVER_CANCER_KRT19_UP	35	0	1	1
ANDERSEN_LIVER_CANCER_KRT19_DN	75	0	1	1
KIM_LIVER_CANCER_POOR_SURVIVAL_UP	22	0	1	1
KIM_LIVER_CANCER_POOR_SURVIVAL_DN	43	0	1	1
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR	17	0	1	1
HOLLERN_EMT_BREAST_TUMOR_UP	136	0	1	1
HOLLERN_EMT_BREAST_TUMOR_DN	122	0	1	1
HOLLERN_SQUAMOUS_BREAST_TUMOR	165	0	1	1
HOLLERN_PAPILLARY_BREAST_TUMOR	19	0	1	1
HOLLERN_MICROACINAR_BREAST_TUMOR_UP	46	0	1	1
HOLLERN_MICROACINAR_BREAST_TUMOR_DN	15	0	1	1
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP	11	0	1	1
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	30	0	1	1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	190	1	0.0545252752284891	1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	367	0	1	1
FLORIO_HUMAN_NEOCORTEX	35	0	1	1
BIOCARTA_PDZS_PATHWAY	17	0	1	1
BIOCARTA_RACC_PATHWAY	15	0	1	1
BIOCARTA_EICOSANOID_PATHWAY	22	0	1	1
BIOCARTA_CHREBP_PATHWAY	19	0	1	1
BIOCARTA_LIS1_PATHWAY	19	0	1	1
BIOCARTA_HSWI_SNF_PATHWAY	12	0	1	1
BIOCARTA_PCAF_PATHWAY	13	0	1	1
BIOCARTA_LYMPHOCYTE_PATHWAY	9	0	1	1
BIOCARTA_AMAN_PATHWAY	15	0	1	1
BIOCARTA_NEUTROPHIL_PATHWAY	8	0	1	1
BIOCARTA_EFP_PATHWAY	16	0	1	1
BIOCARTA_CREM_PATHWAY	6	0	1	1
BIOCARTA_ERAD_PATHWAY	19	0	1	1
BIOCARTA_BTG2_PATHWAY	11	0	1	1
BIOCARTA_TERT_PATHWAY	8	0	1	1
BIOCARTA_GHRELIN_PATHWAY	13	0	1	1
BIOCARTA_VOBESITY_PATHWAY	8	0	1	1
BIOCARTA_ERBB3_PATHWAY	5	0	1	1
BIOCARTA_CTBP1_PATHWAY	8	0	1	1
BIOCARTA_PRION_PATHWAY	12	0	1	1
BIOCARTA_PLK3_PATHWAY	8	0	1	1
BIOCARTA_FXR_PATHWAY	7	0	1	1
BIOCARTA_MHC_PATHWAY	12	0	1	1
BIOCARTA_ACETAMINOPHEN_PATHWAY	5	0	1	1
BIOCARTA_PRC2_PATHWAY	13	0	1	1
BIOCARTA_SM_PATHWAY	14	0	1	1
BIOCARTA_RANBP2_PATHWAY	11	0	1	1
BIOCARTA_IRES_PATHWAY	7	0	1	1
BIOCARTA_PLC_PATHWAY	9	0	1	1
BIOCARTA_BBCELL_PATHWAY	9	0	1	1
BIOCARTA_CDC25_PATHWAY	9	0	1	1
BIOCARTA_DSP_PATHWAY	9	0	1	1
BIOCARTA_NPC_PATHWAY	11	0	1	1
BIOCARTA_FLUMAZENIL_PATHWAY	9	0	1	1
BIOCARTA_MELANOCYTE_PATHWAY	7	0	1	1
BIOCARTA_S1P_PATHWAY	8	0	1	1
BIOCARTA_HBX_PATHWAY	7	0	1	1
BIOCARTA_MALATEX_PATHWAY	8	0	1	1
BIOCARTA_TSP1_PATHWAY	7	0	1	1
BIOCARTA_NPP1_PATHWAY	10	0	1	1
BIOCARTA_CPSF_PATHWAY	9	0	1	1
BIOCARTA_HES_PATHWAY	12	0	1	1
BIOCARTA_ERBB4_PATHWAY	7	0	1	1
BIOCARTA_RHODOPSIN_PATHWAY	10	0	1	1
BIOCARTA_RNAPOL3_PATHWAY	7	0	1	1
BIOCARTA_TERC_PATHWAY	6	0	1	1
BIOCARTA_EOSINOPHILS_PATHWAY	9	0	1	1
BIOCARTA_REELIN_PATHWAY	7	0	1	1
BIOCARTA_BARD1_PATHWAY	8	0	1	1
BIOCARTA_LDL_PATHWAY	6	0	1	1
BIOCARTA_SAM68_PATHWAY	6	0	1	1
BIOCARTA_FBW7_PATHWAY	9	0	1	1
BIOCARTA_CB1R_PATHWAY	7	0	1	1
BIOCARTA_SUMO_PATHWAY	6	0	1	1
BIOCARTA_IFNA_PATHWAY	7	0	1	1
BIOCARTA_PKC_PATHWAY	7	0	1	1
BIOCARTA_PPARG_PATHWAY	8	0	1	1
BIOCARTA_ION_PATHWAY	5	0	1	1
BIOCARTA_PELP1_PATHWAY	6	0	1	1
BIOCARTA_STAT3_PATHWAY	8	0	1	1
BIOCARTA_EEA1_PATHWAY	7	0	1	1
BIOCARTA_MITR_PATHWAY	5	0	1	1
BIOCARTA_CIRCADIAN_PATHWAY	6	0	1	1
BIOCARTA_RECK_PATHWAY	9	0	1	1
BIOCARTA_MSP_PATHWAY	6	0	1	1
BIOCARTA_SLRP_PATHWAY	6	0	1	1
BIOCARTA_ALTERNATIVE_PATHWAY	9	0	1	1
BIOCARTA_FOSB_PATHWAY	5	0	1	1
BIOCARTA_NOTCH_PATHWAY	6	0	1	1
BIOCARTA_TUBBY_PATHWAY	5	0	1	1
BIOCARTA_MRP_PATHWAY	6	0	1	1
BIOCARTA_DICER_PATHWAY	5	0	1	1
BIOCARTA_PLCD_PATHWAY	5	0	1	1
BIOCARTA_RAN_PATHWAY	5	0	1	1
BIOCARTA_WNT_LRP6_PATHWAY	6	0	1	1
BIOCARTA_PEPI_PATHWAY	8	0	1	1
BIOCARTA_IFNG_PATHWAY	6	0	1	1
BIOCARTA_BOTULIN_PATHWAY	5	0	1	1
REACTOME_INTERLEUKIN_6_SIGNALING	11	0	1	1
REACTOME_MAPK3_ERK1_ACTIVATION	10	0	1	1
REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE	39	0	1	1
REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX	30	0	1	1
REACTOME_TRANSLESION_SYNTHESIS_BY_POLH	19	0	1	1
REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1	9	0	1	1
REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR	8	0	1	1
REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA	15	0	1	1
REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA	5	0	1	1
REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS	9	0	1	1
REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA	5	0	1	1
REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE	6	0	1	1
REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE	13	0	1	1
REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE	8	0	1	1
REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE	18	0	1	1
REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB	10	0	1	1
REACTOME_G_PROTEIN_MEDIATED_EVENTS	54	0	1	1
REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	11	0	1	1
REACTOME_NEUROTRANSMITTER_CLEARANCE	10	0	1	1
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION	203	0	1	1
REACTOME_IRS_MEDIATED_SIGNALLING	48	0	1	1
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION	23	0	1	1
REACTOME_MAPK1_ERK2_ACTIVATION	9	0	1	1
REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX	32	0	1	1
REACTOME_DISINHIBITION_OF_SNARE_FORMATION	5	0	1	1
REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS	5	0	1	1
REACTOME_FERTILIZATION	25	0	1	1
REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES	36	0	1	1
REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR	11	0	1	1
REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA	75	0	1	1
REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES	8	0	1	1
REACTOME_METHIONINE_SALVAGE_PATHWAY	6	0	1	1
REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE	9	0	1	1
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	22	0	1	1
REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING	9	0	1	1
REACTOME_INTERLEUKIN_7_SIGNALING	33	0	1	1
REACTOME_CA2_ACTIVATED_K_CHANNELS	9	0	1	1
REACTOME_SPERM_MOTILITY_AND_TAXES	9	0	1	1
REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING	5	0	1	1
REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING	5	0	1	1
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX	19	0	1	1
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1	16	0	1	1
REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS	13	0	1	1
REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	18	0	1	1
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	27	0	1	1
REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	18	0	1	1
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS	16	0	1	1
REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA	9	0	1	1
REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND	16	0	1	1
REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION	5	0	1	1
REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION	23	0	1	1
REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION	22	0	1	1
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	163	0	1	1
REACTOME_REGULATION_OF_SIGNALING_BY_NODAL	11	0	1	1
REACTOME_COLLAGEN_DEGRADATION	63	0	1	1
REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE	70	0	1	1
REACTOME_ALPHA_DEFENSINS	9	0	1	1
REACTOME_REPRODUCTION	134	0	1	1
REACTOME_ACYL_CHAIN_REMODELING_OF_CL	6	0	1	1
REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG	7	0	1	1
REACTOME_HYDROLYSIS_OF_LPC	8	0	1	1
REACTOME_SYNTHESIS_OF_PG	8	0	1	1
REACTOME_SYNTHESIS_OF_PI	5	0	1	1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE	5	0	1	1
REACTOME_INOSITOL_PHOSPHATE_METABOLISM	48	0	1	1
REACTOME_SIGNALING_BY_ACTIVIN	13	0	1	1
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	108	0	1	1
REACTOME_METHYLATION	14	0	1	1
REACTOME_AMINO_ACID_CONJUGATION	8	0	1	1
REACTOME_ELASTIC_FIBRE_FORMATION	45	0	1	1
REACTOME_FIBRONECTIN_MATRIX_FORMATION	6	0	1	1
REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS	16	0	1	1
REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION	49	0	1	1
REACTOME_MITOCHONDRIAL_BIOGENESIS	92	0	1	1
REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	36	0	1	1
REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	43	0	1	1
REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES	32	0	1	1
REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS	9	0	1	1
REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS	21	0	1	1
REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN	5	0	1	1
REACTOME_SULFIDE_OXIDATION_TO_SULFATE	6	0	1	1
REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE	14	0	1	1
REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION	28	0	1	1
REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION	14	0	1	1
REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR	7	0	1	1
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	93	0	1	1
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	5	0	1	1
REACTOME_TRIGLYCERIDE_CATABOLISM	24	0	1	1
REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY	8	0	1	1
REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION	8	0	1	1
REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	7	0	1	1
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	38	0	1	1
REACTOME_DISEASE	1393	0	1	1
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	17	0	1	1
REACTOME_2_LTR_CIRCLE_FORMATION	7	0	1	1
REACTOME_NEF_AND_SIGNAL_TRANSDUCTION	8	0	1	1
REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS	28	0	1	1
REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	67	0	1	1
REACTOME_MTOR_SIGNALLING	40	0	1	1
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	55	0	1	1
REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	127	0	1	1
REACTOME_MITOCHONDRIAL_UNCOUPLING	6	0	1	1
REACTOME_SIGNALING_BY_NTRKS	134	0	1	1
REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION	8	0	1	1
REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	8	0	1	1
REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME	71	0	1	1
REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	23	0	1	1
REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY	35	0	1	1
REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION	9	0	1	1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	95	0	1	1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE	97	0	1	1
REACTOME_INFLUENZA_INFECTION	155	0	1	1
REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	33	0	1	1
REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS	10	0	1	1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	153	0	1	1
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT	19	0	1	1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA	69	0	1	1
REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE	16	0	1	1
REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION	5	0	1	1
REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS	6	0	1	1
REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING	12	0	1	1
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE	13	0	1	1
REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS	28	0	1	1
REACTOME_ACTIVATION_OF_C3_AND_C5	7	0	1	1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE	70	0	1	1
REACTOME_ASSEMBLY_OF_THE_HIV_VIRION	16	0	1	1
REACTOME_PHOSPHORYLATION_OF_EMI1	6	0	1	1
REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE	5	0	1	1
REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	37	0	1	1
REACTOME_SIGNALING_BY_EGFR	50	0	1	1
REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION	5	0	1	1
REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	34	0	1	1
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1	17	0	1	1
REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	18	0	1	1
REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION	7	0	1	1
REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES	16	0	1	1
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA	63	0	1	1
REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS	18	0	1	1
REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION	31	0	1	1
REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION	33	0	1	1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	292	0	1	1
REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	10	0	1	1
REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL	14	0	1	1
REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL	26	0	1	1
REACTOME_ACTIVATION_OF_TRKA_RECEPTORS	6	0	1	1
REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION	5	0	1	1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21	60	0	1	1
REACTOME_CELLULAR_HEXOSE_TRANSPORT	21	0	1	1
REACTOME_HEME_BIOSYNTHESIS	14	0	1	1
REACTOME_HEME_DEGRADATION	14	0	1	1
REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION	13	0	1	1
REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION	20	0	1	1
REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION	6	0	1	1
REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION	7	0	1	1
REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION	12	0	1	1
REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION	10	0	1	1
REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE	19	0	1	1
REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM	6	0	1	1
REACTOME_DIGESTION_OF_DIETARY_LIPID	7	0	1	1
REACTOME_ESTROGEN_BIOSYNTHESIS	6	0	1	1
REACTOME_P75NTR_SIGNALS_VIA_NF_KB	16	0	1	1
REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1	6	0	1	1
REACTOME_P75NTR_REGULATES_AXONOGENESIS	10	0	1	1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL	15	0	1	1
REACTOME_MINERALOCORTICOID_BIOSYNTHESIS	6	0	1	1
REACTOME_GLUCOCORTICOID_BIOSYNTHESIS	10	0	1	1
REACTOME_SIGNALING_BY_VEGF	106	0	1	1
REACTOME_RHO_GTPASE_CYCLE	134	0	1	1
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX	85	0	1	1
REACTOME_RHO_GTPASE_EFFECTORS	312	0	1	1
REACTOME_METABOLISM_OF_STEROID_HORMONES	35	0	1	1
REACTOME_PREGNENOLONE_BIOSYNTHESIS	12	0	1	1
REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE	17	0	1	1
REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM	21	0	1	1
REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES	17	0	1	1
REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM	11	0	1	1
REACTOME_COENZYME_A_BIOSYNTHESIS	8	0	1	1
REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM	11	0	1	1
REACTOME_NICOTINATE_METABOLISM	31	0	1	1
REACTOME_VITAMIN_B1_THIAMIN_METABOLISM	5	0	1	1
REACTOME_VITAMIN_C_ASCORBATE_METABOLISM	8	0	1	1
REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM	7	0	1	1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS	123	0	1	1
REACTOME_NICOTINAMIDE_SALVAGING	19	0	1	1
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	9	0	1	1
REACTOME_CREB_PHOSPHORYLATION	7	0	1	1
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	153	0	1	1
REACTOME_CARNITINE_METABOLISM	14	0	1	1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	224	0	1	1
REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL	8	0	1	1
REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	82	0	1	1
REACTOME_METABOLISM_OF_NITRIC_OXIDE_ENOS_ACTIVATION_AND_REGULATION	15	0	1	1
REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	61	0	1	1
REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS	18	0	1	1
REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS	11	0	1	1
REACTOME_CALCINEURIN_ACTIVATES_NFAT	9	0	1	1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	86	0	1	1
REACTOME_FCGR_ACTIVATION	12	0	1	1
REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	25	0	1	1
REACTOME_ENOS_ACTIVATION	11	0	1	1
REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING	5	0	1	1
REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT	68	0	1	1
REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM	13	0	1	1
REACTOME_LINOLEIC_ACID_LA_METABOLISM	8	0	1	1
REACTOME_NADE_MODULATES_DEATH_SIGNALLING	6	0	1	1
REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	13	0	1	1
REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES	17	0	1	1
REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS	4	0	1	1
REACTOME_THYROXINE_BIOSYNTHESIS	10	0	1	1
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	16	0	1	1
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS	5	0	1	1
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS	8	0	1	1
REACTOME_GENE_SILENCING_BY_RNA	128	0	1	1
REACTOME_VITAMINS	6	0	1	1
REACTOME_FATTY_ACIDS	15	0	1	1
REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	105	0	1	1
REACTOME_MISCELLANEOUS_SUBSTRATES	12	0	1	1
REACTOME_EICOSANOIDS	12	0	1	1
REACTOME_CYP2E1_REACTIONS	11	0	1	1
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	137	0	1	1
REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA	63	0	1	1
REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA	9	0	1	1
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	38	0	1	1
REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET	8	0	1	1
REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS	9	0	1	1
REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX	21	0	1	1
REACTOME_SYNTHESIS_OF_LIPOXINS_LX	6	0	1	1
REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES	7	0	1	1
REACTOME_ARACHIDONIC_ACID_METABOLISM	59	0	1	1
REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES	6	0	1	1
REACTOME_UBIQUINOL_BIOSYNTHESIS	8	0	1	1
REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE	9	0	1	1
REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT	5	0	1	1
REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	55	0	1	1
REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION	10	0	1	1
REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT	5	0	1	1
REACTOME_ABACAVIR_METABOLISM	5	0	1	1
REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX	15	0	1	1
REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	13	0	1	1
REACTOME_DAP12_INTERACTIONS	40	0	1	1
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	42	0	1	1
REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN	9	0	1	1
REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION	7	0	1	1
REACTOME_VISUAL_PHOTOTRANSDUCTION	100	0	1	1
REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	12	0	1	1
REACTOME_MUCOPOLYSACCHARIDOSES	11	0	1	1
REACTOME_ANCHORING_FIBRIL_FORMATION	15	0	1	1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER	101	0	1	1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER	75	0	1	1
REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	18	0	1	1
REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES	64	0	1	1
REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS	7	0	1	1
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R	54	0	1	1
REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE	8	0	1	1
REACTOME_SELENOAMINO_ACID_METABOLISM	117	0	1	1
REACTOME_DAP12_SIGNALING	29	0	1	1
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	42	0	1	1
REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R	9	0	1	1
REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION	23	0	1	1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	131	0	1	1
REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION	10	0	1	1
REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION	11	0	1	1
REACTOME_COHESIN_LOADING_ONTO_CHROMATIN	10	0	1	1
REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE	11	0	1	1
REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION	124	0	1	1
REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES	11	0	1	1
REACTOME_THE_PHOTOTRANSDUCTION_CASCADE	34	0	1	1
REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA	11	0	1	1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE	232	0	1	1
REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	115	0	1	1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP	101	0	1	1
REACTOME_CELLULAR_SENESCENCE	186	0	1	1
REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF	17	0	1	1
REACTOME_ONCOGENE_INDUCED_SENESCENCE	35	0	1	1
REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE	72	0	1	1
REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH	9	0	1	1
REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY	13	0	1	1
REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION	86	0	1	1
REACTOME_SIGNALING_BY_LEPTIN	11	0	1	1
REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER	5	0	1	1
REACTOME_INSULIN_PROCESSING	27	0	1	1
REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT	7	0	1	1
REACTOME_STIMULI_SENSING_CHANNELS	106	0	1	1
REACTOME_EPH_EPHRIN_SIGNALING	92	0	1	1
REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER	15	0	1	1
REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	16	0	1	1
REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE	5	0	1	1
REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	32	0	1	1
REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	31	0	1	1
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	81	0	1	1
REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION	10	0	1	1
REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION	13	0	1	1
REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS	22	0	1	1
REACTOME_PEPTIDE_HORMONE_METABOLISM	90	0	1	1
REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	53	0	1	1
REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7	7	0	1	1
REACTOME_SUMOYLATION	184	0	1	1
REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY	73	0	1	1
REACTOME_LAMININ_INTERACTIONS	30	0	1	1
REACTOME_SYNDECAN_INTERACTIONS	27	0	1	1
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	59	0	1	1
REACTOME_ECM_PROTEOGLYCANS	76	0	1	1
REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS	6	0	1	1
REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS	19	0	1	1
REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS	6	0	1	1
REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1	5	0	1	1
REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9	7	0	1	1
REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED	6	0	1	1
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	77	0	1	1
REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION	7	0	1	1
REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	5	0	1	1
REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA	15	0	1	1
REACTOME_HDACS_DEACETYLATE_HISTONES	85	0	1	1
REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES	66	0	1	1
REACTOME_HDMS_DEMETHYLATE_HISTONES	46	0	1	1
REACTOME_HATS_ACETYLATE_HISTONES	133	0	1	1
REACTOME_RMTS_METHYLATE_HISTONE_ARGININES	75	0	1	1
REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO	10	0	1	1
REACTOME_GLYCOGEN_STORAGE_DISEASES	16	0	1	1
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS	20	0	1	1
REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	39	0	1	1
REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING	26	0	1	1
REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN	13	0	1	1
REACTOME_TRP_CHANNELS	28	0	1	1
REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM	14	0	1	1
REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM	22	0	1	1
REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES	37	0	1	1
REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	36	0	1	1
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER	8	0	1	1
REACTOME_GLYCOGEN_SYNTHESIS	16	0	1	1
REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM	8	0	1	1
REACTOME_REGULATION_BY_C_FLIP	11	0	1	1
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	82	0	1	1
REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR	55	0	1	1
REACTOME_HSF1_ACTIVATION	31	0	1	1
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	101	0	1	1
REACTOME_ATTENUATION_PHASE	28	0	1	1
REACTOME_HSF1_DEPENDENT_TRANSACTIVATION	38	0	1	1
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	15	0	1	1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM	41	0	1	1
REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE	20	0	1	1
REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD	8	0	1	1
REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE	8	0	1	1
REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS	8	0	1	1
REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1	8	0	1	1
REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2	14	0	1	1
REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15	8	0	1	1
REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D	8	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53	360	0	0.999999999999999	1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	330	0	1	1
REACTOME_NETRIN_1_SIGNALING	50	0	1	1
REACTOME_NEPHRIN_FAMILY_INTERACTIONS	23	0	1	1
REACTOME_SIGNALING_BY_ROBO_RECEPTORS	217	0	1	1
REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX	42	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS	15	0	1	1
REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS	17	0	1	1
REACTOME_DISEASES_OF_GLYCOSYLATION	140	0	1	1
REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA	9	0	1	1
REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS	5	0	1	1
REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	27	0	1	1
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES	12	0	1	1
REACTOME_PERK_REGULATES_GENE_EXPRESSION	32	0	1	1
REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES	50	0	1	1
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR	92	0	1	1
REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES	10	0	1	1
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	123	0	1	1
REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	42	0	1	1
REACTOME_TRANSPORT_OF_SMALL_MOLECULES	725	0	1	1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING	146	0	1	1
REACTOME_VASOPRESSIN_LIKE_RECEPTORS	6	0	1	1
REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	20	0	1	1
REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS	8	0	1	1
REACTOME_ALPHA_OXIDATION_OF_PHYTANATE	6	0	1	1
REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION	31	0	1	1
REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA	9	0	1	1
REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	43	0	1	1
REACTOME_PD_1_SIGNALING	21	0	1	1
REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING	32	0	1	1
REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS	11	0	1	1
REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC	10	0	1	1
REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS	5	0	1	1
REACTOME_DOPAMINE_RECEPTORS	5	0	1	1
REACTOME_ADRENOCEPTORS	9	0	1	1
REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	65	0	1	1
REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS	16	0	1	1
REACTOME_LEUKOTRIENE_RECEPTORS	5	0	1	1
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12	22	0	1	1
REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING	42	0	1	1
REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE	29	0	1	1
REACTOME_EPHRIN_SIGNALING	19	0	1	1
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	51	0	1	1
REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION	10	0	1	1
REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION	28	0	1	1
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	119	0	1	1
REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION	11	0	1	1
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP	13	0	1	1
REACTOME_SIALIC_ACID_METABOLISM	33	0	1	1
REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	35	0	1	1
REACTOME_CA2_PATHWAY	62	0	1	1
REACTOME_PCP_CE_PATHWAY	92	0	1	1
REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS	30	0	1	1
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	76	0	1	1
REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION	8	0	1	1
REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	12	0	1	1
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1	25	0	1	1
REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS	8	0	1	1
REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND	10	0	1	1
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING	10	0	1	1
REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS	14	0	1	1
REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS	10	0	1	1
REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION	7	0	1	1
REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	86	0	1	1
REACTOME_BICARBONATE_TRANSPORTERS	10	0	1	1
REACTOME_SODIUM_CALCIUM_EXCHANGERS	11	0	1	1
REACTOME_SODIUM_PROTON_EXCHANGERS	9	0	1	1
REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG	5	0	1	1
REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	7	0	1	1
REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	9	0	1	1
REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION	58	0	1	1
REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION	66	0	1	1
REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS	9	0	1	1
REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS	5	0	1	1
REACTOME_ACTIVATION_OF_RAC1	13	0	1	1
REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO	10	0	1	1
REACTOME_INACTIVATION_OF_CDC42_AND_RAC1	7	0	1	1
REACTOME_ORGANIC_ANION_TRANSPORTERS	10	0	1	1
REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING	8	0	1	1
REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING	12	0	1	1
REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	43	0	1	1
REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS	5	0	1	1
REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT	6	0	1	1
REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION	8	0	1	1
REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY	7	0	1	1
REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION	21	0	1	1
REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS	8	0	1	1
REACTOME_DEPOLYMERISATION_OF_THE_NUCLEAR_LAMINA	15	0	1	1
REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY	10	0	1	1
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	19	0	1	1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE	12	0	1	1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE	8	0	1	1
REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING	28	0	1	1
REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	92	0	1	1
REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR	20	0	1	1
REACTOME_FREE_FATTY_ACID_RECEPTORS	5	0	1	1
REACTOME_RSK_ACTIVATION	7	0	1	1
REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	8	0	1	1
REACTOME_RELAXIN_RECEPTORS	8	0	1	1
REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY	11	0	1	1
REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE	6	0	1	1
REACTOME_SYNTHESIS_OF_GDP_MANNOSE	5	0	1	1
REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE	8	0	1	1
REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS	8	0	1	1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING	139	0	1	1
REACTOME_NRCAM_INTERACTIONS	7	0	1	1
REACTOME_CHL1_INTERACTIONS	9	0	1	1
REACTOME_NEUROFASCIN_INTERACTIONS	7	0	1	1
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING	56	0	1	1
REACTOME_INTERLEUKIN_17_SIGNALING	71	0	1	1
REACTOME_INTERLEUKIN_1_PROCESSING	8	0	1	1
REACTOME_SIGNALING_BY_INTERLEUKINS	452	0	1	1
REACTOME_OTHER_INTERLEUKIN_SIGNALING	24	0	1	1
REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	10	0	1	1
REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA	17	0	1	1
REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA	55	0	1	1
REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA	17	0	1	1
REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA	8	0	1	1
REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA	17	0	1	1
REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING	41	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS	31	0	1	1
REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	68	0	1	1
REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	47	0	1	1
REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS	64	0	1	1
REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	46	0	1	1
REACTOME_DEGRADATION_OF_AXIN	55	0	1	1
REACTOME_DEGRADATION_OF_DVL	57	0	1	1
REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	31	0	1	1
REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	21	0	1	1
REACTOME_REPRESSION_OF_WNT_TARGET_GENES	14	0	1	1
REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS	16	0	1	1
REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS	11	0	1	1
REACTOME_SIGNALING_BY_WNT_IN_CANCER	34	0	1	1
REACTOME_PHOSPHORYLATION_SITE_MUTANTS_OF_CTNNB1_ARE_NOT_TARGETED_TO_THE_PROTEASOME_BY_THE_DESTRUCTION_COMPLEX	15	0	1	1
REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	28	0	1	1
REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS	21	0	1	1
REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC	14	0	1	1
REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3	5	0	1	1
REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TN_POLYAGGLUTINATION_SYNDROME_TNPS	15	0	1	1
REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4	15	0	1	1
REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING	46	0	1	1
REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2	13	0	1	1
REACTOME_O_LINKED_GLYCOSYLATION	108	0	1	1
REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	39	0	1	1
REACTOME_MITOPHAGY	29	0	1	1
REACTOME_PINK_PARKIN_MEDIATED_MITOPHAGY	22	0	1	1
REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS	11	0	1	1
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	27	0	1	1
REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION	19	0	1	1
REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS	26	0	1	1
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	96	0	1	1
REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	98	0	1	1
REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BONT_D	5	0	1	1
REACTOME_DISEASES_OF_IMMUNE_SYSTEM	24	0	1	1
REACTOME_DNA_METHYLATION	55	0	1	1
REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN	6	0	1	1
REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS	29	0	1	1
REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING	6	0	1	1
REACTOME_RNF_MUTANTS_SHOW_ENHANCED_WNT_SIGNALING_AND_PROLIFERATION	8	0	1	1
REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY	26	0	1	1
REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING	13	0	1	1
REACTOME_PROGRAMMED_CELL_DEATH	180	0	1	1
REACTOME_REGULATION_OF_TNFR1_SIGNALING	33	0	1	1
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY	30	0	1	1
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS	65	0	1	1
REACTOME_SIGNALING_BY_HEDGEHOG	149	0	1	1
REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2	8	0	1	1
REACTOME_MISMATCH_REPAIR	15	0	1	1
REACTOME_SIGNALING_BY_RETINOIC_ACID	43	0	1	1
REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL	8	0	1	1
REACTOME_RA_BIOSYNTHESIS_PATHWAY	22	0	1	1
REACTOME_MITOCHONDRIAL_TRANSLATION	94	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS	5	0	1	1
REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR	5	0	1	1
REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION	19	0	1	1
REACTOME_ORGANIC_CATION_TRANSPORT	10	0	1	1
REACTOME_METABOLISM_OF_LIPIDS	735	0	1	1
REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL	19	0	1	1
REACTOME_PHASE_3_RAPID_REPOLARISATION	8	0	1	1
REACTOME_CARDIAC_CONDUCTION	137	0	1	1
REACTOME_PHASE_0_RAPID_DEPOLARISATION	42	0	1	1
REACTOME_PHASE_2_PLATEAU_PHASE	25	0	1	1
REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS	7	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	97	0	1	1
REACTOME_PHYSIOLOGICAL_FACTORS	12	0	1	1
REACTOME_ION_HOMEOSTASIS	54	0	1	1
REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES	36	0	1	1
REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS	29	0	1	1
REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID	7	0	1	1
REACTOME_IRAK4_DEFICIENCY_TLR2_4	11	0	1	1
REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING	62	0	1	1
REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION	11	0	1	1
REACTOME_CLEC7A_DECTIN_1_SIGNALING	100	0	1	1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS	18	0	1	1
REACTOME_ORGANIC_ANION_TRANSPORT	5	0	1	1
REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME	60	0	1	1
REACTOME_HEDGEHOG_OFF_STATE	112	0	1	1
REACTOME_CILIUM_ASSEMBLY	200	0	1	1
REACTOME_ABC_TRANSPORTER_DISORDERS	77	0	1	1
REACTOME_SLC_TRANSPORTER_DISORDERS	99	0	1	1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS	176	0	1	1
REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE	96	0	1	1
REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM	21	0	1	1
REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE	51	0	1	1
REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM	23	0	1	1
REACTOME_INTRAFLAGELLAR_TRANSPORT	53	0	1	1
REACTOME_DECTIN_2_FAMILY	23	0	1	1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	137	0	1	1
REACTOME_CD209_DC_SIGN_SIGNALING	21	0	1	1
REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM	5	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_PKNS	84	0	1	1
REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3	57	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_CIT	19	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_KTN1	11	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS	30	0	1	1
REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION	6	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_ROCKS	19	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_PAKS	21	0	1	1
REACTOME_TP53_REGULATES_METABOLIC_GENES	83	0	1	1
REACTOME_LIGAND_RECEPTOR_INTERACTIONS	8	0	1	1
REACTOME_HEDGEHOG_ON_STATE	86	0	1	1
REACTOME_REGULATION_OF_TP53_ACTIVITY	160	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES	44	0	1	1
REACTOME_ACTIVATION_OF_SMO	18	0	1	1
REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION	7	0	1	1
REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY	7	0	1	1
REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR	21	0	1	1
REACTOME_FRUCTOSE_METABOLISM	7	0	1	1
REACTOME_VESICLE_MEDIATED_TRANSPORT	664	0	1	1
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2	18	0	1	1
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4	15	0	1	1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1	31	0	1	1
REACTOME_SHC_MEDIATED_CASCADE_FGFR1	21	0	1	1
REACTOME_PI_3K_CASCADE_FGFR1	21	0	1	1
REACTOME_FRS_MEDIATED_FGFR1_SIGNALING	23	0	1	1
REACTOME_PI_3K_CASCADE_FGFR2	23	0	1	1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2	30	0	1	1
REACTOME_FRS_MEDIATED_FGFR2_SIGNALING	25	0	1	1
REACTOME_SHC_MEDIATED_CASCADE_FGFR3	18	0	1	1
REACTOME_FRS_MEDIATED_FGFR3_SIGNALING	20	0	1	1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3	25	0	1	1
REACTOME_PI_3K_CASCADE_FGFR3	18	0	1	1
REACTOME_FRS_MEDIATED_FGFR4_SIGNALING	22	0	1	1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4	27	0	1	1
REACTOME_SHC_MEDIATED_CASCADE_FGFR4	20	0	1	1
REACTOME_PI_3K_CASCADE_FGFR4	20	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING	33	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING	34	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	29	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING	31	0	1	1
REACTOME_SIGNALING_BY_FGFR1	50	0	1	1
REACTOME_SIGNALING_BY_FGFR2	73	0	1	1
REACTOME_SIGNALING_BY_FGFR3	40	0	1	1
REACTOME_SIGNALING_BY_FGFR4	41	0	1	1
REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE	43	0	1	1
REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE	11	0	1	1
REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE	38	0	1	1
REACTOME_TRANSLESION_SYNTHESIS_BY_POLK	17	0	1	1
REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS	32	0	1	1
REACTOME_REGULATION_OF_RAS_BY_GAPS	68	0	1	1
REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING	13	0	1	1
REACTOME_RESPONSE_TO_METAL_IONS	14	0	1	1
REACTOME_CLEC7A_INFLAMMASOME_PATHWAY	6	0	1	1
REACTOME_METALLOTHIONEINS_BIND_METALS	11	0	1	1
REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE	5	0	1	1
REACTOME_MELANIN_BIOSYNTHESIS	5	0	1	1
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM	33	0	1	1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	373	0	1	1
REACTOME_INFECTIOUS_DISEASE	733	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES	36	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS	138	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS	9	0	1	1
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY	100	0	1	1
REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	24	0	1	1
REACTOME_DISEASES_OF_METABOLISM	241	0	1	1
REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS	28	0	1	1
REACTOME_RAF_ACTIVATION	30	0	1	1
REACTOME_MAP2K_AND_MAPK_ACTIVATION	40	0	1	1
REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER	25	0	1	1
REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY	6	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	40	0	1	1
REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY	17	0	1	1
REACTOME_PROTEIN_REPAIR	6	0	1	1
REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS	61	0	1	1
REACTOME_LGI_ADAM_INTERACTIONS	14	0	1	1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	294	0	1	1
REACTOME_SURFACTANT_METABOLISM	29	0	1	1
REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION	16	0	1	1
REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA	37	0	1	1
REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ	10	0	1	1
REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	67	0	1	1
REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND	19	0	1	1
REACTOME_MAPK6_MAPK4_SIGNALING	93	0	1	1
REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM	9	0	1	1
REACTOME_DEUBIQUITINATION	270	0	1	1
REACTOME_DEFECTIVE_CSF2RB_CAUSES_PULMONARY_SURFACTANT_METABOLISM_DYSFUNCTION_5_SMDP5	7	0	1	1
REACTOME_UCH_PROTEINASES	102	0	1	1
REACTOME_JOSEPHIN_DOMAIN_DUBS	12	0	1	1
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	193	0	1	1
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES	38	0	1	1
REACTOME_METALLOPROTEASE_DUBS	37	0	1	1
REACTOME_CD22_MEDIATED_BCR_REGULATION	5	0	1	1
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR	158	0	1	1
REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	34	0	1	1
REACTOME_HOMOLOGY_DIRECTED_REPAIR	130	0	1	1
REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS	6	0	1	1
REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA	26	0	1	1
REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ	61	0	1	1
REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE	42	0	1	1
REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE	69	0	1	1
REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS	90	0	1	1
REACTOME_CARGO_CONCENTRATION_IN_THE_ER	33	0	1	1
REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER	38	0	1	1
REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER	25	0	1	1
REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER	83	0	1	1
REACTOME_DUAL_INCISION_IN_GG_NER	40	0	1	1
REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS	7	0	1	1
REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	9	0	1	1
REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX	52	0	1	1
REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER	77	0	1	1
REACTOME_DUAL_INCISION_IN_TC_NER	64	0	1	1
REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL	43	0	1	1
REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE	6	0	1	1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING	24	0	1	1
REACTOME_INTERLEUKIN_10_SIGNALING	46	0	1	1
REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS	59	0	1	1
REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION	5	0	1	1
REACTOME_ERBB2_REGULATES_CELL_MOTILITY	14	0	1	1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING	108	0	1	1
REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION	9	0	1	1
REACTOME_GDP_FUCOSE_BIOSYNTHESIS	6	0	1	1
REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS	17	0	1	1
REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL	60	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES	49	0	1	1
REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION	6	0	1	1
REACTOME_NEUREXINS_AND_NEUROLIGINS	56	0	1	1
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	87	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES	63	0	1	1
REACTOME_CHOLINE_CATABOLISM	6	0	1	1
REACTOME_NEUTROPHIL_DEGRANULATION	475	0	1	1
REACTOME_COMPLEX_I_BIOGENESIS	49	0	1	1
REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS	6	0	1	1
REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS	45	0	1	1
REACTOME_ONCOGENIC_MAPK_SIGNALING	72	0	1	1
REACTOME_ANTIMICROBIAL_PEPTIDES	90	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE	20	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN	14	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES	12	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS	12	0	1	1
REACTOME_FGFR2_ALTERNATIVE_SPLICING	27	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST	18	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN	21	0	1	1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST	14	0	1	1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION	92	0	1	1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	30	0	1	1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS	14	0	1	1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION	19	0	1	1
REACTOME_KERATINIZATION	206	0	1	1
REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION	37	0	1	1
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS	48	0	1	1
REACTOME_SIGNALING_BY_MET	79	0	1	1
REACTOME_MET_RECEPTOR_ACTIVATION	6	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY	21	0	1	1
REACTOME_PTEN_REGULATION	139	0	1	1
REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES	77	0	1	1
REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT	100	0	1	1
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	126	0	1	1
REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	98	0	1	1
REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	51	0	1	1
REACTOME_INTRA_GOLGI_TRAFFIC	44	0	1	1
REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK	49	0	1	1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC	201	0	1	1
REACTOME_PI5P_REGULATES_TP53_ACETYLATION	9	0	1	1
REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING	42	0	1	1
REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM	7	0	1	1
REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION	6	0	1	1
REACTOME_MITOTIC_PROPHASE	133	0	1	1
REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS	13	0	1	1
REACTOME_M_PHASE	403	0	1	1
REACTOME_G2_PHASE	5	0	1	1
REACTOME_DNA_REPLICATION_INITIATION	8	0	1	1
REACTOME_DNA_REPLICATION_PRE_INITIATION	85	0	1	1
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE	90	0	1	1
REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	24	0	1	1
REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT	5	0	1	1
REACTOME_STABILIZATION_OF_P53	57	0	1	1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS	68	0	1	1
REACTOME_MITOTIC_SPINDLE_CHECKPOINT	110	0	1	1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	85	0	1	1
REACTOME_FRUCTOSE_CATABOLISM	5	0	1	1
REACTOME_GALACTOSE_CATABOLISM	5	0	1	1
REACTOME_UREA_CYCLE	10	0	1	1
REACTOME_HISTIDINE_CATABOLISM	8	0	1	1
REACTOME_PROPIONYL_COA_CATABOLISM	5	0	1	1
REACTOME_LYSINE_CATABOLISM	12	0	1	1
REACTOME_CREATINE_METABOLISM	11	0	1	1
REACTOME_PENTOSE_PHOSPHATE_PATHWAY	14	0	1	1
REACTOME_MRNA_EDITING_C_TO_U_CONVERSION	8	0	1	1
REACTOME_TRNA_PROCESSING	109	0	1	1
REACTOME_RRNA_PROCESSING	203	0	1	1
REACTOME_EUKARYOTIC_TRANSLATION_INITIATION	120	0	1	1
REACTOME_RECYCLING_OF_EIF2_GDP	8	0	1	1
REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS	9	0	1	1
REACTOME_PYRIMIDINE_SALVAGE	11	0	1	1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	46	0	1	1
REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE	80	0	1	1
REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION	18	0	1	1
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	66	0	1	1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION	30	0	1	1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION	100	0	1	1
REACTOME_DEATH_RECEPTOR_SIGNALLING	137	0	1	1
REACTOME_DNA_DAMAGE_BYPASS	48	0	1	1
REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION	55	0	1	1
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	38	0	1	1
REACTOME_DNA_DAMAGE_REVERSAL	8	0	1	1
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION	23	0	1	1
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION	41	0	1	1
REACTOME_KETONE_BODY_METABOLISM	10	0	1	1
REACTOME_IRS_ACTIVATION	5	0	1	1
REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX	13	0	1	1
REACTOME_MRNA_EDITING	10	0	1	1
REACTOME_FASL_CD95L_SIGNALING	5	0	1	1
REACTOME_TRAIL_SIGNALING	8	0	1	1
REACTOME_DISSOLUTION_OF_FIBRIN_CLOT	13	0	1	1
REACTOME_TNF_SIGNALING	43	0	1	1
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER	28	0	1	1
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	28	0	1	1
REACTOME_SYNTHESIS_OF_KETONE_BODIES	8	0	1	1
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS	11	0	1	1
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS	6	0	1	1
REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA	5	0	1	1
REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA	6	0	1	1
REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA	5	0	1	1
REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA	5	0	1	1
REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA	5	0	1	1
REACTOME_TRANSPORT_OF_FATTY_ACIDS	8	0	1	1
REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE	11	0	1	1
REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	13	0	1	1
REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS	7	0	1	1
REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING	5	0	1	1
REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1	9	0	1	1
REACTOME_PTK6_REGULATES_CELL_CYCLE	6	0	1	1
REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES	14	0	1	1
REACTOME_PTK6_EXPRESSION	5	0	1	1
REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	21	0	1	1
REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS	8	1	0.00261807835165562	1
REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS	12	0	1	1
REACTOME_SIGNALING_BY_FGFR2_IIIA_TM	19	0	1	1
REACTOME_MET_ACTIVATES_RAS_SIGNALING	11	0	1	1
REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING	6	0	1	1
REACTOME_PROTEIN_UBIQUITINATION	74	0	1	1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT	77	0	1	1
REACTOME_SIGNALING_BY_MST1	5	0	1	1
REACTOME_SIGNALING_BY_FGFR3_FUSIONS_IN_CANCER	10	0	1	1
REACTOME_RET_SIGNALING	40	0	1	1
REACTOME_TBC_RABGAPS	43	0	1	1
REACTOME_AURKA_ACTIVATION_BY_TPX2	71	0	1	1
REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING	26	0	1	1
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT	132	0	1	1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS	104	0	1	1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS	144	0	1	1
REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION	6	0	1	1
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	29	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS	38	0	1	1
REACTOME_MET_ACTIVATES_PTPN11	5	0	1	1
REACTOME_REELIN_SIGNALLING_PATHWAY	5	0	1	1
REACTOME_VLDL_ASSEMBLY	5	0	1	1
REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION	12	0	1	1
REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES	30	0	1	1
REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS	54	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS	10	0	1	1
REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	12	0	1	1
REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS	15	0	1	1
REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS	5	0	1	1
REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION	10	0	1	1
REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION	5	0	1	1
REACTOME_RAB_GERANYLGERANYLATION	63	0	1	1
REACTOME_MET_ACTIVATES_PTK2_SIGNALING	30	0	1	1
REACTOME_CREB3_FACTORS_ACTIVATE_GENES	9	0	1	1
REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL	15	0	1	1
REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS	5	0	1	1
REACTOME_MET_ACTIVATES_RAP1_AND_RAC1	11	0	1	1
REACTOME_MET_RECEPTOR_RECYCLING	10	0	1	1
REACTOME_MET_PROMOTES_CELL_MOTILITY	41	0	1	1
REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS	89	0	1	1
REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS	20	0	1	1
REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS	9	0	1	1
REACTOME_PROTEIN_METHYLATION	17	0	1	1
REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS	10	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	96	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2	120	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	228	0	1	1
REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION	6	0	1	1
REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY	17	0	1	1
REACTOME_RECEPTOR_MEDIATED_MITOPHAGY	11	0	1	1
REACTOME_DIGESTION	22	0	1	1
REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS	5	0	1	1
REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION	87	0	1	1
REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING	7	0	1	1
REACTOME_ESR_MEDIATED_SIGNALING	211	0	1	1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS	120	0	1	1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES	8	0	1	1
REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	37	0	1	1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING	6	0	1	1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS	7	0	1	1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING	5	0	1	1
REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING	6	0	1	1
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY	73	0	1	1
REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION	24	0	1	1
REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION	5	0	1	1
REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT	31	0	1	1
REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION	8	0	1	1
REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION	7	0	1	1
REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	14	0	1	1
REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY	55	0	1	1
REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	9	0	1	1
REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION	61	0	1	1
REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	44	0	1	1
REACTOME_COMPETING_ENDOGENOUS_RNAS_CERNAS_REGULATE_PTEN_TRANSLATION	8	0	1	1
REACTOME_REGULATION_OF_PTEN_LOCALIZATION	9	0	1	1
REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY	69	0	1	1
REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT	22	0	1	1
REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION	6	0	1	1
REACTOME_CRISTAE_FORMATION	29	0	1	1
REACTOME_PROCESSING_OF_SMDT1	15	0	1	1
REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION	38	0	1	1
REACTOME_RUNX3_REGULATES_WNT_SIGNALING	8	0	1	1
REACTOME_NEDDYLATION	233	0	1	1
REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION	8	0	1	1
REACTOME_RUNX3_REGULATES_P14_ARF	10	0	1	1
REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION	5	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6	34	0	1	1
REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI	599	0	1	1
REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN	41	0	1	1
REACTOME_NUCLEOBASE_CATABOLISM	36	1	0.0103111268259252	1
REACTOME_NUCLEOBASE_BIOSYNTHESIS	15	0	1	1
REACTOME_NUCLEOTIDE_SALVAGE	23	0	1	1
REACTOME_METABOLISM_OF_STEROIDS	151	0	1	1
REACTOME_INTESTINAL_ABSORPTION	5	0	1	1
REACTOME_TYROSINE_CATABOLISM	5	0	1	1
REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM	11	0	1	1
REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM	11	0	1	1
REACTOME_DIGESTION_AND_ABSORPTION	27	0	1	1
REACTOME_CHYLOMICRON_ASSEMBLY	10	0	1	1
REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES	18	0	1	1
REACTOME_HDL_ASSEMBLY	8	0	1	1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	19	0	1	1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING	31	0	1	1
REACTOME_CHYLOMICRON_REMODELING	10	0	1	1
REACTOME_HDL_CLEARANCE	5	0	1	1
REACTOME_CHYLOMICRON_CLEARANCE	5	0	1	1
REACTOME_LDL_CLEARANCE	19	0	1	1
REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE	33	0	1	1
REACTOME_VLDL_CLEARANCE	6	0	1	1
REACTOME_HDL_REMODELING	10	0	1	1
REACTOME_PHENYLALANINE_METABOLISM	6	0	1	1
REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM	14	0	1	1
REACTOME_LIPID_PARTICLE_ORGANIZATION	6	0	1	1
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42	20	0	1	1
REACTOME_FATTY_ACID_METABOLISM	176	0	1	1
REACTOME_METABOLISM_OF_COFACTORS	19	0	1	1
REACTOME_TRIGLYCERIDE_METABOLISM	38	0	1	1
REACTOME_GLYCOGEN_METABOLISM	27	0	1	1
REACTOME_INTERLEUKIN_15_SIGNALING	14	0	1	1
REACTOME_OAS_ANTIVIRAL_RESPONSE	9	0	1	1
REACTOME_INTERLEUKIN_35_SIGNALLING	12	0	1	1
REACTOME_INTERLEUKIN_9_SIGNALING	8	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2	63	0	1	1
REACTOME_SIGNALING_BY_NTRK2_TRKB	25	0	1	1
REACTOME_SIGNALING_BY_ERYTHROPOIETIN	25	0	1	1
REACTOME_INTEGRIN_SIGNALING	27	0	1	1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	303	0	1	1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	287	0	1	1
REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	503	0	1	1
REACTOME_SIGNALING_BY_TGF_BETA_FAMILY_MEMBERS	102	0	1	1
REACTOME_RAB_REGULATION_OF_TRAFFICKING	121	0	1	1
REACTOME_INTERLEUKIN_37_SIGNALING	21	0	1	1
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING	75	0	1	1
REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC	21	0	1	1
REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS	172	0	1	1
REACTOME_ROBO_RECEPTORS_BIND_AKAP5	9	0	1	1
REACTOME_INTERLEUKIN_18_SIGNALING	8	0	1	1
REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS	25	0	1	1
REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	25	0	1	1
REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	20	0	1	1
REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS	11	0	1	1
REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH	6	0	1	1
REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7	12	0	1	1
REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX	11	0	1	1
REACTOME_INTERLEUKIN_36_PATHWAY	7	0	1	1
REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3	8	0	1	1
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	140	0	1	1
REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS	19	0	1	1
REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS	6	0	1	1
REACTOME_BIOSYNTHESIS_OF_MARESINS	8	0	1	1
REACTOME_INTERLEUKIN_2_SIGNALING	12	0	1	1
REACTOME_INTERLEUKIN_12_SIGNALING	46	0	1	1
REACTOME_INTERLEUKIN_1_SIGNALING	102	0	1	1
REACTOME_INTERLEUKIN_23_SIGNALING	9	0	1	1
REACTOME_INTERLEUKIN_27_SIGNALING	11	0	1	1
REACTOME_INTERLEUKIN_21_SIGNALING	10	0	1	1
REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX	7	0	1	1
REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY	32	0	1	1
REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS	18	0	1	1
REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS	8	0	1	1
REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS	5	0	1	1
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS	9	0	1	1
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K	12	0	1	1
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG	7	0	1	1
REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5	7	0	1	1
REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS	14	0	1	1
REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS	6	0	1	1
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K	7	0	1	1
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3	11	0	1	1
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN	7	0	1	1
REACTOME_NTRK2_ACTIVATES_RAC1	5	0	1	1
REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5	6	0	1	1
REACTOME_PEROXISOMAL_PROTEIN_IMPORT	63	0	1	1
REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS	7	0	1	1
REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS	21	0	1	1
REACTOME_SIGNALING_BY_NTRK3_TRKC	17	0	1	1
REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS	8	0	1	1
REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING	25	0	1	1
REACTOME_NONSENSE_MEDIATED_DECAY_NMD	116	0	1	1
REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION	24	0	1	1
REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10	12	0	1	1
REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING	34	0	1	1
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	10	0	1	1
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX	16	0	1	1
REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS	6	0	1	1
REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K	6	0	1	1
REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT	20	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING	54	0	1	1
REACTOME_PROTEIN_LOCALIZATION	162	0	1	1
REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE	22	0	1	1
REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS	42	0	1	1
REACTOME_AUTOPHAGY	149	0	1	1
REACTOME_LIPOPHAGY	9	0	1	1
REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY	22	0	1	1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION	65	0	1	1
REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	11	0	1	1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	16	0	1	1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES	29	0	1	1
REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY	34	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS	80	0	1	1
REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION	21	0	1	1
REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	10	0	1	1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES	17	0	1	1
REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS	7	0	1	1
REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS	27	0	1	1
REACTOME_LONG_TERM_POTENTIATION	23	0	1	1
REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	12	0	1	1
REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ	6	0	1	1
REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING	24	0	1	1
REACTOME_STAT5_ACTIVATION	7	0	1	1
REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI	5	0	1	1
REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY	10	0	1	1
REACTOME_AMYLOID_FIBER_FORMATION	99	0	1	1
REACTOME_SERINE_BIOSYNTHESIS	9	0	1	1
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	30	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN	32	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN	10	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP	16	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN	11	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN	14	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP	17	0	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN	8	0	1	1
REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE	48	0	1	1
REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS	5	0	1	1
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER	26	0	1	1
REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN	13	0	1	1
REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION	94	0	1	1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE	97	0	1	1
REACTOME_HIV_TRANSCRIPTION_INITIATION	46	0	1	1
REACTOME_HIV_TRANSCRIPTION_ELONGATION	44	0	1	1
REACTOME_THE_FATTY_ACID_CYCLING_MODEL	5	0	1	1
REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE	84	0	1	1
REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	41	0	1	1
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	32	0	1	1
REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	86	0	1	1
REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE	17	0	1	1
REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION	7	0	1	1
REACTOME_SNRNP_ASSEMBLY	54	0	1	1
REACTOME_RETINOID_CYCLE_DISEASE_EVENTS	13	0	1	1
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS	188	0	1	1
REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	58	0	1	1
REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION	19	0	1	1
REACTOME_CHROMATIN_MODIFYING_ENZYMES	264	0	1	1
REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER	7	0	1	1
REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS	20	0	1	1
REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION	81	0	1	1
REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS	112	0	1	1
REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII	15	0	1	1
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	64	0	1	1
REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS	7	0	1	1
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1	43	0	1	1
REACTOME_SIGNALING_BY_PTK6	54	0	1	1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX	40	0	1	1
REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME	13	0	1	1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING	47	0	1	1
REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS	9	0	1	1
REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	37	0	1	1
REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE	5	0	1	1
REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE	5	0	1	1
REACTOME_NGF_STIMULATED_TRANSCRIPTION	39	0	1	1
REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR	5	0	1	1
REACTOME_FLT3_SIGNALING	263	0	1	1
REACTOME_HCMV_INFECTION	151	0	1	1
REACTOME_HCMV_EARLY_EVENTS	127	0	1	1
REACTOME_HCMV_LATE_EVENTS	107	0	1	1
REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION	27	0	1	1
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION	29	0	1	1
REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	9	0	1	1
REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS	5	0	1	1
REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY	102	0	1	1
REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2	11	0	1	1
REACTOME_SUPPRESSION_OF_APOPTOSIS	7	0	1	1
REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS	27	0	1	1
REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION	9	0	1	1
REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM	7	0	1	1
REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION	13	0	1	1
REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS	23	0	1	1
REACTOME_AMINO_ACIDS_REGULATE_MTORC1	55	0	1	1
REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY	11	0	1	1
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH	24	0	1	1
REACTOME_AGGREPHAGY	42	0	1	1
REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY	15	0	1	1
REACTOME_LEISHMANIA_INFECTION	249	0	1	1
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	133	0	1	1
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION	24	0	1	1
REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE	9	0	1	1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	166	0	1	1
REACTOME_SELECTIVE_AUTOPHAGY	80	0	1	1
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	38	0	1	1
REACTOME_PARASITE_INFECTION	59	0	1	1
REACTOME_KILLING_MECHANISMS	12	0	1	1
REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION	7	0	1	1
REACTOME_PEXOPHAGY	11	0	1	1
REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS	16	0	1	1
REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III	29	0	1	1
REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE	20	0	1	1
REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS	12	0	1	1
REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB	5	0	1	1
REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	577	0	1	1
REACTOME_DISEASES_OF_DNA_REPAIR	10	0	1	1
CASTELLANO_HRAS_TARGETS_UP	5	0	1	1
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN	5	0	1	1
BIERIE_INFLAMMATORY_RESPONSE_TGFB1	5	0	1	1
MALTA_CURATED_STEMNESS_MARKERS	21	0	1	1
